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The first part of this thesis aimed to examine the stability and validity of potential cognitive- 
electrophysiological biomarkers in Attention-Deficit/Hyperactivity Disorder (ADHD) in a large 
sample of adolescents and young adults. In part two, this thesis proceeded to a cross-disorder 
comparison with Bipolar Disorder (BD) in a novel sample of adult women, beginning by 
investigating symptom overlap between the two disorders and testing the efficacy of standard 
clinical instruments to delineate ADHD from euthymic BD. The next two chapters then went on 
to investigate the ability of cognitive-electrophysiological markers to delineate ADHD from BD 
in this cross-disorder sample, both through re-examining event-related potential (ERP) 
components which were investigated in part one, and by exploring additional ERP 
components. Presented herein are data which demonstrate that ADHD-control differences are 
sensitive to differences in experimental context, such as recording duration, as well as sample 
characteristics and certain methodological factors such as electrode selection. This research 
identified possible candidate biomarkers for both ADHD and BD; including two disorder-
specific cognitive-electrophysiological markers which dissociated ADHD from BD. A further 
comparison of symptoms of inattention, hyperactivity, mania, depression and emotional 
lability (EL) in ADHD and BD using typical diagnostic measures indicated that depression, mania 
and EL measures were not able to distinguish ADHD from euthymic BD. Conversely, ADHD 
measures had good discrimination potential, and may currently be the best available method 
of delineating ADHD from BD in clinical contexts. This thesis recommended further research to 
confirm if the potential cognitive-electrophysiological biomarkers highlighted here are reliable 
indicators for either ADHD or BD. Further work is also needed to clarify the effects of 
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Thesis outline  
 
This thesis is divided into two parts: part one consisting of two studies (SEFOS sample), and 
part two consisting of three further studies (FEBA sample). The content of each chapter is 
briefly described below: 
 
Chapter one provides the introduction to the thesis with an overview and methodological 
critique of relevant literature conducted to date concerning diagnostic boundaries, clinical 






Chapter two examines the stability of ADHD spectral EEG profiles in a large adolescent and 
young adult sample across two resting state recordings separated by 1.5 testing session. This 
study evaluates a number of methodological approaches in examining spectral EEG and 
attempts to quantify the effect of IQ differences on reported case-controls differences. 
 
Chapter three details an ERP study which aimed to confirm ADHD-associated deficits in a 
conflict monitoring task using ADHD, unaffected ADHD siblings and unaffected controls in a 
large sample of adolescents and young adults. This study also examines conflict monitoring 







Chapter four presents data from a cross-disorder comparison of symptoms in ADHD, BD and 
controls in an adult female sample, and examines the sensitivity and specificity of these 
measures to ADHD or BD. This chapter also describes the recruitment process for this sample 
and discusses how clinical assessments might be refined to better delineate ADHD and BD in 
clinical contexts. 
 
Chapter five reports a study which utilised the same paradigm as that reported in chapter two, 
but extended into the cross-disorder sample in order to compare ADHD and BD ERP responses 
on a conflict monitoring task. This chapter goes on to suggest possible sources of sample 
heterogeneity within these disorders. 
 
Chapter six presents data from a further ERP comparison between ADHD and BD in the cross-
disorder sample, examining potential attentional deficits in the Novelty Oddball Task. This 
chapter also explores fronto-central theta power in relation to ERP components and highlights 
potential candidates for future research. 
 
Chapter seven is the overall discussion, which summarises the findings presented in the 
preceding chapters, reviews the clinical implications of this research, discusses avenues for 





Distinct and original contributions 
 
A list of publications arising from this thesis is provided in Appendix 1. Chapter two represents 
a research article published in a scientific journal. Chapters three to six are adaptions from 
manuscripts currently in preparation. Work from this thesis has also generated four poster 
presentations at international conferences.  
 
This work represents an original contribution and advancement of knowledge in several areas 
of research, as summarised by the following: 
 
Chapter two explored changes in spectral resting state EEG across a recording session using 
data recorded at two separate time points recorded 1.5 hours apart in a large sample of over 
160 participants. This time-sensitive approach is rare in EEG ADHD research, and therefore 
represents valuable new data. 
 
Chapter two also evaluated the effect of using different methodological approaches, such as 
electrode selection or controlling for IQ on ADHD-control spectral profile differences, which 
has not previously been undertaking in a consistent manner in other research. 
 
Chapter three investigated the ERP correlates of performance monitoring deficits in ADHD, 
unaffected sibling and unrelated controls in a combined sample of over 370 participants 




Chapter three attempted to replicate in a large sample findings from two smaller studies 
which suggested that conflict monitoring deficits represent an endophenotype for ADHD. 
 
Chapter four assessed ADHD and BD adults on a battery of common clinical ADHD and BD 
assessments, to identify symptom overlap and provide data on the potential for misdiagnosis 
between these two disorders. No other study has to date cross-compared ADHD and BD on 
such a large range of clinical measures. 
 
Chapters four, five and six report clinical, behavioural and cognitive-electrophysiological 
research data on a sample of adult women with ADHD, a group for which very limited data 
currently exists, as most previous research on ADHD has focused on males only. 
 
Chapters five and six report data from two cross-disorder cognitive-electrophysiological 
comparisons between ADHD and BD in a novel sample of adult participants; a currently 




Chapter 1 - An Introduction to the Search for 
Biomarkers in Attention‐Deficit/Hyperactivity 




1.1 Biomarkers for psychiatric illness 
 
Psychiatric illness is currently diagnosed based on behavioural observations and description of 
symptoms, which have been clustered into diagnostic categories, based on symptom patterns 
and co-occurrence. These diagnostic systems, the Diagnostic and Statistical Manual of Mental 
Disorders (American Psychiatric Association, 2013) and the Classification of Mental and 
Behavioural Disorders (World Health Organisation, 1992), are categorical in nature with illness 
definitions being added or refined over time as increasing knowledge around symptom 
patterns has emerged. These standard categorical frameworks have been important in 
providing mental health professionals with a consistent language to discuss psychiatric illness 
and have formed the cornerstone of diagnosis, treatment and psychiatric research since their 
introduction in the early 20th century. However, as they are based on categorical definitions, 
these frameworks have had to utilise standardised cut-offs between “normal” and “abnormal” 
classifications. This can mean that those with significant symptoms and/or impairments but 
not fully meeting criteria for a particular diagnosis are treated very differently from those who 
might only have marginally more severe symptoms but reach a clinical threshold (Morris and 
Cuthbert, 2012). Furthermore, many common symptoms overlap between diagnostic 
classifications, and as these criteria are reliant on changeable observations and self-report of 
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symptoms, there can sometimes be disagreement between clinicians as to diagnosis within the 
same individual (Freedman et al., 2013). There is also differing expressions of symptoms within 
diagnostic classifications, meaning phenotypes can be heterogeneous (Miller, 2010).  
 
 
Indeed, the growing body of psychiatric quantitative genetic literature have clarified that 
illness risk is likely to be conferred by a large number of genes, each contributing a very small 
effect to underlying neurophysiological anomalies (Smoller et al., 2013), or by extremely rare 
mutations which contribute larger effects (Malhotra and Sebat, 2012, Williams et al., 2012). 
This implies that there can be both shared and unique pathways to the same symptoms or 
neurophysiological deficits, making the task of identifying the biological causes of psychiatric 
disorders a challenging prospect. It has therefore been suggested that in order to advance our 
understanding of complex heterogeneous psychiatric illnesses, a new more adaptable research 
framework in needed, which integrates the increasing amounts of biological evidence from the 
fields of neuroscience and genetics. One such approach is the NIHR’s Research Domain Criteria 
(RDoC) (National Institute of Mental Health, 2014, Insel et al., 2010), which aims to link 
individual observable symptoms with abnormalities in underlying neurobiological systems. 
These approaches are data-driven, rather than being constrained by existing diagnostic 
boundaries, but argue that psychiatric illnesses may be considered as a cluster of greater or 
lesser deviations from normal functioning in multiple brain systems, such as those responsible 
for cognitive function, arousal or mood (Insel et al., 2010). The study of these biological 
markers, or “biomarkers”, which are objectively measured indicators of a biological state or 
condition (Biomarkers Definitions Working Group, 2001), may therefore also provide clarity 
relating to the boundaries and overlap between current categorical definitions of mental 
illness, further help us understand the aetiology of these disorders and suggest new avenues 
for the treatment and management of symptoms (Morris and Cuthbert, 2012). In this thesis, I 
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present several studies which have attempted to identify biomarkers and have examined 
symptom overlap in two potentially related disorders: Attention Deficit/Hyperactivity Disorder 
(ADHD) and Bipolar Disorder (BD); specifically to explore potential similarities and differences 
in underlying neurocognitive systems, and ultimately contribute to potential future 
developments of a biologically grounded framework for understanding mental disorders. 
 
 
1.2 Clinical expressions of ADHD and BD 
 
1.2.1 Clinical symptoms and epidemiology of ADHD 
 
DSM-IV (American Psychiatric Association, 2000) classification of ADHD, as used in this thesis,  
consists of nine inattention items, six hyperactivity items and three impulsivity items, grouped 
into inattention and hyperactivity-impulsivity subscales. A clinical diagnosis of ADHD requires 
the presence of six or more symptoms on at least one subscale, which are maladaptive and 
inconsistent with developmental level, for a period of at least six months. Symptoms must 
have caused some impairment before age seven, in at least two or more settings such as 
school and home, and must not occur exclusively as part of another disorder. Clear evidence of 
significant impairment in social, academic or occupational functioning must also be present. If 
scores of six symptoms are present on both subscales then a diagnosis of combined type ADHD 
is made, otherwise predominantly inattentive or predominantly hyperactive-impulsive 
diagnosis may be applied depending on symptom distribution.  However, these subtypes have 
been shown to be unstable in longitudinal follow-up, with 50% changing between subtypes 
(Valo and Tannock, 2010), and those with the hyperactive-impulsive subtype being particularly 
likely to shift to a combined type diagnosis (Lahey et al., 2005). This subtype instability may 
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therefore either represent a tendency for symptom range to broadening with age or, more 
likely, an inaccurate representation of the underlying disorder by existing diagnostic criteria.   
 
 
The recent update to the criteria with DSM-5 recognised subtypes as unstable by redefining 
them as ‘current presentations’ (American Psychiatric Association, 2013). However, the 
existing structure has been retained, with minor corrections including the requirement for 
symptoms to occur before age seven being increased to twelve. In addition, diagnosis of ADHD 
in adulthood has been acknowledged, adding adult specific examples to symptom items, and 
reducing symptom requirements to four symptoms on either subscale, as it has been 
recognised symptom severity declines with age (Biederman et al., 2000, Faraone et al., 2006). 
There are indications that these changes have increased prevalence rates across the whole age 
spectrum, and may also increase the heterogeneity of ADHD presentation (van de Glind et al., 
2014, Vande Voort et al., 2014). However, these broader criteria may arguably better 
represent the underlying phenotype.  
 
 
ADHD-type symptoms appear throughout the population at subclinical levels, so ADHD should 
be considered a continuous dimensional trait (Chen et al., 2008, Hudziak et al., 1998). 
Quantitative genetic investigations support the concept of ADHD diagnostic criteria as 
representing the extreme end of an continuum for inattention and hyperactive/impulsive 
symptoms, at which meaningful levels of impairment are likely to be present (Larsson et al., 
2012, Levy et al., 1997). Thus, although the epidemiology of ADHD is better explained as 
continuous trait, use of a categorical definition is justified when interested in clinically 
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significant expressions of the syndrome, such as when making treatment decisions (Haslam et 
al., 2006). 
Using DSM-IV criteria, the average childhood prevalence of an ADHD diagnosis is 5%, although 
reports of prevalence have ranged from 1%-20% (Polanczyk et al., 2007). In general, ADHD 
symptom severity, and therefore prevalence, declines with age in studies using DSM-IV criteria 
(Simon et al., 2009). ADHD has been reported to persist into adulthood in approximately 15% 
of childhood cases, with residual sub-clinical symptoms and impairments into adult life in an 
additional 50% of cases (Faraone et al., 2006). Estimates for adult prevalence range from 1% to 
6%  (Das et al., 2012, Kessler et al., 2006, Murphy and Barkley, 1996, Weiss et al., 1985, de 
Zwaan et al., 2012), averaging around 3-5% based on DSM-IV criteria (Faraone and Biederman, 
2005, Willcutt, 2012), which may now be higher under DSM-5 classifications which has a 
reduced requirement for the number of symptoms present (Vande Voort et al., 2014). 
Prevalence is highly sensitive to the diagnostic criteria used in defining the diagnosis, with 
DSM-III or ICD-10 definitions producing lower prevalence rates against DSM-IV criteria, which 
are lower again than those estimates created using DSM-5 criteria (Lee et al., 2008, Skounti et 
al., 2007, Vande Voort et al., 2014). This variability in classification of ADHD underlies the 
importance of identifying robust reliable biomarkers for the disorder. 
 
 
1.2.2 Gender difference in ADHD symptoms 
 
In community sampling of child and adult ADHD the ratio of males to females meeting DSM-IV 
clinical thresholds is placed at 1.6-2.3 : 1 (Ramtekkar et al., 2010, Scahill and Schwab-Stone, 
2000), although gender distributions of adults attending clinics are roughly equal, meaning 
that one possibility is that men may be less disposed to seek out psychiatric support (Retz-
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Junginger et al., 2012). Another alternative is that developmental differences in men and 
women alter gender prevalence ratios over time (Onnink et al., 2014), although the 
persistence of ADHD symptoms into early adulthood is equal in girls and boys (Biederman et 
al., 2004). However, other literature on symptom severity between genders is inconsistent. 
Some studies have suggested that women have greater severity of symptoms, impairments 
and increased levels of associated symptoms such as emotional lability and sleep disturbances, 
compared to men (Fedele et al., 2012, Robison et al., 2008). Yet other studies have observed 
increased primary symptoms in males compared to females (Gershon, 2002), or have 
concluded that there is little to suggest differences in the severity symptoms between adults 
males and females with ADHD (Rasmussen and Levander, 2009, Retz-Junginger et al., 2012, 
Wilens et al., 2009). This conclusion has been supported by large population-based studies of 
ADHD trait scores in which no gender differences in the rate of clinical-range ADHD symptoms 
have been reported (Das et al., 2012, de Zwaan et al., 2012). These inconsistences in published 
findings are likely to arise out of the limited amount of data available for adult female ADHD 
populations in relation to their male counterparts, both in terms of symptom patterns and 
potential neurocognitive investigations. 
 
 
1.2.3 Clinical symptoms and epidemiology of BD 
 
Bipolar Disorder (BD) is characterised by long-term extreme episodic fluctuations in mood 
from depression to elation or manic states (Miklowitz and Johnson, 2006, Treuer and Tohen, 
2010). The 5 year relapse rate of mania or depression episodes has been placed at 73% (Gitlin 
et al., 1995), with episodes typically lasting between 2 and 7 months (Angst and Sellaro, 2000). 
Manic states are periods of elevated mood, which can include symptoms of euphoria, rapid 
speech, grandiosity, a decreased need for sleep, elevated hedonic pursuit with a lack of 
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inhibition, distractibility and racing thoughts. Symptoms of psychosis, such as delusion and 
hallucinations, can also be common in the more severe form of the disorder, but are not 
required for diagnosis (American Psychiatric Association, 2013). Between these episodes, 
sufferers do not usually display extreme symptoms of mania or depression but many mild to 
moderate sub-syndromal symptoms and residual impairments do persist during periods of 
euthymia (Fava, 1999, Judd and Akiskal, 2003, Post et al., 2003). 
 
 
BD is another example of a highly heterogeneous diagnostic classification, showing varied 
expression among those with the disorder, and with symptom severity also viewed as falling 
along a continuum (Ghaemi, 2013, Judd and Akiskal, 2003, Merikangas et al., 2011). Varying 
severity of mania, hypomania and depression symptoms are common, with psychosis and/or 
rapid cycling also being associated with BD in a proportion of cases (Akiskal et al., 2005, Judd 
et al., 2002, Schneck et al., 2004). This therefore argues for the possibility that the phenotype 
may have several aetiologies deriving from differing deficits in underlying neuro-cognitive 
systems. The DSM-IV categorical definition of the disorder, used in this thesis, identifies three 
mutually exclusive categories: Bipolar Disorder I (BD-I), Bipolar Disorder II (BD-II) and 
Cyclothymia (American Psychiatric Association, 2000). BD-I is the most severe form requiring at 
least one lifetime episode of mania lasting a week or more, and often is accompanied by 
depressive episodes. The boundaries between BD-I and BD-II as categorically differing 
conditions is contested (Parker and Fletcher, 2014), but according to DSM-IV diagnosis of BD-II 
requires a hypo-manic episode, which has similar symptoms to mania but which is not severe 
enough to cause marked social or occupational impairment. The category of Cyclothymia 
captures those with chronic symptoms of mood instability over two years, but whom do not 
meet criteria for manic or major depressive episodes. DSM-5 has preserved these criteria and 
thresholds, and has not substantially altered reported prevalence of BD (Fassassi et al., 2014), 
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however one addition has been the inclusion of ‘persistently increased goal-directed activity or 
energy’, or hyperactivity, as a description of a manic or hypo-manic state. 
 
 
This disorder typically has onset in late teens or early adulthood (Merikangas et al., 2011). 
Estimates of lifetime prevalence for combined BD-I and II range from 1% to 3.9%, with BD-I 
prevalence being estimated as ranging from between 0.6%  to 2.2% (Judd and Akiskal, 2003, 
Kessler et al., 2005, Lee et al., 2009, Merikangas et al., 2007, Merikangas et al., 2011). There 
are indications that epidemiological data is influenced by the measures and exact criteria used, 
with small alterations leading to large increases in prevalence rates, highlighting the argument 
that these diagnostic boundaries are to some degree arbitrary, in that they do not fully capture 
the underlying phenotype, as moderate sub-threshold symptoms are relatively common (Judd 
and Akiskal, 2003, Lee et al., 2009, Mitchell et al., 2013).  
 
 
1.2.4 Gender difference in BD symptoms 
 
Equivalent prevalence rates for BD-I have been observed in both men and women, although 
BD-II is reported to occur more frequently in women, owing to an increase propensity to 
depression symptoms in this gender (Malhi et al., 2009, Schneck et al., 2004). However, a more 
recent epidemiological study found elevated lifetime rates of BD-I in men and confirmed 
higher rates of BD-II in women (Merikangas et al., 2011). Other studies have generally reported 
that mania symptom severity, prevalence of psychotic symptoms, total number of episodes, 
and age of onset are similar in men and women (Hendrick et al., 2000, Kawa et al., 2005, 
Kessing, 2004). However, rates of comorbid disorders are frequently reported to be greater in 
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men (Hendrick et al., 2000, Kawa et al., 2005, Kessing, 2004), as with ADHD (Kessler et al., 
2006). Evidence also exists suggesting rapid cycling forms of BD-I and II may also be more 
common in women (Schneck et al., 2004). 
1.2.5 Comorbidities and familial relationship in ADHD and BD 
 
In both ADHD and BD, co-occurring psychiatric disorders are common, especially substance 
abuse disorders in BD; and depression and conduct disorders in ADHD (Gillberg et al., 2004, 
Jensen et al., 1997, Mitchell et al., 2004, Strakowski and DelBello, 2000, Treuer and Tohen, 
2010). ADHD and BD also frequently co-occur (Faraone et al., 1997, Faraone et al., 2001). A 
systematic review suggested that the comorbidity between the two disorders in adults may be 
up to 10-21% in ADHD, and up to 5-20% in BD (Asherson et al., 2014b).  
 
 
Twin and family studies have shown both ADHD and BD to be highly heritable psychiatric 
disorders (Levy et al., 1997, Lichtenstein et al., 2009, Smoller and Finn, 2003), with family 
studies also showing that ADHD and BD aggregate in families at higher than expected rates 
(Faraone et al., 2012). For example, the incidence of ADHD in the offspring of parents with BD-I 
is reported at 30% (Birmaher et al., 2009). This suggests the presence of some shared genetic 
or environmental factors between ADHD and BD. Cross-disorder Genome Wide Association 
studies (GWAS) have provided confirmation that a set of common genetic variants confer risk 
for several psychiatric disorders including ADHD and BD, possibly as a consequence of an 
atypical neurodevelopmental trajectory (Smoller et al., 2013). These large scale genomic 
investigations also indicate that the range of variance in risk explained by common genetic 
mutations is larger in ADHD and BD than autistic spectrum disorder, schizophrenia and major 
depression, highlighting that the risk factors for these two disorders are likely to be common in 
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the general population (Lee et al., 2013). A more detailed discussion of molecular genetics 
research for ADHD and BD falls beyond the scope of this summary; however for the purposes 
of this thesis, it should be noted that evidence indicates some common genetic factors 
between ADHD and BD which may contribute to atypical neurodevelopmental trajectories and 
therefore may underlie shared abnormalities in higher order neurocognitive systems.  
 
 
1.2.6 Overlap of symptoms in ADHD and BD 
 
Diagnostic formulations for both ADHD and the manic phase of BD include common symptoms 
such as distractibility, psychomotor restlessness, talkativeness, lack of social inhibition and 
impulsivity (Galanter and Leibenluft, 2008, Kent and Craddock, 2003); many of which persist as 
milder stable traits in euthymic BD (Najt et al., 2007, Peluso et al., 2007). Debate over 
delineation has also ensued regarding evidence of mood dysregulation, such as irritability and 
emotional lability in ADHD, which match the symptoms of mood fluctuation in BD (Chan et al., 
2011, Geller et al., 2002, Skirrow et al., 2009, Skirrow et al., 2012, Skirrow and Asherson, 
2013). The introduction of DSM-5 has further blurred these boundaries, recognising mood 
dysregulation as an associated feature of ADHD, and hyperactivity as a symptom of BD 
(American Psychiatric Association, 2013). Such similarities can lead to challenges in 
distinguishing the two disorders, or recognising comorbidity in clinical practice where many 
atypical cases of both ADHD and BD present, and where the primary diagnosis (ADHD, BD or 
both) is unclear (Asherson et al., 2014a, Atmaca et al., 2009, Carlson, 1998, Galanter et al., 
2005). Further complications arise when considering the fluctuation of symptoms over time, 
particularly related to the episodicity in BD and the milder clinical expressions of each disorder 
along their respective spectrums, for instance adult inattentive ADHD which can show 
relatively few easily observable symptoms or BD-II where there may not be noticeable 
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impairment in general functioning (Hantouche et al., 1998, Hudziak et al., 1998, Judd and 
Akiskal, 2003, Levy et al., 1997). 
 
 
Although conceptually issues of symptom overlap may only represent poor diagnostic 
delineation by clinical categorisation or be the result of common aetiological pathways; in the 
clinical diagnosis of ADHD or BD accurate delineation can be a critical issue as treatments differ 
(stimulants or atomoxetine for ADHD, and antipsychotics or mood stabilisers for BD) and 
misdiagnosis can result in individuals being administered inappropriate treatments with 
adverse effects or the potential to exacerbate symptoms (Asherson et al., 2014b, Atmaca et 
al., 2009). Clinical delineation is further complicated by unresolved debate around the 
relationship between mood dysregulation and ADHD, and therefore the boundaries of each 
condition (Skirrow and Asherson, 2013). Furthermore, in relation to BD, whereas the 
episodicity of symptoms was thought to be the key identifying feature of the disorder, there is 
now debate over which definitions of episodicity are required for diagnosis across lifespan, as 
some authors have proposed that BD presents with chronic mood symptoms of anger and 
irritability at younger age ranges, concurrent with those ages where ADHD is typically 
diagnosed (Geller and Luby, 1997, Pavuluri et al., 2005).  
 
 
1.2.7 Delineation using clinical measures 
 
To date very few studies have attempted to delineate these two disorders using direct 
comparison on standard clinical measures which might be employed in a clinical environment; 
those that have done so have been small and have used a limited range of self-report 
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measures. One such comparison using  a depression scale showed both clinical groups to have 
elevated scores compared to controls (Torralva et al., 2011). Another study reported that 
ADHD measures were effective at distinguishing ADHD from BD, but that the ADHD group had 
higher depression and manic symptoms than euthymic BD participants (Ibanez et al., 2012). 
The comparative degree of these overlapping symptoms and their severity in each disorder 
therefore remains an important question to clarify, along with the effectiveness of clinical 
measures to delineate ADHD and BD in a cross-disorder comparison studies. 
 
 
1.2.8 Section summary 
 
BD and ADHD share several symptoms with indications of a genetic relationship between the 
two disorders, suggesting some common aetiological pathways between them. However, as 
both diagnoses have other non-shared characteristic symptoms, and have different effective 
treatments, there are also clearly divergent aetiological pathways underling these separate 
clinical expressions. Purely based on the clinical observation of symptoms, it is clear that the 
boundaries between ADHD and BD are, however, blurred, with empirical evidence examining 
the precise nature of shared vs. specific deficits still lacking, of which one question is the role 
of mood instability within each disorder. Neurocognitive evidence may therefore be essential 
in formulating theories to understand this pattern of shared and non-shared symptoms, 
familial/genetic relationships and broad heterogeneity within ADHD and BD, as such 
approaches may be able to highlight individual common or specific deficits in neurocognitive 








1.3 Cognitive and neurophysiological impairments 
 
1.3.1 Neurophysiological methods 
 
Beyond symptom observation, cognitive neuropsychological approaches can be used to 
further help elucidate the boundaries between these disorders. For instance, performance on 
neuropsychological tests can indicate impaired executive function or attentional processes, 
which can then be further investigated at the layer of cognition processes with the use of 
direct sub-second functional neuroimaging, such as electroencephalography (EEG) and event-
related potentials (ERPs) to search for atypical patterns of brain activity. Electrophysiological 
techniques, including EEG and ERP, record small voltage fluctuations in brain activity which can 
either be evoked by particular stimuli or arise as part of background processes such as arousal 
or activation. Electrophysiological activity recorded at the scalp is proposed to represent the 
summed voltage from a number of different cortical sources (Woodman, 2010). In ERP 
analysis, the averaging of activity over multiple stimulus- or response-locked trials can remove 
the spontaneous background EEG fluctuations unrelated to the event and produce 
characteristic positive and negative deflections in voltage with functional significance. The 
nomenclature of these individual components is often dictated by their polarity (P = positive, N 





Figure 1.1.  Simulated ERP waveform showing several components and typical naming 
conventions 
 
In this image negative voltages are plotted upwards, a common convention in older ERP 
studies. More recent studies now usually opt to plot positive voltages upwards, so positive 
components appear above the 0 µV baseline. 
Image is available under the Creative Commons Attribution-ShareAlike License 
 
 
Raw EEG recordings consist of multiple overlaid waveforms of different frequencies (Hz), with 
higher frequency waveforms having shorter wavelengths between each peak and trough. In 
quantitative-EEG analyses, a raw recording is split into its constituent frequencies and the 
power of each measured to provide indications of activity and variability. Traditionally, spectral 
EEG has been divided in several bands each with particular functional significance including 
arousal and attention: delta (0.5 – 3.5 Hz), theta (3.5 -7.5 Hz), alpha (7.5 – 12 Hz), beta (12 – 30 
Hz), and gamma (30+ Hz). These approaches are becoming more sophisticated, in relation to 
the analysis techniques available to reduce noise and isolate individual sources of EEG activity, 
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such as the use of Independent Component Analysis (ICA) to extract individual components 
from raw EEG data, and source based localisation approaches which are able to approximate 
the spatial locational of ERP source generators within the cortex (McLoughlin et al., 2014a). 
This has meant EEG and ERP measures are becoming increasingly useful in psychiatric contexts, 
as they provide reliable, highly heritable and sensitive methods for measuring brain functions 
across a wide age range, without ceiling effects, and with high levels of internal consistency 
and temporal stability (McLoughlin et al., 2014a, Olvet and Hajcak, 2009b, Olvet and Hajcak, 
2009a). In this way, research can begin to map out deficits in specific components of 
neurocognitive systems in each disorder, including arousal states, attention, inhibition and 
perceptual processes, and their temporal sequence, enabling detailed delineation of 
underlying neurophysiological processes, thereby allowing us to understand the relationship 
between these cognitive impairments and observable behaviours or symptoms (Banaschewski 
and Brandeis, 2007). Furthermore, examination of these neurobiological correlates, although 
initially based upon the categorical diagnostic definitions, is potentially capable of moving 
beyond potentially arbitrary diagnostic distinctions to explore how individual system-level 
cognitive abnormalities collectively contribute to overall syndromes or impairment as 
observed in any given psychiatric illnesses (Insel et al., 2010). In this way, such methods may 
provide insight into the commonalities, characteristic differences, and within-disorder 
heterogeneity (through the exploration of functional subgroups), which could be of great value 
in furthering our understanding of the aetiologies of psychiatric illnesses, their relationships to 
one another, and provide new markers to support diagnosis and treatment in clinical settings.  
 
 
The use of ERP and EEG measures as potential endophenotypes has been proposed 
(Banaschewski and Brandeis, 2007). Endophenotypes are defined as traits, such as a cognitive 
impairment, which share genetic factors with a disorder and may therefore represent an 
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intermediate phenotype or an associated pleiotropic phenotype. It has been proposed that 
individual traits (i.e. endophenotypes) associated with a disorder may be less genetically 
diverse than the disorder concept as a whole, and therefore enable the study of underlying 
pathways (Gottesman and Gould, 2003, Kendler and Neale, 2010). EEG and ERP measures,  are 
well suited to this approach as they may represent an intermediate level measure between 
genetic susceptibility and behaviour (Tye et al., 2011). As endophenotypes are likely to also be 
present at a level proportional to one’s genetic susceptibility for the trait, they would be 
expected to be observed in genetically related individuals. Family studies are therefore able to 
take advantage of this potential endophenotype indicator by examining if EEG or ERP deficits 
observed in those with psychiatric illness are also present in first-degree relatives at 
intermediate levels. While only twin studies can distinguish genetic factors from the influence 
of shared environment, suitable twin samples with adequate numbers of probands with 
psychiatric diagnoses are rarely available and therefore sibling designs are commonly 
employed when recruiting samples from clinics.  
 
 
1.3.2 Cognitive-neurophysiological abnormalities in ADHD 
 
A range of cognitive deficits are associated with ADHD in both children and adults, including 
deficits in working memory, planning and organisation, set shifting, processing speed, 
attention regulation, variability in reaction times and response inhibition (Doyle, 2006, Kofler 
et al., 2013, Tamm et al., 2012, Willcutt et al., 2005). Measures of reaction times (in particular 
reaction time variability, RTV), response inhibition and sustained attention (indexed, for 
example, by commission errors and omission errors on a go/no-go task, respectively), 
consistently show impaired performance in children and adolescents with ADHD (Klein et al., 
2006, Kuntsi et al., 2009, Willcutt et al., 2005).  Incentives can affect performance on RT tasks 
37 
 
in children with ADHD, as RTV has been reported to show ADHD-sensitive improvement under 
reward conditions (Andreou et al., 2007, Kuntsi et al., 2009, Uebel et al., 2010), although this 
has not been observed in some studies (Kofler et al., 2013), suggesting ADHD performance can 
be highly sensitive to exact task parameters. In contrast, the elevated omission or commission 
errors did not show modification by incentives in ADHD, suggesting different underling 
processes (Kuntsi et al., 2009). The dissociation between RT and accuracy processes has been 
further supported by work using multivariate familial factor analysis, which indicated the 
familial covariance of RT measures vs. those of accuracy measures (omission errors and 
commission errors) separated into two separate factors, indicating two separate familial 
processes were related to the impaired performance in ADHD: one relating to bottom-up 
arousal regulation, indexed by the speed and consistency of reaction time performance, and 
the other relating to top-down sustained attention and inhibition processes as indexed by 
omission and commission errors (Kuntsi et al., 2010).  
 
 
A general IQ deficit of 7-12 points is also associated with ADHD (Kuntsi et al., 2004). One view 
relates this to attentional-arousal problems, which have themselves been linked to lower 
levels of scholastic achievement (Biederman et al., 2006). However, other studies have shown 
the genetic covariance of IQ to be largely independent from the covariance between ADHD 
and reaction time or executive function measures (Rommelse et al., 2008, Wood et al., 2010, 
Wood et al., 2011). This suggests that the IQ deficits seen in ADHD may be the result of a yet 
unknown aspect or component in the underlying pattern of cognitive deficits in ADHD. Overall, 
in terms of neuropsychological understanding of ADHD, evidence points to several distinct 
deficits in ADHD which commonly co-occur within the phenotype, and may therefore be 
related via a common atypical neurodevelopment pathway. However questions remain about 
the relationship of these deficits to one another, their interaction, the relationship between 
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specific cognitive deficits and broader ADHD symptoms, and to the variability of impairments 
in these systems across individuals with ADHD. That being the case, there remains much work 
to do in order to demonstrate if these neuropsychological performance indicators are reliable 
indicators of the ADHD phenotypes and if they represent stable biomarkers which might be 
useful in diagnostic contexts. 
 
 
In relation to neuroimaging research, a meta-analysis of 55 fMRI studies in ADHD reported 
evidence for fronto-parietal and ventral hypoactivation in children, which are networks 
associated with executive processes and attention; while in adults, only hypoactivation in 
fronto-parietal networks were identified, although visual and dorsal attention systems showed 
hyperactivation, suggesting a compensatory role (Cortese et al., 2012). The number of EEG and 
ERP investigations into the cognitive processes of ADHD are increasing but much work remains 
to be done to provide a full mapping of cognitive deficits in ADHD at a functional level. For 
example, DSM-5 highlights that individuals with ADHD typically show increased slow-wave EEG 
power (American Psychiatric Association, 2013), which is thought to related to arousal 
dysregulation in ADHD; yet results to date, particularly in more recent studies have called into 
question the consistency of these indicators, suggesting that the picture of spectral EEG 




In both the child and adult ADHD ERP research, overall, the most commonly altered attentional 
and inhibitory ERP correlates include the go-P3 (impaired target processing to rare targets, 
‘oddballs’), no-go-P3 (inhibition), cue-P3 (attentional orienting) and CNV (response 
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preparation) on the cued continuous performance task (CPT). Research using this paradigm 
has proved valuable in beginning to understand the relationship of cognitive deficits in ADHD, 
showing that abnormal inhibitory processing in ADHD is typically preceded or accompanied by 
attentional processing deficits, which also show genetic/familial effects (Albrecht et al., 2013, 
Albrecht et al., 2014, Cheung et al., under review, Doehnert et al., 2013, McLoughlin et al., 
2011). There is also growing evidence of performance monitoring deficits in ADHD, observed 
on tasks such as the Eriksen Arrow Flanker Task, which have highlighted N2 and error-related 
negativity (ERN) abnormalities in both children and adults (Albrecht et al., 2008, Geburek et al., 
2013, Johnstone et al., 2009, McLoughlin et al., 2009, McLoughlin et al., 2014b, Wild-Wall et 
al., 2009). ERN deficits have also been reported in some studies using the Go/NoGo paradigm, 
which have also shown, more robustly, attenuation of the Pe component in children and 
adolescents with ADHD, which is a positive error-detection component elicited by an error 
response (Groom et al., 2010, Groom et al., 2013, O'Connell et al., 2009a, Wiersema et al., 
2009). Abnormalities of P2, N2 and P3 components have also been reported in some studies 
using the oddball task, which may suggest altered attentional resource allocation processes in 
ADHD (Barry et al., 2003, Gumenyuk et al., 2004, Holcomb et al., 1986, Marzinzik et al., 2012, 
Ozdag et al., 2004). 
 
 
ERP components are also good candidates as endophenotypes of ADHD and have been studied 
in this regard. In ERP studies of both children and adults using the flanker task, there are 
indications that first degree relatives show intermediate conflict monitoring deficits relative to 
ADHD and control groups, as indexed by N2 and ERN components (Albrecht et al., 2008, 
McLoughlin et al., 2009). Similarly, fathers of children with ADHD, show intermediate deficits 
in cue-P3 and no-go-P3 components in the CPT, which are related to attentional and inhibitory 
processes, in comparison to adults with ADHD (McLoughlin et al., 2011). These endophenotype 
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studies have highlighted initial candidates for subsequent molecular genetic investigations 
which are now yielding results, for example indicating that certain genetic polymorphisms 
have specific effects on cue-P3 amplitude and attentional performance (Albrecht et al., 2014). 
Furthermore, there is evidence of links between the ERN and the dopaminergic function which 
suggest that impairments in this component may be the consequence of altered neural 
signalling (Meyer et al., 2012). As ADHD status has also been repeatedly linked to altered 
dopaminergic genetic markers (DiMaio et al., 2003, Kirley et al., 2002, Swanson et al., 2000), 
the study of ERP measures, such as the ERN and N2 components may provide further evidence 
for  dopaminergic signalling theories of ADHD. 
 
 
Although evidence of cognitive deficits in ADHD is emerging across several related 
neurocognitive domains, sketching out the dimensions of impairment in this broad 
heterogeneous diagnostic concept will require much more research, as on the whole studies 
remain sparse and findings not widely replicated, meaning additional factors which might 
influence results (i.e. methodology, age, gender, sample characteristics etc.) have not been 
fully explored. However, evidence from neuropsychological and electrophysiological studies, 
taken together, does provide strong indications for an emerging pattern of cognitive 
impairments in ADHD. Yet, data that are acutely lacking relate to the specificity of these 
impairments to ADHD, either individually or as a ‘profile’, or whether these emerging 
electrophysiological indicators only represent common markers of cognitive impairment for 
general psychiatric illness. This question must first be answered to determine if such indicators 





1.3.3 Cognitive-neurophysiological abnormalities in BD 
 
In comparison to those with ADHD, who show impaired performance from childhood, people 
diagnosed with BD do not show evidence of impaired premorbid functioning (Reichenberg et 
al., 2002). However, neuropsychological studies reveal that cognitive performance can be 
severely impaired during manic or depressive phases showing that adults with BD consistently 
present with impairments in executive functions, and in particular, verbal working memory, 
attention and psychomotor speed (Fleck et al., 2003, Glahn et al., 2007, Martinez-Aran et al., 
2004). Relatives of individuals with BD also show impairments in verbal working memory and 
other aspects of executive functions, suggesting some familial influence in these 
neurocognitive deficits (Glahn and Burdick, 2011). Impairments in BD persist during phases of 
remission, with significant residual deficits in verbal memory and executive functioning being  
consistently reported during euthymic phases of the disorder (Bora et al., 2009, Frangou et al., 
2005, Robinson et al., 2006, Thompson et al., 2009). Premorbid IQ in BD does not show 
differences from the general population, with IQ showing a weak association with BD in 
general, even as the disorder progresses (Toulopoulou et al., 2006, Zammit et al., 2004), 
although impaired performance is observed on some specific areas of intellectual testing such 
as Block Design and Digit Symbol tasks (Frantom et al., 2008). Experimental cognitive designs, 
which seek to map performance deficits in specific underlying cognitive systems, is a relatively 
underdeveloped area in the field of BD research, compared to that of ADHD. A few studies 
have presented evidence suggesting that RTV may be increased in adolescents with BD (Bora 
et al., 2006, Brotman et al., 2009), although this metric remains uncommon in BD research 





Familial studies have suggested potential neurocognitive endophenotypes for BD. Verbal 
memory and working memory are the most consistently found to be impaired in family 
members of people with BD (Balanza-Martinez et al., 2008). Recent research supports this 
indicating that executive function deficits are the primary candidates as endophenotypes of 
BD, showing impairment in both BD participants and their first-degree relatives (Civil Arslan et 
al., 2014, Schulze et al., 2011). Twin-studies have also highlighted response inhibition as 
showing impairment in both BD twins and their unaffected co-twins (Juselius et al., 2009). 
 
 
In ERP studies, reports of early perceptual deficits as indicated by abnormalities in P50 and 
Mismatched Negativity (MMN) components are often reported in BD, indicating potential pre-
attentive dysfunctions (Cabranes et al., 2013, Jahshan et al., 2012, Maekawa et al., 2013, 
Onitsuka et al., 2013, Swann et al., 2013). Little work has been conducted examining conflict 
monitoring components in BD, such as the ERN and N2, yet given that BD and depression have 
been linked to potential deficits in dopaminergic signalling (Dunlop and Nemeroff, 2007, 
Strakowski et al., 2005), which have in turn been linked to the ERN component (Meyer et al., 
2012), research directly examining these components in BD would be beneficial. Attenuation 
of later P3 components in BD, related to attention and processing speed (Bestelmeyer, 2012, 
Bestelmeyer et al., 2009, Degabriele and Lagopoulos, 2009), is also a common finding, with 
evidence of similar impairments among their first-degree relatives, indicating a contribution of 
familial factors  to this indicator (Pierson et al., 2000). Yet, overall, familial investigations using 





Similar deficits in the P3a component, assumed to reflect covert orienting or shift in attention, 
have also been evidenced in BD, albeit much less frequently (Jahshan et al., 2012). Also 
observed less consistently are P2 abnormalities during the auditory oddball task, which may 
relate to psychotic features found in some expressions of the disorder (Ethridge et al., 2014). 
In EEG studies, elevated delta and theta power and decreases in alpha power have been 
associated with BD (Degabriele and Lagopoulos, 2009); a similar profile to that found in some 
studies of ADHD, creating questions as to whether there are commonalities in brain 
dysfunction and therefore the specificity of such measures. 
 
 
Taken together, cognitive and electrophysiological studies indicate that impairments in BD can 
be severe and persist during periods of euthymia. However, the understanding of how these 
performance abnormalities relate to deficits in underlying cognitive systems in BD is less well 
developed than in the study of ADHD at present. Investigation of these potential biomarkers 
has to date been largely limited to a few cognitive components, such as the P3 component in 
the oddball paradigm, but investigations into the broader range of specific cognitive processes 
which could be altered in BD is notably lacking. One example is that of performance 
monitoring correlates, such as the N2 and ERN components, in tasks with considerable 
attentional load and perceptual conflict between target and distractor stimuli.  If we are to 
understand the full profile of cognitive deficits in BD, along with the interrelationships 
between these areas of impairments, researchers must first map out the understudied 
avenues of cognitive performance in BD, and then compare recorded deficits to those of other 
disorders to illuminate the pattern of characteristic deficits in BD vs. those shared with other 
psychiatric disorders. It is in this way that research into neurobiological systems may improve 
our understanding to the aetiology of BD, helping to clarify diagnostic distinctions with those 





1.3.4 Cross-disorder comparisons 
 
Cross-disorder comparisons using ERP techniques between ADHD or BD and other psychiatric 
disorders are present in the literature; with BD being most commonly compared with 
schizophrenia (Chun et al., 2013, O'Donnell et al., 2004, Souza et al., 1995), while ADHD has 
been compared, for example, with schizophrenia (Groom et al., 2008) and with autism (Tye et 
al., 2014). Certain disorder-specific differences and commonalities have been highlighted, 
demonstrating the growing value of cross-disorder approaches to chart functional 
neurocognitive boundaries between diagnostic classifications. However, there is a strong need 
for more data and the application of advanced methodological and analytical approaches. 
 
 
Data on direct comparisons between ADHD and BD samples for cognitive and ERP measures is 
very limited, particularly for adult populations, and are needed to elucidate whether symptom 
similarities in ADHD and BD reflect identical or unique underlying impairments (Skirrow et al., 
2012). While data is currently sparse, there are suggestions that cognitive performance may 
show both shared and unique impairments between ADHD and BD. A review of neurocognitive 
studies in each disorder concludes that, although there were similarities in neuropsychological 
deficits, ADHD and BD may be associated with different executive function deficits (Walshaw 
et al., 2010). Direct comparisons of ADHD and BD adults have shown common deficits in both 
disorders, such as visual and spatial working memory deficits (Baez et al., 2014), as well as 
some specific differences, such as memory acquisition and storage in BD, unlike ADHD which 





Literature directly comparing reaction time performance across ADHD and BD is also limited, 
particularly for adult samples, with results reported in current studies being variable and 
inconclusive. One study examining RT measures in children, found higher RTV and slower 
mean reaction time (MRT) in those with comorbid ADHD and BD compared to ADHD children 
without comorbidities (Mattis et al., 2011). In contrast, another study of early onset BD and 
ADHD in adolescents reported increased RTV in ADHD and ADHD with comorbid BD, but 
reduced RTV in BD compared to these other groups. This caused the study to conclude that 
undiagnosed comorbid ADHD may account for many of the neurocognitive deficits observed in 
BD (Udal et al., 2014). Another study reported RTV deficits in both ADHD and BD but in 
different tasks, leading the authors to conclude that these deficits are related to impairments 
in different underlying neurocognitive systems in ADHD compared to BD (Dickstein et al., 
2005). 
 
Direct comparisons of brain structure in ADHD and BD in child and adult samples also support 
views of a neurobiological dissociation between them, with disorder-specific structural MRI 
differences being identified particularly in subcortical regions and the prefrontal cortex for 
ADHD, and thalamic, orbital-prefrontal and nucleus accumbens for BD (Biederman et al., 2008, 
Lopez-Larson et al., 2009). Functional measures also provide supporting evidence for disorder 
specific differences. Using fMRI, one study showed that, although response inhibition was 
impaired in both children with ADHD and BD-I, the brain regions involved in their inhibitory 
processes differed suggesting two distinctive neurocognitive aetiologies for the impairment 
(Passarotti et al., 2010). Studies of face emotional processing using fMRI also showed 
differences between ADHD and BD, with the former showing increased activation of the 
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amygdala, and the latter showing reduced activation of working memory circuits in different 
studies (Brotman et al., 2010, Passarotti et al., 2010).  
 
 
EEG and ERP comparison studies between ADHD and BD remain limited, although have been 
appearing more frequently over the last few years. In each case the investigations represent 
an example of a study comparing a particular cognitive deficit in ADHD and BD, with the 
samples mostly being small and therefore results preliminary and requiring replication. An 
investigation examining  feedback-related negativity (FRN) and P3 in a gambling task, using a 
sample of adults with BD (n = 13), ADHD (n = 12) or controls (n = 25), reported that both the 
BD and ADHD groups showed impairments in cortical response based on feedback (FRN). The 
authors suggest that this indicates that impulsivity, rather than information provided by task 
feedback, was driving responses in both disorders (Ibanez et al., 2012). Furthermore, in this 
study, the BD group showed enhancement of the P3 component relative to reward magnitude, 
also observed in controls, although this effect was absent from the ADHD group, which instead 
showed an equivalent P3 response to both large and small rewards. Another study compared 
adults with ADHD (n = 16), BD (n = 14), schizophrenia (n = 15), the unaffected relatives of 
schizophrenia participants (n = 14) and controls (n = 41) using a face-emotional processing task 
(Ibanez et al., 2014). In this study ADHD, BD and schizophrenia groups all showed N170 
deficits, linked to the processing of emotional stimuli, suggesting a shared impairment in this 
domain for all three disorders (Ibanez et al., 2014). A further study adopted a graph theory 
approach, examining the EEG functional connectivity of scalp regions using the temporal 
variability of delta activity (0.5 - 3.5 Hz) in a sample of adult ADHD (n = 9), BD (n = 11) and 
control participants (n = 15). Their data suggested that ADHD was linked to increased 
variability, related to connectivity abnormalities, while participants with BD showed less 
variability and had evidence of more long-range neural connectivity (Barttfeld et al., 2014). 
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Finally, another study using resting-state EEG data from adults with ADHD (n = 21) or BD (n = 
22) examined mathematical approaches of classifying groups using EEG data, reporting the 
successful identification of ADHD and BD participants in a test sample around 80% of the time, 
based on EEG data alone. However, this study was largely focused on the application of 
mathematical models to complex data rather than clinical applications of this approach, 
making its validity, when applied to a general sample, unclear (Sadatnezhad et al., 2011). 
These studies overall indicate that there is growing suggestive evidence of neurocognitive 
distinctions between ADHD and BD, although a full neurobiological understanding of them is 
far from resolved, beyond a few basic dissociations in those cognitive domains which have 
been chosen for study to date. Nonetheless, despite their relative infrequency and small 
sample sizes, cross-disorder comparisons between ADHD and BD have shown potential 
contributions in increasing the neurocognitive understanding of these disorders. This area 
would now benefit greatly from further cross-disorder investigations in larger samples, 




1.3.5 Gender differences in cognitive-electrophysiological research on ADHD and BD 
 
No previous studies, to the best of our knowledge, have explored the effects of gender on EEG 
or ERP outcome measures in BD. In ADHD, the majority of data from EEG and ERP studies 
consist of a high proportion of data from male participants, with a few exceptions described 
here. EEG resting-state studies in girls with ADHD have suggested that while the overall 
pattern of ADHD-linked deficits is similar to that of boys, there is evidence for reduced 
variability in EEG power in girls (Clarke et al., 2003, Dupuy et al., 2011). Direct comparisons 
between boys and girls with ADHD have evidenced topographic differences in EEG power, 
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indicative of different cortical maturational patterns between the genders (Dupuy et al., 2013, 
Hermens et al., 2005a). Although data are limited to a single study, similar findings of 
topographic EEG differences between men and women have been reported in a gender 
comparison of adults with ADHD (Hermens et al., 2004). ERP studies which have explored 
gender differences in ADHD are also fairly uncommon, although a meta-analysis of six studies 
was performed and indicated that P3 target response in the Go/NoGO paradigm was more 
highly attenuated in females participants with ADHD compared to male participants with 
ADHD (Szuromi et al., 2011). However, as female participants have been shown to display a 
differing P3 response to stimulus novelty (Yuan et al., 2012), and differing N2 response to 
conflict monitoring demands (Clayson et al., 2011) compared to males in general population 
samples, it would seem important to collect data and compare case-control differences in 
female samples independently from male samples. This seems particularly important in ADHD, 
where data from adult female samples is currently very limited.  
 
 
1.3.6 Section Summary 
 
Individually, there is strong, well-replicating evidence for cognitive and neurophysiological 
impairments in ADHD and BD, which is starting to elucidate the underlying neurobiological 
underpinnings of each disorder, and which will be vital in developing biologically-informed 
classifications and diagnostic aids in each disorder. However, data on the specificity of 
proposed biomarkers is lacking from this growing field of research. The few neurophysiological 
comparison studies between ADHD and BD to date, and particularly those using EEG and ERP 
techniques which have the potential to directly measure cognitive processes with high 
temporal resolution, have been impressive in their ability to identify various shared and 
specific neurobiological deficits in each case. However, consistently the samples employed in 
49 
 
these studies have been small and results have yet to be replicated. There also remain many 
cognitive processes known to be impaired in one disorder but which have yet to be studied in 
the other; and many which have not been the subject of direct comparison between the 
disorders to determine specificity. Only with such work using cognitive-electrophysiological 
methods among others, in conjunction with consistent replication and an increased 
understanding of heterogeneity in neurocognitive processes within each disorder, will 









Chapter 2 - A Matter of Time: The Influence of 
Recording Context on EEG Spectral Power in 


























































































































































2.4.2 Group by time interactions 
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2.4.6 Global field synchronisation 







































Chapter 3 - Neurophysiological Conflict Monitoring 
Impairments in Adolescents and Young Adults with 
ADHD: A Comparison with Their Unaffected 
Siblings and Unrelated Controls 
 
 
3.1 Abstract   
 
Individuals with ADHD show behavioural difficulties compared to typically developing controls 
during performance monitoring tasks. However, few studies have investigated the 
neurophysiological correlates of error detection and performance monitoring during these 
tasks, with results being inconsistent. Questions also remain about possible familial 
associations with performance monitoring deficits, and whether such deficits represent stable 
endophenotypes in ADHD. One hundred and five adolescents and young adults with ADHD, 95 
of their unaffected siblings and 136 unrelated controls were assessed on the Eriksen Flanker 
Task, where ERP performance monitoring correlates (N2, ERN, Pe) and performance variables 
were measured. Additionally, analysis was rerun on older and younger subgroups within the 
full sample (11-17, 18+) to examine potential developmental differences. The ADHD group was 
impaired on all performance measures compared to controls (correct hits, commission errors, 
omission errors, mean reaction time and reaction time variability (RTV)). In the incongruent 
condition, the ADHD group showed trend-level attenuation of the Pe amplitude component at 
channel Cz and trend-level attenuation of N2 amplitude at FCz compared to controls. 
Compared to siblings, both N2 and Pe components were attenuated at trend-level in ADHD. 
The groups did not differ on ERN amplitude at either Fz or FCz. No familial effects were 
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identified, with unaffected siblings not differing from controls on N2, ERP and Pe mean 
amplitude. This study reports evidence of potentially impaired conscious error processing in 
ADHD as indexed by Pe attenuation, which alongside observations of more omission errors and 
greater RTV, supports arguments for increased attentional lapses in ADHD. Finally, contrary to 
a recent meta-analysis of adolescent and adult participants of equivalent sample size, we did 
not find evidence of ERN amplitude attenuation in ADHD; which suggests variation in ERN 





Attention-deficit/hyperactivity disorder (ADHD) occurs in around 5% of children (Polanczyk et 
al., 2007), frequently persists into adolescence and adulthood (Faraone et al., 2006), and 
manifests as symptoms of inattention and/or hyperactivity/impulsivity. Lapses in attention and 
distractibility in particular are thought to underlie performance monitoring deficits commonly 
observed in ADHD (Larson and Clayson, 2011).  
 
 
Examination of event-related potentials (ERP) allows direct measurement of brain activity 
which correlates with performance on cognitive tasks, and so is important for better 
understanding deficits in the cognitive processes in ADHD. One example is the study of 
performance monitoring, such as error detection and conflict monitoring which support the 
adaptation of behaviour for optimum performance, yet which are likely to be impaired by the 
lapses in attention and distractibility present in ADHD (Larson and Clayson, 2011). Despite this, 
64 
 
use of ERP methods to study performance monitoring in ADHD has not yet been widely 
employed, with studies in larger samples remaining uncommon. 
 
 
Performance monitoring has been linked to particular fronto-central negative deflections in 
ERP waves, which vary with task-demands and the accuracy of responses. When a participant 
makes a correct response to a target stimulus, the N2 component is elicited peaking 
approximately 200–400 ms post stimulus. When an error is made to the same target, a 
stronger error-related negativity (ERN or Ne) component is elicited in place of the N2, at 
around 50 ms post response (Falkenstein et al., 1991, Falkenstein et al., 2000, Segalowitz and 
Dywan, 2009, Yeung and Cohen, 2006). These components are highly correlated and are 
thought to both relate to competing or corrective process of conflict monitoring systems 
(Falkenstein et al., 2000, McLoughlin et al., 2009, Yeung and Cohen, 2006). Studies also 
indicate that ERN is consistent across different modalities and types of error (Riesel et al., 
2013). The ERN is also followed by a P3-like centro-parietal positive deflection in amplitude 
(Pe), thought to represent the conscious processing of the error response related to processes 
to improve performance (Endrass et al., 2007, Falkenstein et al., 2000, Hughes and Yeung, 
2011, Nieuwenhuis et al., 2001). In contrast to the Pe, the ERN is not dependent on the 
conscious perception of an error, which represents unconscious performance monitoring 
processes (Falkenstein et al., 2000, Nieuwenhuis et al., 2001). Further supporting evidence for 
this link comes from studies which show that the amplitude of the N2 and the ERN is increased 
when discrimination of target is confounded by similar distractors which presuppose an 
alternative response, indicating that these components may represent competing activation 
between the immediate erroneous response evoked by distractors and a subsequent 
corrective response (Carter and van Veen, 2007, Danielmeier et al., 2009, Donkers and van 
Boxtel, 2004, Nieuwenhuis et al., 2003, Yeung et al., 2004). 
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In ADHD, several studies examining the ERN and Pe components using Go/NoGo and flanker 
tasks in adults and adolescents were recently combined into meta-analysis. Although in the 
majority of these individual studies ADHD-control differences did not reach significance, likely 
due to small sample size, when aggregated in meta-analysis ERN attenuation in ADHD in both 
Go/NoGo and flanker tasks was reported (Geburek et al., 2013). For Pe, attenuation in the 
ADHD group was significant only in the Go/NoGo paradigm, as studies using the flanker 
paradigm reported more heterogeneous results. However, the authors indicate that they 
expect overall Pe attenuation in ADHD to emerge in the flanker task with additional data. In a 
recent review of nine studies of the ERN and Pe in childhood ADHD, albeit mostly very small 
studies, Shiels and Hawk (2010) concluded, in contrast to studies of older participants, that 
evidence for ERN attenuation in participants with ADHD was more inconsistent than reported 
deficits in Pe, with the majority of studies showing Pe attenuation in ADHD compared to 
controls. However, more recent studies have reported both ERN and Pe attenuation in children 




Geburek et al. (2013) suggested that stronger Pe deficits would be more likely to be observed 
in childhood ADHD if Pe represented conscious recognition of an error, as adolescents and 
adults would have more conscious task processing resources available, and therefore early 
error processing deficits indexed by the ERN could be partially compensated for by allocation 
of additional monitoring resources. Yet, while ERN amplitude shows developmental increases 
in amplitude thought to be related to prefrontal cortex maturation, including the anterior 
cingulate cortex (ACC) (Segalowitz and Dywan, 2009), Pe amplitude appears more 
developmentally stable with age in children and young adults (Davies et al., 2004, Wiersema et 
al., 2007).  In addition, Geburek et al.’s own exploratory analysis indicated no effect of age in 
their meta-analytic findings of the ERN and Pe, demonstrating that age was not a significant 
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moderator in adolescent and young adult samples (Geburek et al., 2013). It has also been 
shown that ERN and Pe deficits can be improved by performance-based rewards in ADHD 
groups compared to controls, or by methylphenidate medication in comparisons of ADHD 
participants on and off treatment (Groom et al., 2013). This shows that the additional 
allocation of cognitive resources can improve Pe amplitude and task-performance and also 
highlights that this improvement is possible in childhood samples. Therefore the variable 
results to date and evidence of the alteration of reported deficits by rewards suggest that the 
picture of ERN and Pe deficits is more complex than simple child/adult divisions of cognitive 
resource availability and demonstrates the need for additional research using larger samples, 
which span larger developmental windows. This would help to clarify if Pe deficits show 
developmental differences and whether it can be reliability associated with ADHD. 
 
 
N2 attenuation in flanker tasks has been reported in children (Albrecht et al., 2008, Johnstone 
et al., 2009, Wild-Wall et al., 2009), adolescents (McLoughlin et al., 2014) and adults with 
ADHD (McLoughlin et al., 2009), although some studies with small samples have failed to 
replicate N2 deficits in ADHD (Johnstone and Galletta, 2013, Jonkman et al., 1999, Jonkman et 
al., 2007). N2 deficits in children and adults with ADHD have also been reported in additional 
paradigms which also involve conflict monitoring, such as auditory odd-ball and Go/NoGo 
paradigms (Barry et al., 2009, Groom et al., 2008, Woltering et al., 2013). Overall, however, 
studies with large samples examining the N2 in adolescent and adult populations remain rare.   
 
 
One potential explanation for some variability in the N2 literature is the potential effects of IQ 
on ERP amplitudes. ADHD is associated with lower IQs (Kuntsi et al., 2004), yet IQ is a factor 
which is inconsistently controlled for in those studies where differences in mean IQ between 
ADHD and controls are present (Johnstone et al., 2009, Johnstone and Galletta, 2013, Jonkman 
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et al., 1999). Evidence from EEG studies indicates that reduced IQ in ADHD may have a small 
but significant influence effect on case-control differences in spectral EEG power (Chabot and 
Serfontein, 1996, Kitsune et al., 2014, chapter two), but studies have not yet attempted to 
quantify the effect of IQ differences on ERP performance monitoring correlates in ADHD. 
 
 
Furthermore, there is some evidence that the performance monitoring correlates might 
represent familial endophenotypes for ADHD, as first-degree relatives have been reported to 
show intermediate profiles of attenuation compared to ADHD and control groups (Albrecht et 
al., 2008, McLoughlin et al., 2009). Endophenotypes are defined as traits which are influenced 
by the same genetic and shared environmental factors as the disorder and so could represent 
meditational intermediaries (Gottesman and Gould, 2003, Kendler and Neale, 2010). As 
heritability estimates for ADHD are high (Faraone et al., 2005), and ADHD is considered to be 
the extreme end of a quantitative trait for behaviours of inattention and hyperactivity within 
the general population (Levy et al., 1997), it is feasible that multiple genetic variants could 
contribute to the function of performance monitoring cognitive systems, and therefore some 
degree of performance monitoring deficits would be expected in first-degree relatives of 
individuals with ADHD. This hypothesis has been supported by preliminary data from first 
degree relatives collected using the Flanker Task, although both studies present their 
conclusions as tentative and have called for additional replication (Albrecht et al., 2008, 
McLoughlin et al., 2009). Although sibling designs cannot distinguish between genetic and 
shared environmental effects, there is limited evidence for the contribution of shared 






Overall, additional research into performance monitoring in ADHD is required using larger 
samples including adolescents and young adults in order to clarify which deficits are reliably 
associated with ADHD, and to confirm if performance monitoring and error recognition deficits 
appear consistently across older and younger groups. Questions also remain about possible 
familial associations with performance monitoring deficits, and whether such deficits 
represent an endophenotype for ADHD. This study therefore aimed to compare N2, ERN and 
Pe components during a flanker task in adolescents and young adults with ADHD, against their 
unaffected siblings and unrelated controls. Previous literature predicted that the ADHD group 
would show attenuated N2, ERN and Pe components compared to controls, while their 







One hundred sixteen young adults and adolescents with ADHD, 96 of their unaffected siblings 
and 170 controls from sibling pairs who had taken part in a previous familial association study 
(Chen et al., 2008, Kuntsi et al., 2010), were invited to participate in this follow-up study. 
During the initial study ADHD participants aged between 6 and 17 years were recruited from 
specialist clinics in the UK from among those who had a clinical diagnosis of DSM-IV combined 
subtype ADHD during childhood. Closest-age siblings were also then recruited and assessed for 
ADHD using the same procedures. The control group was recruited from primary (ages 6-11 
years) and secondary (ages 12-18 years) schools in the UK. In the follow-up study, participants 
were aged between 11 and 27, and for this investigation ADHD participants and unaffected 
siblings were re-assessed, with only ADHD participants who continued to meet DSM-IV criteria 
for any ADHD subtype in adolescence/early adulthood being included in current analyses, with 
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those who remitted being excluded from this analysis. Unaffected ADHD siblings (sibs) were 
also re-assessed to ensure that they did not meet DSM-IV criteria for ADHD. For all groups, the 
exclusion criteria, as defined by those used in the initial investigation, were the presence of 
autism, epilepsy, learning difficulties, brain disorders and any genetic or medical disorder 
associated with externalising behaviours that might mimic ADHD. All participants were of 
European Caucasian decent. Written informed consent was obtained and the study was 
approved by the London-Surrey Borders Research Ethics Committee (NRES 09/H0806/58).  
 
 
Seven eligible ADHD participants were initially excluded from the analysis due to equipment 
failure (n=2) or incomplete EEG (n=3) or clinical data (n=2). Additionally, a further five 
participants (ADHD: n=4; sibs: n=1) were excluded from the N2 ERP data analysis as they had 
<20 acceptable ERP segments available after processing, leaving 105 ADHD participants, 95 
sibs and 170 controls available. Seventy-eight participants (ADHD: n=27; sibs: n=17; controls: 
n=34) from the ERN/Pe analysis did not produce enough errors during the Flanker tank to 
provide <20 acceptable ERP segments after processing (approximately 20% of each sample, 
similar to other studies using an identical paradigm: Albrecht et al. (2008) 10-15%; McLoughlin 
et al. (2009) 0-23%; and reflecting a comparable exclusion ratio across groups, χ2(2) = 1.67, p = 
0.43), resulting in a final sample of 82 ADHD, 79 sibs and 136 controls. The impact of genetic 
relatedness between control participants was assessed using a mixed regression model which 
clustered by family status, and was found to not alter results. In the full sample, for both N2 
and ERN analyses, the groups did not differ in mean age, although in sub-samples employed in 
secondary analysis there was a significant age difference between groups which was 
subsequently statistically controlled (Table 3.1). In all the group compositions studied, there 
were significant IQ and gender distribution differences between groups, which were also 
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controlled for during analysis. To assess the effects of IQ differences on reported findings the 
primary analysis were re-run without controlling IQ.  
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Table 3.1. Mean and standard deviation of Age and IQ, and percentage of gender for each group composition studied.  




Siblings F  p ADHD Control 
ADHD 
Siblings F p 
           
Full Sample n = 105 n = 170 n = 95   n = 82 n = 136 n = 79   
           
Age 18.4 (3.0) 17.8 (2.2) 18.4 (3.3) 2.5 0.09 18.2 (2.8) 17.7 (2) 18.2 (3.3) 1.7 0.19 
IQ 97.6 (15.5) 109.8 (12.5) 102.6 (14.2) 6.3 0.04 97.6 (15.3) 108.9 (12.5) 101.7 (13.2) 19.5 0.001 
Male (%) 85% 76% 41% *52.4 0.001 89% 76% 46% *39.5 0.001 
 
          
Younger subset (11-17) n = 47 n = 86 n = 44   n = 38 n = 73 n = 41   
           
Age 15.6 (1.5) 16 (1.5) 15.7 (1.6) 2.9 †0.06 15.6 (1.3) 16.1 (1.4) 15.6 (1.6) 2.1 0.12 
IQ 95.9 (15.2) 106.1 (12) 97.2 (12) 25.5 0.001 95.5 (14.5) 105.5 (12.4) 98.8 (11.9) 8.5 0.001 
Male (%) 81% 71% 45% *14.0 0.001 87% 70% 49% *13.4 0.001 
 
   
       
Older subset (18+) n = 58 n = 84 n = 51   n = 44 n = 63 n = 38   
           
Age 20.7 (1.6) 19.5 (1) 20.9 (2.2) 15.5 0.001 20.5 (1.5) 19.4 (1) 20.9 (2.3) 12.4 0.001 
IQ 99.6 (15.7) 113.7 (11.8) 107 (14.5) 18.1 0.001 99.4 (15.9) 113 (11.4) 104.8 (13.9) 13.5 0.001 
Male (%) 88% 82% 37% *42.1 0.001 91% 83% 42% *29.4 0.001 
           
 








Participants attended a single research session for cognitive-EEG assessments, IQ assessment 
and clinical interviews. Prior to completing the task, participants completed 2 x 3 minute 
resting state recordings and a Continuous Performance task (Cheung et al., under review, 
Doehnert et al., 2008). ADHD participants were asked to not take stimulant medication 48 
hours before testing, and all participants were asked to refrain from caffeinated drinks and 
nicotine two hours prior to the testing session. 
 
 
3.3.3 Tasks and measures 
 
The task was an adaptation of the Eriksen Flanker paradigm designed to increase cognitive 
load (Albrecht et al., 2009, McLoughlin et al., 2009). In each trial a central black fixation mark 
was replaced by a target arrow (a black 18 mm equilateral triangle). Participants had to 
indicate whether this arrow pointed towards the left or right by pressing corresponding 
response buttons with their left or right index fingers. Two flanker arrows identical in shape 
and size to the target appeared 22 mm above and below the centre of the target arrow 100ms 
prior to each target arrow.  Both flankers either pointed in the same (congruent) or opposite 
(incongruent) direction to the target. As such, conflict monitoring is maximal during the 
incongruent condition. When the target appeared, both target and flankers remained on the 
screen for a further 150 ms, with a new trial being presented every 1650 ms. Trials were 





Congruent versus incongruent and the direction of responses (left versus right) were counter-
balanced and randomised. After each block, feedback was presented on screen to emphasise 
both speed and accuracy, in order to encourage participants to make enough errors to enable 
analysis of ERN/Pe components, and enough correct responses for analysis of N2 components. 
Where participants made >10% errors on congruent or >40% errors on incongruent trials, they 
were instructed to slow down. Where participants made <10% errors on congruent or <40% 
errors on incongruent trials, they were instructed to perform faster. If neither rule applied, 
feedback informed participants to continue the same way. Two practice blocks of 24 trials 
were administered before the real task. Where necessary, participants were told to minimise 
movement or blinking.  
 
  
The two-subtest form of the Wechsler Abbreviated Scale of Intelligence Fourth Edition (WASI-
IV; (Wechsler, 1999)) was administered to all participants to derive an estimate of IQ. 
 
 
3.3.4 EEG recording and analysis 
 
Recording and analysis parameters from McLoughlin et al. (2009) were adopted. The EEG was 
recorded from a 62 channel DC-coupled recording system (extended 10–20 montage), using a 
500 Hz sampling-rate, impedances under 10kΩ, and FCz as the recording reference. The 
electro-oculograms (EOGs) were recorded from electrodes above and below the left eye and at 





EEG data were analysed using Brain Vision Analyzer 2.0 (Brain Products, Germany). Raw EEG 
recordings were down-sampled to 256 Hz, re-referenced to the average of all electrodes, and 
filtered using Butterworth band-pass filters (0.1 to 30 Hz, 24 dB/oct). Ocular artefacts were 
identified using the infomax Independent Component Analysis algorithm (ICA, (Jung et al., 
2000)). Sections of data containing artefacts exceeding ± 100 μV in any channel or with a 
voltage step greater than 50 μV were rejected. All trials were also visually inspected for other 




Data were segmented based on three different response conditions: (1) stimulus-locked 
congruent trials where a correct response was made, (2) stimulus-locked incongruent trials 
where a correct response was made and (3) response-locked incongruent trials where an 
incorrect response was made. Individual averages were created based on each condition, 
requiring at least 20 clean segments for each participant. Baseline correction was applied using 
the -300 to -100 ms pre-target interval (-200 to 0 ms pre-flanker). After averaging, mean 
amplitude was calculated within a designated window, as defined by reference to the grand 
average. For the N2 in both conditions, this was 250 – 425 ms after flanker onset (150 – 325 
ms after the target). For the ERN and Pe this was 0 - 150ms and 150 – 450 ms respectively 




3.3.5 Statistical analyses 
 
Performance measures were total number of correct hits, total number of errors, total number 
of misses, target reaction time (MRT, i.e. mean latency of responding in ms after target onset), 
within-subject variability in reaction times (RTV, SD of RTs). For all measures except total 
misses, scores were calculated independently for congruent and incongruent conditions. All 
performance data were non-normally distributed, and with the exception of RTV, were not 
able to be transformed successfully using any available transformations (cubic, square, square 
root, log, 1/square root, inverse, 1/square, 1/cubic). Group differences were therefore 
compared using non-parametric Kruskal-Wallis tests with appropriate post-hoc pairwise 
comparisons to resolve group differences. RTV data were successfully transformed using the 
1/square transformation and compared using univariate ANOVA and post-hoc comparisons.  
 
 
Maps of the topographic scalp distribution of activity revealed that the N2 and ERN 
components were maximal at fronto-central electrodes (Figure 3.1 and Figure 3.2). We 
analysed stimulus-locked N2 mean amplitude at Fz and FCz, with ANOVA carried out in SPSS 
(factors: group (ADHD, control, sibs), condition (congruent, incongruent) and site (Fz, FCz)). 
Similarly, response-locked ERN mean amplitude in the incongruent condition was also 
compared at Fz and FCz using ANOVA ((factors: group (ADHD, control, sibs), and site (Fz, FCz)), 
with Pe mean amplitude being compared at Cz using univariate ANOVA (factors: group (ADHD, 
control, sibs)). IQ and gender were included as covariates in primary analyses. To examine the 
potential effect of IQ differences on results, primary analyses were re-run without using IQ as a 
covariate. In addition, given the large age range in this study and to further explore 
developmental effects in this ERP data, additional analysis was conducted by dividing the 





Pairwise post-hoc comparisons were conducted for all tests in conjunction with the calculation 
of effect sizes to fully explore the data (eta squared (η2) for main effect and interactions, 
Cohen’s d for post-hoc pairwise comparisons). Based on Cohen’s (1988) estimates for η2, 
0.0099 constitutes a small effect, 0.0588 a medium effect and 0.1379 a large effect; and for 





In comparisons of behavioural performance all measures showed group differences. Post-hoc 
comparisons showed that the ADHD group was significantly different from controls on all 
performance measures, showing fewer correct hits, more commission errors (incorrect 
responses), greater MRT, and greater RTV in both conditions, as well as increased omission 
errors (non-responses) overall (Table 3.2). The ADHD group also differed from the unaffected 
sibling group on some measures recording fewer correct hits in both conditions, more 
commission errors in congruent condition, and greater RTV in both conditions, as well as 
increased commission errors overall. There were no significant differences between the sibling 
and controls groups on any measure. 
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Table 3.2.  Means (standard deviation), significance testing and pairwise comparison for behavioural performance measures on the flanker task. 
 
Mean (SD) Group comparison  Post-hoc pairwise comparison 
 
ADHD Siblings Control H p  A-C A-S S-C 
      
 
   Correct hits cong 175.82 (33.96) 188.62 (17.42) 191.33 (16.72) 43.87 <0.001  <0.001 <0.001 0.4 
Correct hits incong 126.39 (33.91) 141.15 (25.31) 145.18 (23.21) 29.89 <0.001  <0.001 <0.001 0.19 
Commission errors cong 9.55 (15.79) 5.12 (5.74) 4.55 (7.49) 22.09 <0.001  <0.001 0.01 0.89 
Commission errors incong 57.19 (20.77) 51.94 (18.4) 50.1 (18.28) 11.12 0.004  0.002 0.14 0.57 
Omission errors (non-responses) 31.05 (49.43) 13.18 (24.53) 8.84 (22.92) 59.33 <0.001  <0.001 <0.001 0.29 
MRT cong (ms) 353.24 (57.75) 346.54 (37.06) 340.44 (35.65) 7.27 0.03  0.01 0.62 0.24 
MRT incong (ms) 447.66 (53.69) 445.13 (41.93) 436.76 (41.95) 8.69 0.01  0.02 0.97 0.08 
RTV cong (ms) 109.74 (62.42) 89.04 (34.69) 82.28 (32.92) *17.02 <0.001  <0.001 0.002 0.17 
RTV incong (ms) 113.36 (75.02) 90.26 (37.6) 82.8 (34.57) *16.12 <0.001  <0.001 0.003 0.19 
          
 
*indicates F statistic not H. Bold denotes p < 0.05. 
A = ADHD, C = Control, S = unaffected ADHD siblings, MRT = mean reaction time to correct hits, RTV = reaction time variability to correct hits (mean standard 




Table 3.3. ANOVA significance testing and effect sizes for N2, ERN and Pe components across 
ADHD, control and ADHD sibling groups 
 
  Test 
statistic 
(F) 
p-value Effect size 
(η2) 
  
     N2 RM ANOVA    
 
Site (Fz, FCz), Condition (Cong, Incong), 
Group    
 
covariates: IQ and gender    
     
 
Group 0.40 0.67 0.0021 
 
Site 2.10 0.15 0.0057 
 
Condition 10.36 *0.001 0.0265 
 
Site*group 1.86 0.16 0.0101 
 
Site*condition 29.04 *<0.001 0.0108 
 
Condition*group 6.79 *0.001 0.0348 
    
 
     
ERN RM ANOVA    
 Site (Fz, FCz); Group     
 covariates: IQ and gender    
     
 Group 0.68 0.51 0.0046 
 Site 4.13 *0.04 0.0131 
 Site*group 2.25 0.11 0.0143 
     
     
Pe Univariate ANOVA    
 Site (Cz); covariates: IQ and gender    
     
 Group 3.00 *0.05 0.0188 
     
 
RM ANOVA = repeated measures analysis of variance, Cong = congruent condition, Incong = 
incongruent condition. N2 from trials where participants correctly responded to stimuli. ERN 
and Pe from response-locked trials where participants incorrectly responded to target stimuli.  




Table 3.4. Mean amplitude (standard deviation), and pairwise comparisons for N2, ERN and Pe components in ADHD, unrelated controls and unaffected ADHD 
siblings  
  
Mean amplitude in µV (SD) Pairwise comparisons 
 
Condition and site ADHD Control  ADHD Siblings ADHD-Control ADHD-Sibs Control – Sibs 
     
p p p 
        
N2        
 
Congruent Fz 
-3.62 (3.05) -2.89 (2.38) -3.36 (2.59) 
0.20 0.95 0.24 
 
Congruent FCz 
-1.55 (3.33) -1.69 (2.58) -2.01 (2.59) 
0.34 0.18 0.57 
 
Incongruent Fz 
-4.3 (3.37) -3.74 (2.73) -4.02 (2.98) 
0.67 0.88 0.81 
 
Incongruent FCz 
-1.9 (3.61) -2.55 (3.15) -2.65 (3.26) 
†0.06 †0.07 0.81 
     




   
ERN   
  
   
 
Incongruent Fz 
-4.34 (2.54) -4.15 (2.75) -4.63 (2.87) 
0.93 0.42 0.42 
 
Incongruent FCz 
-3.28 (2.73) -4.05 (3.14) -4.28 (3.32) 
0.18 0.19 0.89 
     
   
     
   
Pe 
    
   
 
Incongruent Cz 
5.52 (3.31) 6.33 (3.76) 5.7 (3.65) 
*0.02 †0.06 0.87 
 
       
 




Analysis of N2 amplitude indicated a main effect of condition with mean amplitude being 
enhanced in the incongruent condition (Table 3.3 & 3.4). Site also showed significant 
interaction with condition, with condition also showing a significant interaction with group. All 
significant results had a small effect size. There were no main effects of group or site 
independent of condition. Differences in N2 topographies and amplitude between the two 
conditions were apparent in grand averages and topographic maps (Figure 3.1). Post-hoc 
pairwise comparisons indicated that the ADHD group showed attenuation of N2 amplitude 
compared to both controls and unaffected siblings in the incongruent condition at trend-level 
at FCz, but not Fz. Unaffected siblings did not differ from controls at either FCz or Fz. N2 
amplitude did not differ between any of the three groups in the congruent condition where 
conflict monitoring demands were lowest.  
 
 
ERN mean amplitude showed a main effect of site, with the ERN being greater at Fz than FCz, 
but there was no significant main effect of group (Table 3.3), although grand averages seemed 
to suggest reductions in amplitude in the ADHD group at FCz (Figure 3.2a). The group*site 
interaction was not significant. Pe group comparison was significant, although showed a very 
small effect size. Grand averages (Figure 3.2b) were indicative of attenuated Pe in ADHD and 
siblings compared to controls, although statistical post-hoc comparisons indicated that the 
ADHD group had significantly attenuated Pe amplitude compared to the control group, and 
trend-level attenuation compared to the unaffected sibling group. Conversely, control and 



















Rerunning of the primary analysis without IQ as a covariates did not alter overall N2 results; 
the condition main effect, and site*condition and conditions*group interactions remained 
significant (Table 3.5). However in the post-hoc analysis, the trends for ADHD-control and 
ADHD-sibling differences weakened (Table 3.6). In the ERN analysis, the main effect of site 
became non-significant and the interaction of site*group significant, although post-hoc 
comparisons continued to indicate no significant differences between any of the three groups. 
The Pe analysis weakened slightly to a trend-level overall, but continued to show significant 
attenuation in the ADHD group compared to controls, and trend-level differences between the 
ADHD group and sibling group in post-hoc analyses. 
 
 
Independent analysis of older and younger subsets of the full sample revealed differences 
between the age groups. For the N2, the group aged 11-17 showed a main effect of condition, 
which was absent in the 18+ sample, with both groups also showing significant 
group*condition interactions (Table 3.7). Post-hoc analysis revealed further differences, with 
significant N2 enhancement in the ADHD group compared to controls being observed in the 
younger sample in the congruent condition at Fz electrode. In contrast, in the older subsample 
the ADHD group had attenuated N2 at trend-level compared to controls in the incongruent 
condition at FCz, the more centrally located electrode (Table 3.8). Group differences, either as 
a main effect or interaction with condition, were not observed for the ERN component within 
either age group. The Pe showed trend-level group differences in the younger sample group 
but not the older sample. Exploratory post-hoc analysis in the younger group of these 
components highlighted significant reductions in Pe amplitude in the ADHD group compared 
to controls, and trend-level reductions in amplitude compared to the sibling group, similar to 




Table 3.5. ANOVA significance testing and effect sizes for N2, ERN and Pe components across 
ADHD, control and ADHD sibling groups, without IQ being controlled for in the analysis. 
 
  Test 
statistic 
(F) 
p-value Effect size 
(η2) 
  
     N2 RM ANOVA    
 
Site (Fz, FCz), Condition (Cong, Incong), 
Group    
 
covariates: IQ and gender    
     
 
Group 0.49 0.61 0.0027 
 
Site 4.63 0.32 0.0124 
 
Condition 14.35 *<0.001 0.0372 
 
Site*group 1.78 0.17 0.0095 
 
Site*condition 10.81 *0.001 0.0042 
 
Condition*group 9.74 *<0.001 0.0505 
  
 
       
ERN RM ANOVA    
 Site (Fz, FCz); Group     
 covariates: IQ and gender    
     
 Group 0.57 0.57 0.0039 
 Site 1.51 0.22 0.0049 
 Site*group 5.47 *0.01 0.0353 
     
     
Pe Univariate ANOVA    
 Site (Cz); covariates: IQ and gender    
     
 Group 2.70 †0.07 0.0171 
     
 
RM ANOVA = repeated measures analysis of variance, Cong = congruent condition, Incong = 
incongruent condition. N2 from trials where participants correctly responded to stimuli. ERN 
and Pe from response-locked trials where participants incorrectly responded to target stimuli. † 
trend level (p < 0.07), * p <0.05.  η2 effects sizes:  0.0099 small,  0.0588 medium and  0.1379 
large. Cohen’s d effect sizes: 0.2 small, 0.5 medium and 0.8 large.. Underlined values denote 
those where findings became significant or non-significant in comparison to results from the 




Table 3.6. Mean amplitude (standard deviation) and pairwise comparisons for N2, ERN and 
Pe components in ADHD, unrelated controls and unaffected ADHD siblings, without IQ being 












p p p 
     
N2     
 
Congruent Fz 0.33 0.73 0.12 
 
Congruent FCz 0.70 0.26 0.36 
 
Incongruent Fz 0.13 0.59 0.44 
 
Incongruent FCz 0.10 0.09 0.67 
  
   
  
   
ERN     
 
Incongruent Fz 0.61 0.56 0.25 
 
Incongruent FCz 0.12 0.17 0.94 
  
   
  
   
Pe 
 
   
 
Incongruent FCz *0.03 †0.07 0.99 
 
    
 
† trend level (p < 0.07), * p <0.05. Underlined values denote those where findings became 
significant or non-significant in comparison to results from the primary analysis which 
controlled for IQ differences between groups. 
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Table 3.7. ANOVA significance testing and effect sizes for N2, ERN and Pe components across 11-17 and 18+ subgroups of full sample. 
  Age 11 - 17  Age 18+ 
  F p η
2  F p η2 
     
    
N2 RM ANOVA: Site (Fz, FCz), Condition (Cong, Incong), Group        
 covariates: IQ and gender        
     
    
 
Group 0.93 0.40 0.0106  0.40 0.67 0.0042 
 
Site 0.23 0.63 0.0013  3.24 †0.07 0.0165 
 
Condition 11.82 *0.001 0.0592  0.00 0.99 0.0000 
 
Site*group 0.84 0.43 0.0412  1.31 0.27 0.0648 
 
Site*condition 22.56 *<0.001 0.0172  3.54 †0.06 0.0023 
 
Condition*group 4.12 *0.02 0.0095  6.60 *0.002 0.0134 
    
     
         
ERN RM ANOVA: Site (Fz, FCz); Group; covariates: IQ and gender        
         
 Group 0.13 0.88 0.0017  1.62 0.20 0.0224 
 Site 3.28 †0.07 0.0193  0.68 0.41 0.0048 
 Site*group 2.12 0.123 0.0250  1.04 0.37 0.0146 
         
         
Pe Univariate ANOVA: Site (Cz); covariates: IQ and gender        
         
 Group 2.60 †0.07 0.0315  0.23 0.79 0.0031 
         
RM ANOVA = repeated measures analysis of variance, Cong = congruent condition, Incong = incongruent condition. N2 from trials where participants correctly 
responded to stimuli. ERN and Pe from response-locked trials where participants incorrectly responded to target stimuli. † trend level (p < 0.07), * p <0.05, η2 effects 
sizes: * 0.0099 small, ** 0.0588 medium and *** 0.1379 large. 
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Table 3.8. Mean amplitude (standard deviation), and pairwise comparisons for N2, ERN and Pe components in ADHD, unrelated controls and unaffected ADHD 
siblings  
a) Age 11 - 17 
  
Mean amplitude in µV (SD) Pairwise comparisons 
 
Condition and site ADHD Control  ADHD Siblings ADHD-Control ADHD-Sibs Control – Sibs 
  
   p p p 
        
        
N2  n = 47 n = 86 n = 44    
 
Congruent Fz -4.69 (3.27) -3.43 (2.53) -4.27 (2.5) *0.05 0.73 0.12 
 
Congruent FCz -2.33 (3.77) -2.05 (2.63) -2.87 (2.56) 0.59 0.37 0.13 
 
Incongruent Fz -5.76 (3.75) -4.64 (2.78) -4.99 (2.98) 0.12 0.64 0.35 
 
Incongruent FCz -2.52 (4.47) -3.11 (3.28) -3.5 (3.26) 0.69 0.17 0.29 
     




   
ERN  n = 38 n = 73 n = 41    
 
Incongruent Fz -5 (2.77) -4.91 (3.03) -5 (3.08) - - - 
 
Incongruent FCz -3.52 (3) -4.83 (3.57) -4.46 (3.75) - - - 
     
   
     
   
Pe 
 
n = 38 n = 73 n = 41    
 
Incongruent FCz 5.6 (3.45) 6.51 (4.04) 6.33 (3.85) *0.04 †0.06 0.96 
 





b) Age 18+ 
  
Mean amplitude in µV (SD) Pairwise comparisons 
 
Condition and site ADHD Control  ADHD Siblings ADHD-Control ADHD-Sibs Control – Sibs 
  
   p p p 
        
        
N2  n = 58 n = 84 n = 51    
 
Congruent Fz -2.76 (2.57) -2.35 (2.1) -2.55 (2.41) 0.39 0.83 0.56 
 
Congruent FCz -0.93 (2.82) -1.31 (2.48) -1.27 (2.41) 0.17 0.31 0.86 
 
Incongruent Fz -3.12 (2.49) -2.81 (2.37) -3.17 (2.73) 0.82 0.64 0.49 
 
Incongruent FCz -1.39 (2.65) -1.99 (2.94) -1.91 (3.09) †0.06 0.11 0.99 
     




   
ERN  n = 44 n = 63 n = 38    
 
Incongruent Fz -3.76 (2.18) -3.26 (2.09) -4.22 (2.6) - - - 
 
Incongruent FCz -3.08 (2.49) -3.13 (2.27) -4.09 (2.82) - - - 
     
   
     
   
Pe 
 
n = 44 n = 63 n = 38    
 
Incongruent FCz 5.45 (3.23) 6.13 (3.42) 5.01 (3.34) - - - 
 
       
 




3.5 Discussion  
 
In this study of N2, ERN and Pe components in the flanker task on a large sample of ADHD 
children and young adults we report a significant group*condition interaction in the N2,  
limited evidence for group differences on the ERN, and evidence for attenuation of the Pe 
component in ADHD. These results demonstrate impaired conflict monitoring and conscious 
error processing in ADHD. We also report highly significant differences between ADHD and 
control groups in all performance indices with fewer correct hits, increased commission errors, 
greater MRT and RTV, and increased omission errors being observed in the ADHD group, 
suggesting that these deficits may have contributed to impaired performance. Comparisons 
with siblings showed no differences from controls, with the ADHD group also having 
significantly reduced performance compared to siblings on many of the measures. We 
therefore find no evidence for performance monitoring deficits being an endophenotype for 
ADHD in the present study of adolescents and young adults.   
 
 
Few of the performance indices were included in the meta-analytic results of behavioural data 
from adolescents and adult samples in Guburek et al. (2013); however, the present study does 
replicate their findings of increased commission errors in ADHD for flanker task performance 
data, in an equivalently sized ADHD sample. Two studies have tested RTV in the flanker, also 
reporting significantly greater variability in the ADHD group in adults (McLoughlin et al., 2009), 
and in adolescents (Albrecht et al., 2008), which we confirm in this sample. It is worth noting 
that these two studies and this investigation have all used an identical 3-arrow array version of 
the flanker task, with flanker arrows appearing 100 ms before the target arrow, which may be 
particularly effective at eliciting RTV differences, and may also underpin the consistency of 
these results. The value of measuring RTV is further highlighted by several other 
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neuropsychological studies which present evidence showing that RTV is a robust performance 
measure of ADHD (Adamo et al., 2012), potentially more so than for rates of errors (Kuntsi et 
al., 2010). Increasingly, studies are demonstrating that the examination of performance 
variability may be increasingly important in the understanding of cognitive impairments in 
ADHD, as performance may significantly improve by rewards or medication (Andreou et al., 
2007, Castellanos et al., 2005, Epstein et al., 2006, Kuntsi et al., 2009, Leth-Steensen et al., 
2000, McLoughlin et al., 2014b, Uebel et al., 2010). It would therefore be of benefit if future 
investigations could consistently report measures of variability such as RTV alongside MRT and 
other behavioural indices.  
 
 
The flanker task, unlike the Go/NoGo paradigm, requires the participants to respond correctly 
or incorrectly to every trial. Although rates of omission errors (non-responses) were low 
compared to commission errors for all three groups, the ADHD group had a higher number of 
omission errors than control or sibling groups. This index may therefore be capturing 
performance interference arising from lapses in attention, which would prevent participants 
making correct or incorrect responses to targets during the task. It may therefore be valuable 
for future studies to also examine this measure independently of commission errors, to 
quantify if these markers represent different aspects of cognitive deficits in ADHD. 
 
 
Trend-level N2 attenuation was observed in the ADHD group compared to both controls and 
unaffected siblings in the incongruent condition at FCz but not Fz, and not in the congruent 
condition. Firstly, this suggests that ADHD-sibling or ADHD-control differences may only 
emerge in high conflict conditions, and not when conflict demands are minimal. This is 
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consistent with the computational model of conflict monitoring, which suggests that the N2 
represents dominant correct response programming before the correct response, which is 
then reinforced by continued stimulus processing (Yeung and Cohen, 2006). Critically, N2 
amplitude is dependent on levels of conflicting incorrect stimuli processing (i.e. attending to 
the flanker stimuli) and thus the level of cognitive processing needed to overcome this. 
Applying this model to our findings of potential N2 attenuation in the ADHD group, our 
findings could suggest that this group did not perceive differences between flankers and 
targets and thus had reduced conflict processing. This theory is supported by performance 
data which showed that the ADHD group had an elevated number of omission errors, which 
may be indicative of increased lapses in attention, and highlights potential reduced attentional 
application to the task in the ADHD group. 
 
 
We note that the pattern of results differed by electrode site, with all groups having 
comparable N2 mean amplitude at Fz where N2 amplitude was maximal. This, in addition to 
the absence of a group main effect, demonstrates that overall mean amplitude, and therefore 
the degree of conflicting incorrect response processing according to Yeung and Cohen (2006), 
did not differ between ADHD, sibling and control groups. However, the significant 
site*condition and condition*group interactions, supported by topographic maps of N2 mean 
amplitude, indicate that correct response programming may have been carried out differently 
in the ADHD group, having a more frontal scalp topography for the N2 component compared 





Secondary analysis to examine the effect of IQ differences on results showed a small but 
significant effect on findings, slightly weakening several comparisons beyond significance 
thresholds when IQ was not controlled for. These results are consistent with similar 
exploratory analysis presented in chapter two (Kitsune et al., 2014), which further 
demonstrates the importance of considering the contribution from lower mean IQ when 
studying groups where this is common, such as within ADHD samples.  
 
 
Within the age ranges of our sample, high levels of cortical maturation are underway, 
particularly in the prefrontal cortex and anterior cingulate cortex (Botvinick et al., 2001, Rubia 
et al., 2000, Shaw et al., 2007), thought to be source of the N2 and ERN components 
(Segalowitz and Dywan, 2009). In order to explore potential developmental differences across 
age, the sample was divided into 11-17 and 18+ groups and analysed separately. 
Group*condition interactions for N2 amplitude emerged at both time points, as with the 
primary analysis, yet post-hoc analysis revealed a different pattern of ADHD-linked differences 
compared to controls within each sub group, with the suggestion of frontal enhancement in 
the younger subset, and fronto-central attenuation in the older group. This contrast by age is 
suggestive of changing markers for atypical cortical maturation across adolescent and 




There was limited evidence of ERN differences between the groups, which was unexpected 
given our large sample and high power to detect differences. For the Pe, there was evidence of 
attenuation in the ADHD group, indicating potentially reduced conscious error awareness in 
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children and adolescents with ADHD. Indications of potential Pe differences appeared stronger 
in the younger subgroup, but were absent in older subgroup, which is also consistent with 
other studies which have tended to find attenuated Pe amplitude in children opposed to adults 
(Herrmann et al., 2010, Jonkman et al., 2007, Rosch and Hawk, 2013). It has been argued that 
the Go/NoGo paradigm is more sensitive than the Flanker Task at detecting Pe attenuation in 
ADHD, as results have been more consistent to date (Groom et al., 2010, Groom et al., 2013, 
O'Connell et al., 2009a, Wiersema et al., 2009). However, our findings support the assertions 
of recent meta-analysis that more consistent Pe attenuation in the Flanker task was likely to 
emerge given additional data (Geburek et al., 2013). 
 
 
ERN attenuation in ADHD was not apparent despite this finding being reasonably consistent 
among studies of children, adolescent and adults using the flanker paradigm (Albrecht et al., 
2008, Chang et al., 2009, Herrmann et al., 2010, McLoughlin et al., 2009, Rosch and Hawk, 
2013, van Meel et al., 2007). Those studies which have not reported differences have either 
consisted of small samples (Jonkman et al., 2007, Wild-Wall et al., 2009), or have reported ERN 
attenuation in younger adults with ADHD (mean age (sd) = 24.2 (3.1)) but not older adults 
(mean age (sd) = 40.9 (6.8) (Herrmann et al., 2010). ERN amplitude is known to increase during 
development, assumed to be the result of prefrontal cortex maturation (Segalowitz and 
Dywan, 2009) and then decreases with age in older adults (Falkenstein et al., 2001, Herrmann 
et al., 2010). These factors may therefore alter detectable ADHD-control differences across 
lifespan. However, there was no evidence for ERN differences in this sample either amongst 
older or younger subgroups during secondary analysis, which might suggest that other factors 
such as methodological differences or sample composition may explain the absence of ERN 





Generally studies investigating performance monitoring using the flanker task to date have 
been methodologically heterogeneous, which may partially explain inconsistencies in the 
literature (Shiels and Hawk, 2010). In this study, we adopted a mean amplitude measure as 
this method is more robust to the variability in peak amplitude (latency jitter), which can 
reduce the peak amplitude of ERP component, and may be particularly prevalent in ADHD 
(Lazzaro et al., 1997). The two other studies which used identical 3-arrow array versions of 
flanker task, and reported ERN attenuation in ADHD, both adopted a peak-to-peak measure of 
the ERN in reference to the preceding positive component, which may be susceptible to peak 
amplitude reductions on account of individual trial variability (Albrecht et al., 2008, 
McLoughlin et al., 2009). Our results may therefore be a more accurate reflection of 
unconscious error processing in ADHD, advancing that overall ERN amplitude is not reduced, 
only more variable on a trial by trial basis. Indeed, more recent studies suggest that measuring 
the variability in brain oscillations which underlie cognitive performance may be critical in 
understanding ADHD (McLoughlin et al., 2014b), and show that additional research using 
alternative methods is required to conclusively demonstrate whether ERN attenuation has a 
functional relationship with ADHD or whether the mixed findings to date have been a product 
of the variety of methods employed within the literature (Shiels and Hawk, 2010). 
 
 
A further aim of this study was to examine if performance monitoring deficits showed the 
characteristics of a familial endophenotype, in that ‘intermediate’ deficits were apparent in 
first degree relatives, as suggested by other studies (Albrecht et al., 2008, McLoughlin et al., 
2009). Although the large sample employed in this study should have meant it was well placed 
to detect familial factors hinted at in Albrecht et al. (2008), unaffected ADHD siblings did not 
differ from controls in any of the comparisons of performance or electrophysiological 
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measures which otherwise showed ADHD-control differences. Given that no differences were 
detected on performance measures between controls and ADHD siblings either, this suggests 
that methodological differences in ERP analysis are unlikely to be sole cause of differences in 
results between this study and others, and therefore questions whether performance 
monitoring deficits do represent familial endophenotypes for ADHD. However, although no 
statistically significant differences were present between siblings and controls for Pe, the 
grand average graphs and means did imply that ADHD and siblings showed similar attenuation 
in the Pe component, suggesting sample differences which were managed by the use of 
covariates may modify results. Further research will be required to clarify this matter, and the 
application of techniques such as sibling modelling is likely to give more information, such as 
whether ERP markers of performance monitoring deficits show familial covariation. 
 
 
Overall, this study found evidence of altered performance monitoring processes in ADHD 
under high conflict conditions, with the ADHD showing a more frontally orientated topographic 
distribution of amplitude compared to controls, but with no overall differences where 
amplitude is maximal. Evidence of unstable deficits across older and younger subgroups argues 
for the differences being driven by atypical maturational processes in ADHD. No familial effects 
were detected, with unaffected ADHD siblings being indistinguishable from unrelated controls. 
Also despite a large sample, effect sizes were small, suggesting sample heterogeneity and/or 
methodological differences between studies may complicate the detection of stable 
performance monitoring biomarkers for ADHD. There was also evidence of impaired conscious 
error processing in ADHD, particularly among younger subgroups, alongside evidence of 
increased omission errors, which could be linked with lapses in attention, and greater RTV. This 
study did not find evidence of impaired unconscious error processing in this large sample of 
ADHD children and young adults, contrary to other studies including a meta-analysis with a 
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sample size equivalent in size to this investigation. Further replication will be required to fully 
evaluate these results in light of other studies, to determine if methodological factors are 





Chapter 4 - Delineating ADHD and Bipolar 




4.1 Abstract  
 
Overlapping symptoms can make the diagnostic differentiation of attention-
deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) challenging in adults using 
current clinical assessments. This study sought to determine if current clinical measures 
delineate ADHD from euthymic BD in adults, comparing relative levels of ADHD, BD and 
emotional lability (EL) symptoms. Sixty adult women with ADHD, BD or controls were 
compared on self-report and interview measures for ADHD symptoms, mania, depression, EL, 
and impairment.  ADHD interview measures and self-ratings of ADHD symptoms best 
discriminated between ADHD and BD. Self-report measures of EL and depression showed non-
specific enhancement in both clinical groups. BD-specific items may distinguish BD from ADHD 
if a retrospective time-frame is adopted. Using measures which capture specific symptoms of 







The diagnostic differentiation of attention-deficit/hyperactivity disorder (ADHD) from bipolar 
disorder (BD) is important for the correct treatment and management of both conditions 
(Asherson et al., 2014b, Atmaca et al., 2009, Galanter et al., 2005, Mosholder et al., 2009). Yet, 
similarities in symptoms such as restlessness, increased production of speech and distractibility 
in both conditions and evidence of persistent impulsive behaviours in euthymic BD (Najt et al., 
2007, Peluso et al., 2007) can make differentiation of the two conditions challenging (Kent and 
Craddock, 2003, Galanter and Leibenluft, 2008). The emergence of evidence showing high 
levels of emotional lability (EL) in ADHD (Barkley and Fischer, 2010, Skirrow et al., 2012, 
Skirrow et al., 2014, Surman et al., 2013), independent of comorbidity (Skirrow et al., 2012), 
and the recognition of EL as an associated feature of ADHD (American Psychiatric Association, 
2013), further complicate the diagnostic boundaries between ADHD and BD. Meta-analysis 
examining comorbidity of ADHD and BD in adults identified rates ranging from 5-47% (Wingo 
and Ghaemi, 2007), and studies of familial co-variation indicate that the disorders co-occur at a 
higher rate than in the general population, suggesting a potential familial relationship between 
them (Skirrow et al., 2012, Larsson et al., 2013).  
 
 
Although delineation has been widely discussed in paediatric populations, there are few 
studies comparing the extent to which symptoms are similar or different between ADHD and 
BD in adult populations. The few direct comparisons used self-report measures of ADHD and 
depression symptoms, which were limited in their potential to delineate the two disorders 
(Ibanez et al., 2012, Torralva et al., 2011). The comparative degree and specificity of EL within 
each disorder is also an important question to clarify, as mood fluctuations are seen as a 
characteristic feature of BD, and could result in the misdiagnosis of adults with ADHD and high 
EL. The aim of this study was to determine the potential of current clinical measures to 
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delineate ADHD from BD in adults, comparing relative levels of ADHD, BD and EL symptoms 
across the two disorders. 
 
 




Sixty adult women were recruited (20 with ADHD, 20 with BD and 20 control 
participants). Participants with ADHD were recruited from the National Adult ADHD 
Clinic at the Maudsley Hospital. Participants with BD were recruited from the 
Maudsley Psychosis Clinic and a sample that had previously participated in another 
research study (Hosang et al., 2012). Control participants were recruited from the 
Mindsearch volunteer database maintained by the Institute of Psychiatry, which 
comprises several thousand potential participants. Participants were randomly 
selected from all those meeting recruitment criteria for this study (described below).  
 
 
4.3.2 Diagnosis and recruitment 
 
Fifty-seven people with ADHD, 75 people with BD, and 120 controls matching 
requirements of age, gender and clinical diagnosis based upon DSM-IV criteria were 
approached to participate. The ADHD participants met current criteria for combined-
type ADHD or inattentive-type ADHD with sufficient past reported symptoms of 
hyperactivity-impulsivity to have met combined-type criteria during childhood. 
102 
 
Participants in the BD group had a diagnosis of bipolar I disorder (BD-I) with evidence 
of a past manic episode lasting one week or more. BD-I patients were selected if they 
were currently euthymic. Eligibility to participate was ascertained by checking medical 
records for details of diagnosis and psychiatric history. Exclusions for all groups were 
drug or alcohol dependency in the last six months, autism, epilepsy, neurological 
disorders, brain injury, past ECT treatment, current involvement in another research 
trial likely to alter symptomatology, pregnancy or a limited proficiency in English 
language. Those with a reported diagnosed comorbidity of both ADHD and BD at 
screening or who were currently experiencing a manic episode were excluded. Other 
comorbidities in the clinical groups were permitted. This included one participant with 
comorbid Depression and one with Obsessive Compulsive Disorder (OCD) in the ADHD 
group, and one participant with comorbid anxiety disorder and one with borderline 
personality disorder (BPD) in the BD group. All primary analyses were later re-run after 
excluding these individuals, to check for the influence of these comorbidities on 
results. Control participants reporting a history of psychiatric disorders or currently 
taking medication at screening were excluded. Recruitment continued until 20 
participants were recruited for each group (Table 4.1). Samples were age-matched at a 
group level during recruitment. ADHD participants were asked to stop stimulant 
medication 48-hours before research assessments. For ethical reasons, BD participants 
were not asked to stop taking mood-stabilisers or any anti-psychotic medication they 
had been prescribed. All participants were asked to refrain from caffeinated drinks and 





Table 4.1. Number of participants recruited and reasons for exclusion.   
     
  
ADHD BD Control 
Number approached 57 75 120 
     Recruitment 
   
 
Un-contactable 17 26 45 
 
Declined 4 15 25 
 
Travel or childcare difficulties 5 4 5 
 
Did not attend or cancelled 1 1 13 
     Exclusions 
   
 
Unsuitable diagnosis  3 7 
 
 
ADHD with comorbid BD 4 
  
 



























     Final Sample 20 20 20 
 
Abbreviations: attention-deficit/hyperactivity disorder (ADHD), bipolar disorder (BD), 
electroconvulsive therapy (ECT). An “unsuitable diagnosis” was a diagnosis of BD-II (i.e. without 
a manic episode) in the BD group, or an inattentive-subtype ADHD diagnosis with no evidence 





Participants attended a single research session to complete self-report measures and clinical 
interviews alongside other research evaluations. All participants completed the same set of 
assessments. For informant ratings, participants were given a questionnaire to take home in a 
stamped address envelope, for a family member or close friend to complete. Interviews were 
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conducted by an experienced researcher (GK), trained by a consultant psychiatrist (PA) with 





4.3.4.1 ADHD symptoms 
 
Measures of ADHD symptoms were obtained using the 18-item Barkley Adult ADHD Rating 
Scale (BAARS-IV) (Barkley and Murphy, 2006), which consists of the DSM-IV items related to 
inattention and hyperactivity–impulsivity. Respondents indicated how frequently they 
experienced behaviours on a scale of 0 to 3 (never or rarely, sometimes, often, very often) 
during the past 6 months. Total scores were calculated for each symptom dimension. The 
Barkley’s functional impairment scale (Barkley and Murphy, 2006) used the same scoring 
system and was included with the (BAARS-IV) to create a third impairment subscale, indexing 
functional impairments across several domains including occupational, daily responsibilities 
and social relationships. Both self-rated and informant-rated versions of the BAARS-IV were 
used to obtain measures of ADHD symptoms.  
 
 
The Diagnostic Interview for ADHD in Adults (DIVA) (Kooij and Francken, 2007) was used to 
assess ADHD symptoms in participants. The DIVA, like the BAARS-IV, consists of 18 items used 
to define the DSM-IV symptom criteria for ADHD, but is a semi-structured interview conducted 
by a trained clinical investigator. Each item is scored “yes”, if the behavioural symptom is 
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present often within the past 6 months. Outcomes were total current ADHD symptom score, 
and separate totals for inattentive and hyperactive-impulsive symptom domains.  
 
 
4.3.4.2 Mania and depression symptoms 
 
The Beck’s Depression Inventory II (DI) (Beck et al., 1996) was included as a self-rated measure 
of depression symptoms. The scale has 21 questions, rated 0-3 based on the severity of 
symptoms, during the past two weeks. The test variable was total score. 
 
 
The self-report Altman Self-Rating Mania Scale (ASRM) (Altman et al., 1997) was used to 
measure mania symptoms in the past week. This is a 5-item measure scored 0-4 based on the 
strength of the behaviour. The total score was used as the test variable. 
 
 
A second measure of mania symptoms was collected using the Young Mania Rating Scale 
(YMRS) (Young et al., 1978), completed by the investigator following clinical interview. This 11-
item measure uses subjective report of mental phenomena and clinical observations to rate 
behaviours associated with mania in the past 48 hours. Seven items are scored 0-4 based on 
severity and the remaining four items (irritability, rate or amount of speech, 
delusional/grandiose thought content, and severe aggressive or uncontrollable behaviour) are 
scored 0-8, as characteristic features of manic episodes. For this study, a change indicator 
asking “Is this how you normally feel?”, scored yes/no, was added to each item to distinguish 
between episodic symptoms which are characteristic of BD, and the more stable trait-like 
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symptoms which are characteristic of ADHD. A further question asking “Has there ever been a 
time other than the last 48 hours when you have felt…”, was added to each of the 8 self-report 
items to count the number of symptoms experienced in the past, including worst ever episode, 
to determine the range of symptoms experienced by BD patients during episodes of mania. 
Outcomes for this measure were total score, number of present symptoms (excluding 
observer-rated items to make this comparable with the past symptoms scale) and number of 
past symptoms.  
 
 
We also examined whether particular items on the YMRS, which related to specific symptom 
domains or loaded on previously identified factors, were able to delineate the two clinical 
groups.  We compared two approaches. The first approach was based on diagnostic criteria for 
ADHD which grouped YMRS items on whether they overlapped with ADHD symptoms 
(increased motor activity/energy, increased rate of production of speech, and 
language/thought disorder including distractible thought processes and changing topics 
frequently); or did not overlap with ADHD (inappropriate elevated mood, 
increased/inappropriate sexual interest, delusions and grandiosity, and severe 
disruptive/aggressive or uncontrollable behaviour); or are associated features of ADHD that 
overlap with BD (difficulty sleeping and irritable mood). The second approach used three 
groupings previously identified by Hanwella and de Silva (2011) in a factor analysis of YMRS 
items, which were labelled: irritable mania (increased motor activity/energy, irritable moods, 
and severe disruptive/aggressive or uncontrollable behaviour); elevated mania (elevated 
mood, language/thought disorder, sexual interest and insight); and psychotic mania (increased 





4.3.4.3 Emotional lability 
 
The self-rated Affective Lability Scale Short Form (ALS-SF) (Oliver and Simons, 2004), 
comprising of 18 items scored 1-4 (very un-descriptive, rather un-descriptive, rather 
descriptive, very descriptive) was used as one of two measures of mood lability. The ALS-SF 
measures fluctuations from a normal mood to other emotional states from moment to 
moment during the past week, and has been shown to comprise of three domains of anxiety–
depression, depression–elation and anger (Oliver and Simons, 2004). Total overall score and 
total score on each subscale were used as the test variables.  
 
 
The second measure of emotional lability was the auxiliary subscale of the Centre for 
Neurologic Study-Lability Scale (CNS-LS) (Moore et al., 1997), adapted by removing two items 
related to impatience which have clear overlap with impulsive symptoms of ADHD. This 
created a self-rated 8-item measure focusing on negative emotions, such as getting easily 
frustrated, upset and angry occurring in the past month and past 5 years. Each item is scored 
on a scale of 0-4 (applies never, rarely, occasionally, frequently, most of the time), based on 
the frequency of each experience. Total scores for the past month and past 5 years were used 
as the test variables. 
 
 




The Wechsler Abbreviated Scale of Intelligence Fourth Edition (WASI-IV) (Wechsler, 1999) was 
administered to all participants to derive an estimate of IQ. 
4.3.5 Statistical Analyses 
 
Across the three samples, rating scale data were normally distributed for the BAARS-IV 
impairment scales (self-rated and informant), the ALS total score and the hyperactive-
impulsive subscale of the DIVA. Otherwise, the most appropriate transformations were applied 
to the data (log or square-root). For the ALS and YMRS subscales, no available transformations 
normalised the data, so non-parametric Kruskal-Wallis tests were used. Group differences in 
normal and transformed-normal data were tested using univariate ANOVAs. Where 
appropriate, pairwise comparisons were conducted to discriminate which groups differed. On 
the YMRS, the number of symptoms past and present were compared using repeated-
measures ANOVA to explore the interaction of group and symptom change over time. 
Additional post-hoc pairwise comparisons were used to investigate both group differences and 
differences between the number of past and presents symptoms within group. Analyses were 
carried out using STATA (Version 11) and SPSS (Version 21). Given the large number of 
subscales used in this study, and therefore high number statistical comparisons and associated 
risk of type-I error, all reported p-values were adjusted for multiple testing using family-wise 
Bonferroni corrections to maintain α = 0.05 for all 20 independent tests employed in the 




The groups did not differ in mean age (Mean (SD): ADHD = 37.4 (7.65); BD = 40.3 (7.68); 
Control = 36.7 (4.28); F = 1.63, p = 0.21) or IQ (Mean (SD): ADHD = 104.5 (17.85); BD: 108 
(12.50); Control = 112.35 (14.21); F = 1.37, p = 0.26). Mean scores on outcome measures with 
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adjusted p-values are shown in Table 4.2 and the standardised differences between groups for 
all measures are shown in Figure 4.1.
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Table 4.2.  Mean and standard deviations for ADHD and BD symptom measures and emotional lability measures.  
      PAIRWISE  COMPARISONS 
  
 ADHD BD Controls ADHD-BD ADHD-Control BD-Control 
  
total n Mean (SD) Mean (SD) Mean (SD) Adj. p Adj. p Adj. p 
BAARS-IV  self-rated  
   
   
 
Inatt score 58 19.17 (6.22) 8.40 (4.39) 4.35 (2.91) 
<0.001*** <0.001*** 0.01** 
 
Hyp-Imp score 60 15.75 (6.23) 7.75 (5.26) 5.55 (3.62) 
<0.001*** <0.001*** 0.38 
 
Impairment score 58 19.58 (7.58) 10.00 (5.26) 2.85 (3.84) 
<0.001*** <0.001*** <0.001*** 




   
 
Inatt score 51 12.38 (5.67) 8.60 (5.63) 3.85 (3.53) 
0.18 0.001*** 0.03* 
 
Hyp-Imp score 51 9.94 (5.63) 7.07 (5.15) 4.90 (4.89) 
0.34 0.02* 0.80 
 
Impairment score 50 12.47 (7.51) 9.07 (6.35) 3.25 (3.92) 
0.37 0.001*** 0.02* 
DIVA 
 
    
   
 
Total score 60 13.45 (3.02) 4.95 (3.27) 3.35 (2.96) 
<0.001*** <0.001*** 0.34 
 
Inatt symptoms 60 7.55 (1.61) 2.95 (2.14) 1.65 (1.57) 
<0.001*** <0.001*** 0.10 
 
Hyp-Imp symptoms 60 5.90 (2.36) 2.00 (2.03) 1.70 (1.78) 
<0.001*** <0.001*** 1.94 
      
   
ASRM 
 
    
   
 
Total score 58 4.63 (3.98) 4.95 (5.03) 2.42 (2.09) 
2.66 0.31 0.39 
YMRS 
 
    
   
 
Total  score 60 13.35 (7.35) 10.05 (8.06) 6.15 (5.68) 
0.07 0.003** 0.74 
 
No. current symptom 60 4.70 (2.03) 3.95 (2.28) 2.80 (1.91) 




* p < 0.05, ** p < 0.01, *** p < 0.001. “Adj p” family-wise Bonferroni corrected post-hoc p-values. “State change (past 48h)” indexes manic-like symptom change in 
the past 48 hours (appearing or disappearing). Other abbreviations: Inattention (Inatt), Hyperactive-Impulsive (Hyp-Imp), Barkley Adult ADHD Rating Scale-IV 
(BAARS-IV), Diagnostic Interview for ADHD in Adults (DIVA), Altman Self-Rating Mania Scale (ASRM), Young Mania Rating Scale (YMRS), Beck Depression Inventory 
(DI), Affective Lability Scale (ALS), Centre for Neurologic Study-Lability Scale (CNS-LS). 
      PAIRWISE  COMPARISONS 
   ADHD BD Controls ADHD-BD ADHD-Control BD-Control 
  total n Mean (SD) Mean (SD) Mean (SD) Adj. p Adj. p Adj. p 
 
No. past symptoms 60 4.60 (1.47) 7.10 (1.86) 2.35 (1.87) 
0.03** <0.001*** <0.001*** 
 
State change (past 48h) 60 2.05 (1.54) 2.75 (1.97) 1.70 (1.49) 
1.08 1.49 0.11 
DI 
 
    
   
 
Total score 60 17.50 (14.54) 11.90 (11.11) 4.35 (4.03) 
0.33 <0.001*** 0.003*** 
      
   
ALS-SF 
 
    
   
 
Total score 60 41.35 (12.73) 35.65 (12.87) 24.50 (6.61) 
0.33 <0.001*** 0.01** 
 
Anxiety-depression score 60 11.50 (4.71) 10.15 (4.64) 7.25 (2.27) 
0.70 0.01** 0.20 
 Elation-depression score 60 19.45 (5.17) 17.80 (7.05) 11.55 (3.79) 
1.10 <0.001*** 0.01** 
 Anger score 58 10.61 (4.86) 7.70 (2.79) 5.70 (1.81) 
0.11 <0.001*** 0.34 
CNS      
   
 Past month score 59 15.79 (11.21) 7.45 (5.24) 3.60 (4.03) 
0.03* <0.001*** 0.10 
 Past 5 year score 59 19.32 (11.34) 11.75 (6.09) 5.70 (3.67) 




Figure 4.1. Group differences on ADHD, mania, depression and emotional lability measures, as standardised scores with standard error. 
Standardised means total scores for each measure or subscale. ADHD symptoms are presented in the first part, mania and depression symptoms in the second and emotional 
lability in the third part of this graph. “Change (48h)” indexes manic-like symptom change in the past 48 hours (appearing or disappearing). “No. Sym Past” measures current 
manic-like symptoms, “No. Sym Past” measures symptoms experienced in the past. Other abbreviations: Inattention (Inatt), Hyperactive-Impulsive (Hyp-Imp), Anxiety-Depression 
(AnxDep), Elation-Depression (ElaDep), Barkley Adult ADHD Rating Scale-IV (BAARS-IV), Diagnostic Interview for ADHD in Adults (DIVA), Altman Self-Rating Mania Scale (ASRM), 
Young Mania Rating Scale (YMRS), Beck Depression Inventory (DI), Affective Lability Scale (ALS), Centre for Neurologic Study-Lability Scale (CNS-LS).




4.4.1 ADHD Symptoms 
 
Group differences were present for: DIVA total symptom score (F(2,57) = 37.65, p < 0.001), 
inattention (F(2,57) = 33.68, p < 0.001) and hyperactive-impulsive subscales (F(2,57) = 25.65, p 
< 0.001); self-rated BAARS inattention (F(2,55) = 40.51, p < 0.001) and hyperactive-impulsive 
(F(2,57) = 18.39, p < 0.001) subscales; and informant-rated BAARS inattention subscale (F(2,48) 
= 12.05, p = 0.01). Post-hoc analysis indicated that both ADHD and BD groups had higher ADHD 
symptom scores than controls on self and informant reported ADHD rating scales. However, 
only the ADHD group had higher current ADHD symptom scores compared to controls when 
the DIVA interview was used as the measure of ADHD symptoms.  
 
 
The ADHD group had significantly higher symptoms than the BD group for the DIVA and self-
rated BAARS scores, but not for the informant-rated BAARS. To quantify the degree to which 
the DIVA and self-rated BAARS scores can distinguish between patients with ADHD and 
euthymic BD we calculated receiver operating characteristic (ROC) scores. To compare the 
BAARS with the DIVA we made binary variables from the BAARS scores for the absence (never, 
rarely or sometimes) or presence (often, very often) of each individual ADHD item. The results 
are summarised in Table 4.3 with optimal thresholds that balance sensitivity against specificity. 
There was very good sensitivity (90%) and specificity (95%) for the DIVA interview, particularly 
for the inattentive items when the symptoms threshold of 6 or more symptoms was applied. 
This compared to a much lower sensitivity of 65-70% using the BAARS, although specificity 





Table 4.3. Receiver Operating Characteristics (ROC) scores showing sensitivity and specificity 
of BAARS and DIVA measures to ADHD diagnosis compared to BD diagnosis. 
 
 
Abbreviations: Barkley Adult ADHD Rating Scale (BAARS), Diagnostic Interview for ADHD in 





Ratings of impairment showed significant group differences on both self-rated (F(2,55) = 41.55, 
p < 0.001) and informant (F(2,47) = 10.92, p = 0.003) scales. Both clinical groups reported 
elevated impairment compared to controls on both scales. The ADHD group had elevated 
scores compared to the BD group on the self-report measure, but not the informant measure. 
 
  
 ROC scores  
 AUC Threshold Sensitivity Specificity 
     
BAARS inattention 0.87 6/9 0.70 0.95 
BAARS hyper-imp 0.83 6/9 0.45 0.90 
BAARS total score 0.89 11/18 0.65 1.00 
     
DIVA inattention 0.95 7/9 0.90 0.95 
DIVA hyper-imp 0.89 6/9 0.55 0.90 
DIVA total score 0.97 11/18 0.90 0.95 
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4.4.3 Mania and depression 
 
Group differences in self-reported current manic symptoms on the ASRM were not significant 
(F(2,55) = 1.71, p = 1.00). Self-rated current depression symptoms on the DI showed group 
differences (F(2,57) = 13.79, p < 0.001), with both ADHD and BD groups reporting higher scores 
than controls, but not differing compared to each another (Table 4.2). 
 
 
The YRMS interview showed a nominal group difference in total score for current symptoms 
(unadjusted p = 0.005), which did not survive α-correction (F(2,59) = 5.78, p = 0.10). On the 
extension questions added for this study, the groups did not differ in the proportion of mania 
symptoms which had changed within the past 48 hours (F(2,57) = 1.31, p = 1.00). A repeated-
measures ANOVA, comparing the number of past symptoms with the number of present 
symptoms, showed a significant main effect of group (F(2,57) = 6.88, p < 0.001), time period 
(F(1,57) = 15.56, p = 0.01) and interaction of time period x group (F(2,57) = 12.03, p < 0.001). 
Overall, post hoc tests indicated that the BD group had a higher number of mania symptoms in 
the past, but that the two clinical groups did not differ in the number of current symptoms. 
The ADHD group also showed more current mania symptoms than controls, although BD-
control differences were not significant (Table 4.2). 
 
 
We further examined if subsets of items from the YMRS were better able to discriminate ADHD 
from BD than the full measure, based on symptom frequency (Table 4.4). The symptom-based 
division of items only discriminated ADHD from BD using the non-ADHD overlapping symptoms 
grouping (inappropriate elevated mood, increased/inappropriate sexual interest, delusions 
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and grandiosity, and severe disruptive/aggressive or uncontrollable behaviour) and then only 
for past ‘worst episode’ symptoms and not current symptoms. Both clinical groups had 
elevated scores compared to controls on the ADHD overlapping symptom grouping (increased 
motor activity/energy, increased rate of production of speech, and language/thought disorder 
including distractible thought processes and changing topics frequently) for both current and 
past symptoms, but did not differ between themselves. The shared associated symptom 
grouping (sleep disturbance and irritability) indicated elevated scores for past symptoms in the 
BD group compared to controls, but no differences for other comparisons. The factor-based 
item groupings did not show any group differences for current symptoms. For past symptoms, 
on both elevated mania (elevated mood, language/thought disorder, sexual interest and 
insight) and psychotic mania (increased motor activity/energy, motor activity, delusions and 
grandiosity and appearance) item groupings the BD group had elevated scores compared to 
ADHD and controls. Additionally, on the psychotic mania cluster the ADHD group had higher 
scores than controls. For irritable mania items (increased motor activity/energy, irritable 
moods, and severe disruptive/aggressive or uncontrollable behaviour) both clinical groups 
scored higher than controls, but did not differ compared to one another. 
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Table 4.4. Young Mania Rating Scale (YMRS), a comparison of different item groupings to delineate ADHD from bipolar disorder. 




  Kruskal-Wallis  Pairwise Comparisons 
  
  ADHD-BD ADHD-Control BD-Control 
  
H Adj. p Adj. p Adj. p Adj. p 
Symptoms based      
 
ADHD overlapping 17.27 <0.001*** 0.32 <0.001*** 0.04* 
 
ADHD non-overlapping 0.21 1 - - - 
 
Shared ADHD associated 9.14 0.12 - - - 




F1. Irritable mania 8.68 0.16 - - - 
 
F2. Elevated mania 5.25 0.86 - - - 
F3. Psychotic mania 4.94 1 - - - 
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B) Past number of symptoms 
 
 
* p < 0.05, ** p < 0.01, *** p < 0.001. “Adj p” batchwise Bonferroni corrected post-hoc p-values. Symptom-based item groupings consisted of the following items: 
ADHD overlapping (increased motor activity/energy, increased rate of production of speech, and language/thought disorder including distractible thought 
processes and changing topics frequently), ADHD non-overlapping (inappropriate elevated mood, increased/inappropriate sexual interest, delusions and 
grandiosity, and severe disruptive/aggressive or uncontrollable behaviour), and shared ADHD associated symptoms (difficulty sleeping and irritable moods). Factor-
analysis based item groupings consisted of the following items: irritable (increased motor activity/energy, irritable moods, and severe disruptive/aggressive or 
uncontrollable behaviour), elevated mania (elevated mood, language/thought disorder, sexual interest and insight), and psychotic mania (increased motor 
activity/energy, motor activity, delusions and grandiosity and appearance).  
 
  Kruskal-Wallis  Pairwise Comparisons 
  
  ADHD-BD ADHD-Control BD-Control 
  
H Adj. p Adj. p Adj. p Adj. p 
Symptoms based      
 
ADHD overlapping 27.33 <0.001*** 0.98 <0.001*** <0.001*** 
 
ADHD non-overlapping 31.54 <0.001*** <0.001*** 1 <0.001*** 
 
Shared ADHD associated 18.21 <0.001*** 0.13 0.09 <0.001*** 




F1. Irritable mania 24.64 <0.001*** 1 <0.001*** <0.001*** 
 
F2. Elevated mania 19.29 <0.001*** 0.006*** 0.67 <0.001*** 
F3. Psychotic mania 32.89 <0.001*** 0.02* 0.02* <0.001*** 
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4.4.4 Emotional Lability (EL) 
Group differences were detected for ALS total scores (F(2,59) = 11.86, p = 0.001), the elation-
depression subscale (H(2) = 17.60, p < 0.001) and the anger subscale (H(2) = 17.20, p < 0.001). 
Group differences for the anxiety-depression subscale did not survive α-correction (H(2) = 
9.34, p = 0.18). Post-hoc pairwise comparisons did not distinguish ADHD and BD groups on 
either total scores or subscales (Table 4.2). The ADHD group had higher scores compared to 
controls on all scales of the ALS, with the BD group showing higher scores than controls on 
total score and the elation-depression subscale. 
 
 
The CNS-LS, indicated group differences on both time spans (last month: F(2,56) = 11.35, p < 
0.001; last 5 years: F(2,56) = 12.04, p = 0.001). For CNS-LS ratings of EL in the last month, the 
ADHD group had elevated scores compared to both BD and controls, with the BD group not 
differing from controls (Table 4.2). For ratings based on worst ever in the last 5 years, both 






Primary analyses were rerun after excluding the four individuals which had a diagnosed 
comorbidity (ADHD: one depression, one OCD; BD: one BPD, one anxiety disorder). Overall, the 
results did not change with these participants excluded, except for two post-hoc pairwise 
comparisons, which then became non-significant after correcting for multiple testing. These 
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were the ADHD-BD comparison on the CNS-LS (last month), where the adjusted p-value 
became non-significant (adj. p = 0.11, unadjusted p = 0.04) and the ADHD–control comparison 
for the number of present symptoms on the YMRS which weakened to a trend level (adj. p = 





In this study we investigated the similarities and differences between female patients with 
typical ADHD, Bipolar I Disorder (during euthymic periods) and healthy controls, using standard 
measures used in the diagnostic assessment of ADHD and BD. Using ratings for the current 
mental state, increased levels of ADHD and depression symptoms, emotional lability and 
functional impairment were seen in both the ADHD and euthymic BD groups compared to 
controls. The ADHD group generally showed higher levels of psychopathology than the 
euthymic BD group, particularly for current symptoms of emotional lability and mania. Using 
retrospective ratings for mania on the YMRS, which would measure past manic episodes, gave 
higher ratings in the BD than the ADHD group, although both groups had higher ratings than 
the controls. The DIVA interview was the best instrument for separating out the two clinical 
groups, with high sensitivity and specificity for ADHD. Overall, these findings show a significant 
level of residual symptoms and impairments in BD patients during euthymic periods, which 
was similar to the ADHD patients for depression and impairment, but did not reach the levels 






4.5.1 Distinguishing euthymic BD from ADHD  
 
Making this distinction is important because BD patients often present with continued mood 
symptoms and functional impairments in between major affective episodes, raising the 
question of whether any observed psychopathology is due to persistence of BD or could be 
due to comorbid ADHD. Indeed this study showed considerable overlap between euthymic BD 
and ADHD using both rating scale and interview measures. Yet it was possible to distinguish 
between the ADHD and BD groups. We found that the interview measure for current ADHD 
symptoms provided very good sensitivity (around 90%) and specificity (around 95%) to identify 
ADHD in comparison with BD. In contrast, the self-reported ADHD measures showed 
enhancement of scores in both clinical groups, although self-ratings of ADHD inattention were 
moderately good at separating ADHD from BD. For BD the best discrimination came from the 
use of the YMRS mania interview, which was sensitive to differences between ADHD and BD 
groups when using a retrospective ‘worst ever’ adaption included for this study. However, 
even using retrospective data, the ADHD group showed a significant level of symptoms on the 
YMRS, and for current symptoms the ADHD group had more mania symptoms than the 
euthymic BD group. These findings are similar to those reported in previous studies. For the 
ADHD measures, the inattentive symptoms gave the best discrimination of ADHD from BD for 
both the self-rated and interview measure. This is similar to the results of Ibanez et al. (2012), 
who report higher self-rated inattention scores in ADHD compared to BD or control groups 
using the same self-rated scale of ADHD used in this study, although they did not observe a 
significant BD-control difference.  
 
 
The Altman Self-Rating Mania Scale (ASRM) and the Beck Depression Inventory (DI) were not 
able to distinguish the two clinical disorders. High depression scores for both clinical groups 
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highlight that symptoms of depression are commonly seen in ADHD. This replicates findings 
from Torralva et al. (2011) and Ibanez et al. (2012) of elevated depression scores on the DI in 
ADHD compared to BD.  
 
 
Current symptom score and number of current symptoms on the YMRS mania interview 
showed that the ADHD group had higher levels of mania symptoms compared to both the 
controls and the euthymic BD group. These results, collected using the standard form of the 
measure, highlight the potential difficulties of delineating ADHD and BD using cross-sectional 
(present state) mania measures, and replicate findings for Ibanez et al. (2012), which reported 
higher mania symptom scores in the ADHD group compared to controls on this measure. In 
contrast, when the scale was applied to the number of past symptoms, the BD group had a 
greater number of mania symptoms than the ADHD or control groups, even though the ADHD 
continued to report higher past symptoms than controls.  
 
 
Overall, these findings illustrate the considerable overlap of symptoms in ADHD and BD. We 
found greater specificity for the ADHD symptoms elicited at interview to correctly identify the 
ADHD group, than for the traditional BD symptoms to correctly separate BD from ADHD. Thus 
the two disorders can usually be distinguished through a combination of detailed symptom 
review, elicited using a clinical interview, with a consideration of the time course and 
episodicity of the symptoms that are present. These data also illustrate the importance of 
considering ADHD in patients presenting with chronic (non-episodic and trait-like) mood 
symptoms, including symptoms of mania, depression and emotional lability.   
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4.5.2 Use of the YMRS 
 
We completed further exploratory analyses to investigate whether particular YMRS items 
might be specifically associated with either ADHD or BD. We compared a three-cluster DSM 
symptom model (ADHD overlap; no-overlap; mood and sleep problems) against an empirically-
derived three-factor model (irritable mania; elevated mania; psychotic mania) identified by 
Hanwella and de Silva (2011). For current symptom scores, group differences were only found 
on the ADHD overlapping symptoms item grouping, consisting of increased motor 
activity/energy, increased rate of production of speech and language/thought disorder items, 
where both clinical groups scored significantly higher than controls. No other differences were 
found for the symptom-based or factor-based model. In line with our other analysis, this 
implies that the YMRS is poor at distinguishing ADHD and euthymic BD in its standard form.  
 
 
For the number of past symptoms, based on worst ever episode, more differences emerged 
due to the higher number of symptoms reported by the BD group during past manic episodes. 
For the overlapping symptom grouping from the symptom-based model, and the irritable 
mania grouping from the factor-based model, both clinical groups had high scores compared 
to controls, indicating that these clusters both capture shared symptoms. However, only the 
elevated motor activity item was common between them (overlapping items: motor activity, 
speech rate, language/thought disorder; irritable mania: motor activity, irritability, 
disruptive/aggressive behaviour). Scores on item groupings for overlapping symptoms, mood, 
elevated mania and psychotic mania were all higher for the BD group, compared to both ADHD 





Overall, these preliminary findings suggest that ADHD and BD might load separately on specific 
items within the YMRS, and therefore development of a subscale designed to delineate ADHD 
from euthymic BD in adults may be possible. However, as indicated by our findings, any 
measure will require a retrospective component to fully delineate ADHD from BD.  
 
 
4.5.3 Chronicity and validity of symptom measurement 
 
The interview measures provided better discrimination between ADHD and BD. One reason for 
this is likely to be that an interviewer is able to explore both the nature and time course of 
symptoms during an interview, to ensure any reported symptoms meet the question criteria. 
The DIVA measure provides several examples of behaviours associated with each symptom, 
allowing the interviewer to qualitatively explore each symptom before rating as present or 
absent. In contrast, the self-report measures only provide a question, but no examples and rely 
on the interpretation of an untrained person. This means that it is unknown if the items are 
being scored based on equivalent symptoms, as well as severity of symptoms, within each 
clinical group. In terms of the time course, the wording in the rating scales is also more 
ambiguous. For example, the DIVA interview items are scored when symptoms are present for 
at least six months or more. Although to a lesser extent this is also true of the self-report 
ADHD measures, the wording of questions is more ambiguous, stating that symptoms should 
be present during the last six months. These ratings could therefore reflect symptoms of any 






The YMRS, on the other hand, is designed specifically to evaluate manic symptoms in a short-
time window (past 48 hours).  Although our findings suggest that this measure would be 
effective at delineating ADHD from BD as a retrospective measure, or during a BD manic 
episode, it was not effective at delineating ADHD from euthymic BD based on current 
symptoms alone. The YMRS therefore has discriminatory potential, and could be adapted 
either through development of a specific subscale using items which load selectively onto one 
of the clinical disorders, or by adapting the measure to compare the episodicity of symptoms; 
thereby making the distinction between chronic trait symptoms of ADHD from the episodic 
symptoms of BD. Our findings support arguments that chronicity versus episodicity is a key 
delineating factor between ADHD and BD in adulthood (Skirrow et al., 2012).  
 
 
4.5.4 Emotional Lability (EL) 
 
EL is associated with both ADHD (Skirrow and Asherson, 2013) and euthymic BD (Judd et al., 
2003). Our study supports the view of EL as a largely non-specific set of symptoms that are 
seen across different disorders, with high EL scores seen in both the ADHD and euthymic-BD 
groups compared to controls. Indeed, EL occurred at higher rate in the ADHD patients, 
consistent with the emerging view of EL as an associated feature of ADHD. EL cannot therefore 
be relied upon to discriminate ADHD from BD. For this reason the current absence of EL from 
the DSM-5 ADHD criteria, but its inclusion as a characteristic feature of ADHD that supports 
the diagnosis of ADHD, remains a sensible decision (American Psychiatric Association, 2013). 
Health care professionals need to be reminded that the classification systems are not designed 
to capture all aspects of a clinical condition, but to provide an optimal algorithm that helps to 
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separate one condition from another. In this regard, the DSM-5 ADHD items appear to be 
more specific to ADHD than the DSM-5 BD items are to BD (particularly if the definition of BD 
symptoms reflecting a change from the pre-morbid mental state is ignored). 
 
 
4.5.5 Impairment Ratings 
 
ADHD participants showed more functional impairments than BD and controls, yet the BD 
group also showed higher levels of impairment compared to controls. This suggests that while 
impairment is known to be present in both disorders (Brassett-Harknett and Butler, 2007, 
Samalin et al., 2014), ADHD seem to be more severely impaired that BD patients during 
periods of euthymia (Judd et al., 2005). Examining retrospective impairment may also be 
useful at delineating ADHD from BD as evidence suggests that people with BD show normal 
pre-morbid functioning (Reichenberg et al., 2002), while ADHD is associated with chronic 





The samples are relatively small, consisting of selected patients with typical ADHD, typical BD-I 
and healthy controls, and focuses only on female participants. It is therefore not clear the 
extent to which these findings will generalise to more complex patients, of both genders, 
showing features of both ADHD and BD. ADHD is considered to reflect the extreme and 
impairing tail of a dimensional trait and symptoms commonly may also occur at sub-diagnostic 
levels (Hudziak et al., 1999, Simon et al., 2009). This means that BD patients are expected to 
display some ADHD traits as part of a normal population distribution. However, we were 
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unable to determine if the elevated ADHD symptoms in our BD sample represent a 
manifestation of BD or an independent subclinical expression of ADHD. Additional replication 
using prospective approaches would be useful to determine if the development of a subscale 





Overall, we show that ADHD is a chronic, impairing disorder, with a high degree of EL and 
hyperactivity which could be confused with symptoms of mania. Measures such as the DIVA 
interview which combine both a detailed disorder specific description of ADHD symptoms with 
a temporal component that captures the distinction between sustained traits and episodic 
symptoms that reflect a change in the pre-morbid mental state are best at discriminating 
ADHD from BD. We therefore conclude that interview measures combined with a 
developmental account of symptoms and impairments provide good discrimination compared 




Chapter 5 - Neurophysiological Stimulus Processing 
Impairments Distinguish Women with Bipolar 
Disorder from Women with ADHD 
 
 
5.1 Abstract   
 
To better delineate underlying cognitive-neuropsychological differences between attention 
deficit hyperactivity disorder (ADHD) and bipolar disorder (BD), this study aimed to compare 
adult women with ADHD or BD and control participants on event-related potential (ERP) 
components during a conflict monitoring task. Fifty-seven adult women were compared on the 
Eriksen Flanker task: 18 with ADHD, 20 with BD and 19 controls. We examined the amplitude 
of the N2 component at Fz and FCz electrodes, and the P2 component at FCz. A group main 
effect for N2 amplitude emerged at trend level, but with a medium effect size. A post-hoc 
analysis indicated that the BD group had attenuated N2 power, compared to the ADHD group. 
Differences in the P2 were significant, with the BD group having an enhanced P2 compared to 
the ADHD group, and trend-level differences compared to controls. Both N2 and P2 
comparisons showed medium effect sizes. This study suggests that the N2 and, particularly, 
the P2 warrant further investigation as ERP markers for delineating ADHD from BD. Future 
larger-scale studies may be able to clarify further the underlying cause of N2 attenuation and 
P2 enhancement in BD, and elucidate the functional relationship of these components to 
cognitive impairments in ADHD and BD. 
 





In adults, attention-deficit/hyperactivity disorder (ADHD) occurs in around 3% of the 
population (Faraone and Biederman, 2005), and bipolar disorder (BD) in around 1% (Fajutrao 
et al., 2009). Although separate diagnoses, ADHD and BD can share symptoms such as 
distractibility, psychomotor restlessness and talkativeness (Kent and Craddock, 2003, Skirrow 
et al., 2012). Evidence of mood dysregulation in ADHD, such as irritability and emotional 
lability, highlights an additional area of overlap (Skirrow and Asherson, 2013). The 
symptomatic similarities emphasise the need to identify objective biomarkers that can help 
delineate the boundary between ADHD and BD.  
 
  
The study of event-related potentials (ERP) permits direct real-time examination of covert 
brain processes which underlie performance on cognitive tasks.  Integral aspects of cognitive 
behaviour include error detection and conflict monitoring, which support decision making and 
the modification of behaviour. Performance monitoring has been linked to the N2 component, 
a negative deflection around 200 - 400 ms post stimulus with a fronto-central scalp 
distribution; and following errors, the ERN, a fronto-central deflection, which peaks around 
50ms post-response, and the Pe, which peaks around 150 – 450 ms post-response with a 
centro-parietal scalp distribution (Botvinick et al., 2001, Falkenstein et al., 1991, Falkenstein et 
al., 2000, Larson and Clayson, 2011, Yeung and Cohen, 2006). The ERN, unlike the Pe, is not 
dependent on the conscious perception of an error (Falkenstein et al., 2000, Nieuwenhuis et 
al., 2001) supporting links to unconscious stimuli perception, and may represent competing 
activation between the immediate erroneous response and a subsequent corrective response 
(Carter and van Veen, 2007, Yeung et al., 2004). The Pe is thought to represent the conscious 
processing of the erroneous response (Falkenstein et al., 2000, Nieuwenhuis et al., 2001). The 
N2 may index processes involved with the processing of competing responses as it shows 
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enhancement when target stimuli are masked with alternate stimuli, representing higher 
conflict between target and distractor stimuli (Donkers and van Boxtel, 2004, Danielmeier et 
al., 2009, Nieuwenhuis et al., 2003). 
 
 
A recent meta-analysis of seven studies using Go/NoGo and flanker tasks to examine ERN and 
Pe components in adults and adolescents with ADHD concluded that there was support for 
ERN attenuation in both tasks, and Pe attenuation in the Go/NoGo task (Geburek et al., 2013). 
Several studies also observe an attenuation of the N2 component in participants with ADHD, 
compared to controls, in flanker paradigms. N2 attenuation has been reported in children 
(Albrecht et al., 2008, Johnstone et al., 2009, Wild-Wall et al., 2009), adolescents (McLoughlin 
et al., 2014b) and adults (McLoughlin et al., 2009) with ADHD, although not in all studies 
(Johnstone and Galletta, 2013, Jonkman et al., 1999, Jonkman et al., 2007). N2 attenuation in 
children and adults with ADHD has also been reported using other conflict monitoring tasks, 
such as the auditory oddball (Barry et al., 2009) and Go/No-Go paradigms (Groom et al., 2008, 
Woltering et al., 2013), but not in the Continuous Performance Task where level of conflict are 
lower (Banaschewski et al., 2004, Fallgatter et al., 2004, Overtoom et al., 1998). Overall, there 
is evidence for attenuated ERN and N2 ERP amplitudes, the neurocognitive correlates of 
conflict monitoring, in children and adults with ADHD, particularly in flanker tasks, which have 
higher conflict-monitoring demands. Although some studies have failed to detect differences, 
many have had small samples, and therefore null findings may be due to limited power or 
other study/task-specific contextual differences. 
 
 
To date, few studies have examined the neurobiological correlates of performance monitoring 
in BD. No published ERP studies using flanker paradigms were identified. One study, however, 
using the auditory oddball paradigm with participants with psychotic BD reported reduced 
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amplitude in the target-linked N2 (Ethridge et al., 2012). Symptoms of distractibility and 
restlessness are associated with manic episodes in BD, yet individuals who are euthymic still 
demonstrate residual impairments in functional performance (Henry et al., 2013), meaning 
performance monitoring deficits could be present and detectable using brain-level ERP 
measures during the euthymic state. However, at present direct ERP comparisons between 
adults with ADHD or BD are sparse, being limited to one published study of reward processing, 
which examined an ERN based on negative feedback (FRN) and reward-sensitive P3 in a 
gambling task (Ibanez et al., 2012). This study found BD and ADHD both showed similar deficits 
on the FRN compared to controls, while P3 enhancement for a larger reward was attenuated 
in ADHD and enhanced in BD, compared to controls. Other studies of the cognitive 
neurophysiological correlates of BD report abnormalities in early unconscious sensory 
components, such as the mismatch negativity (MMN) and P50, indicating pre-attentive 
dysfunction (Cabranes et al., 2013, Onitsuka et al., 2013, Swann et al., 2013), as well as sensory 
gating deficits (Lijffijt et al., 2009, Swann et al., 2013) and enhancement of the later P2 (P200), 
associated with initial conscious awareness, in BD participants with psychosis, compared to 
healthy controls (Ethridge et al., 2014). It is therefore likely that BD participants might also 




The aim of this study was to directly compare N2, ERN and Pe components during a conflict 
monitoring task in adults with ADHD, BD and controls. Previous literature suggested that the 
ADHD group would show attenuated ERN and N2 components compared to controls. However, 
we were unable to make predictions for the BD group due to the absence of similar studies. 
Following initial results we also undertook an additional data-driven analysis of the P2 
component in these three groups. This study examined differences between the clinical groups 
in order to better delineate underlying cognitive-neuropsychological differences between 
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ADHD and BD. In addition, we focus on an all-female sample, in order to match the groups on 







Sixty adult women aged between 20 and 52 years were recruited into the study. Two ADHD 
participants were later excluded from the analysis due to poor EEG data quality, and one 
control participant was excluded because testing notes and performance data indicated she 
did not perform the task correctly. The final sample was 18 with ADHD, 20 with BD and 19 
control participants (n = 57). Mean age and IQ did not differ by group (age: mean age (SD): 
ADHD = 38.1 (7.68), BD = 40.3 (7.68), Control = 36.8 (4.38), F = 1.35, p = 0.27; IQ: mean (SD): 
ADHD = 106.2 (16.56), BD = 108.0 (12.50), Control = 112.4 (14.21), F = 0.93, p = 0.40). 
Participants with ADHD were recruited from the National Adult ADHD Clinic at the Maudsley 
Hospital. Participants with BD were recruited from the Maudsley Psychosis Clinic and from a 
previous research study (Hosang et al., 2012). Control participants were recruited using the 
Mindsearch volunteer database maintained by the Institute of Psychiatry, which comprises of 
several thousand potential participants. Participants were randomly selected from all those 
meeting recruitment criteria. This study was approved by the Camberwell St Giles Research 
Ethics Committee (approval number 11/LO/0438). All participants provided informed consent. 
 
 
Diagnosis in the clinical groups was confirmed from medical records, following DSM-IV criteria. 
ADHD participants had a current combined-type diagnosis or a current inattentive-type 
diagnosis with sufficient symptoms of hyperactivity in childhood to meet a childhood 
133 
 
combined-type diagnosis. Participants in the BD group had a diagnosis of bipolar I disorder 
(BD-I), having experienced manic episodes, but were currently euthymic (see chapter 4 for 
sample recruitment details). Exclusions for all groups were drug or alcohol dependency, 
autism, epilepsy, neurological disorders, brain injury, past ECT treatment, current involvement 
in treatment trials, pregnancy, or a limited proficiency in English language, as determined by 
an initial screening prior to recruitment and with reference to the participant’s medical 
records. Those with a diagnosed comorbidity of both ADHD and BD or those currently 
experiencing a manic episode were excluded. Control participants with a history of psychiatric 
disorders were also excluded. ADHD participants were asked to not take stimulant medication 
48 hours before testing. BD participants were not asked to stop taking mood-stabilisers or any 
anti-psychotic medication they had been prescribed, as it would not be ethical to do so. 
Information on participants’ current medication usage was collected in order for us to try to 
determine the effect of medication in ERP data. All participants were asked to refrain from 





Participants attended a single 4.5 hour research session (including breaks) for cognitive-EEG 
assessments, IQ assessment and clinical interviews. Prior to completing the Eriksen Flanker 
Task (Albrecht et al., 2008, McLoughlin et al., 2009), participants completed 2 x 3 minute 







The task was an adaption of the Eriksen Flanker paradigm designed to increase cognitive load 
(Albrecht et al., 2008, McLoughlin et al., 2009). In each trial a central black fixation mark was 
replaced by a target arrow (a black 18 mm equilateral triangle). Participants had to indicate 
whether this arrow pointed towards the left or right by pressing corresponding response 
buttons with their left or right index fingers. 100 ms prior to each target arrow, two flanker 
arrows identical in shape and size to the target appeared 22 mm above and below the centre 
of the target arrow.  Both flankers either pointed in the same (congruent) or opposite 
(incongruent) direction to the target. As such, conflict monitoring is maximal during the 
incongruent condition. When the target appeared, both target and flankers remained on the 
screen for a further 150 ms, with a new trial being presented every 1650 ms. Trials were 
arranged in ten blocks of 40 trials. The duration of the task was approximately 13 minutes.  
 
 
Congruent versus incongruent and the direction of responses (left versus right) were counter-
balanced and randomised. After each block, feedback was presented on screen to emphasise 
both speed and accuracy, in order to encourage participants to make enough errors to enable 
analysis of ERN/Pe components, and enough correct responses for analysis of N2 components. 
Where participants made >10% errors on congruent or >40% errors on incongruent trials, they 
were instructed to slow down. Where participants made <10% errors on congruent or <40% 
errors on incongruent trials, they were instructed to perform faster. If neither rule applied, 
feedback informed participants to continue the same way. Two practice blocks of 24 trials 
were administered before the real task. Where necessary, participants were told to minimise 





The Wechsler Abbreviated Scale of Intelligence Fourth Edition (WASI-IV; (Wechsler, 1999)) was 
administered to all participants to derive an estimate of IQ. 
 
 
5.3.4 EEG recording and statistical analysis 
 
Recording and analysis parameters from McLoughlin et al. (2009) were adopted. The EEG was 
recorded from a 62 channel DC-coupled recording system (extended 10–20 montage), using a 
500 Hz sampling-rate, impedances under 10 kΩ, and FCz as the recording reference. The 
electro-oculograms (EOGs) were recorded from electrodes above and below the left eye and at 
the outer canthi.  
 
 
EEG data were analysed using Brain Vision Analyzer 2.0 (Brain Products, Germany). 
Researchers were blind to group status during processing prior to analysis. Raw EEG recording 
were down-sampled to 256 Hz, re-referenced to the average of all electrodes, and filtered 
using Butterworth band-pass filters (0.1 to 30 Hz, 24 dB/oct). Ocular artefacts were identified 
using the infomax Independent Component Analysis algorithm (ICA; (Jung et al., 2000)). 
Sections of data containing artefacts exceeding ± 100 μV in any channel or with a voltage step 
greater than 50 μV were rejected. All trials were also visually inspected for other obvious 
movement or electrical artefacts, and sections containing these removed manually.  
 
 
Data were segmented based on two different response conditions: (1) stimulus-locked 
incongruent correct trials, and (2) response-locked incorrect trials. Individual averages were 
created based on each condition, requiring at least 20 clean segments for each participant. 
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Baseline correction was applied using the -300 to -100 ms pre-target interval (-200 to 0 ms pre-
flanker). After averaging, mean amplitude was calculated within a designated window defined 
by reference to the grand average. For the N2, a 100 ms window was used at 250-350 ms from 
flanker onset, as this window captured all N2-like components from individual participants.  
 
 
After processing error trials, only 31 participants had the necessary 20+ clean segments 
required for producing reliable grand averages (ADHD = 10, BD = 10, Control = 11). We 
reviewed grand averages created using lower thresholds of 15 and 10 clean segments (with 
samples of 40 and 51 participants respectively), but as the ERN and Pe components varied 
between averages generated using 10, 15, and 20 segment thresholds, we did not consider 
these suitable for further analysis (graphs S10, supplementary material). We therefore focus 
on N2 response to correct trials where a higher number of clean segments were available. We 
analysed data from the incongruent condition only, as our previous investigation showed an 
absence of ADHD-control differences in the congruent condition where conflict was minimal 
(chapter 3). The number of clean segments available did not differ significantly by group (mean 
(SD): ADHD = 133 (39), BD = 140 (42), control = 160 (27); F(2,56)= 2.37, p = 0.10). N2 amplitude 
data were normally distributed. Maps of the topographical scalp distribution of activity 
revealed that the N2 component was maximal at fronto-central electrodes (Figure 5.1). We 
analysed stimulus-locked N2 peaks at Fz and FCz, with ANOVA carried out in SPSS (factors: 
group and site (Fz, FCz)).  
 
 
As there is evidence of abnormalities in early sensory components in BD, and based on results 
from the N2 analysis and grand averages, we conducted an additional data-driven analysis on 
the P2 component recorded at FCz. We analysed the mean amplitude 150 - 250 ms after 
stimuli presentation, using ANOVA (factors: group and site). P2 mean amplitude data was 
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normally distributed. For standard statistical tests, we present both p-values and effect sizes 
(eta squared; η2). Based on Cohen’s (1988, p.283) estimates for η2, 0.0099 constitutes a small 
effect, 0.0588 a medium effect and 0.1379 a large effect. As both windows were 100 ms in 
duration we were able to carry out P2-to-N2 average power comparisons; an area-based 
equivalent of a peak to peak comparison. N2 mean amplitude was subtracted from P2 mean 
amplitude to give an indication of amplitude change between these two components. Group 
differences were compared using univariate ANOVA. To assess if participants’ current 
treatments may have influenced N2 or P2 mean amplitude, we also calculated the means and 
effect size for those taking and not taking certain classes of medication (mood stabiliser, anti-
depressant, anti-psychotic, and stimulant) within each group. 
 
 
Performance measures were total number of errors (error), target reaction time (MRT, i.e. 
mean latency of responding in ms after target onset), within-subject variability in reaction 
times (RTV, SD of RTs) and total number of omission errors (non-responses to target). All 
measures except total omission errors were compared at congruent and incongruent 
conditions separately. As performance variables were non-normally distributed, the most 
effective transformation was adopted for each; square root for commission errors, inverse for 
MRT and logarithm for RTV and omissions errors. Univariate ANOVAs were employed to test 
for group differences within each measure, with repeated-measures ANOVA being used to 







A greater number of errors (F(1, 54) = 319.83, p < 0.001), higher MRT (F(1, 54) = 677.49, p < 
0.001) and RTV (F(1, 54) = 677.49, p < 0.001) were observed in the incongruent, compared to 
the congruent, condition. However, no significant group differences were observed in either 
condition for commission errors, MRT or RTV, or total number of omission errors (Table 5.1). 
 
 
A trend-level group difference emerged for N2 amplitude which showed a medium effect size 
(F(1,54) = 2.61, p = 0.08, η2 = 0.0881). Post-hoc analysis indicated that the BD group had a 
significantly attenuated N2 compared to the ADHD group (p = 0.04), with the attenuation 
compared to controls at trend level (p = 0.08). ADHD and control groups did not differ 
significantly (p = 0.76). A significant main effect of site (Fz, FCz) also emerged, with the N2 
being greatest at FCz (F(1,54) = 9.16, p = 0.004, η2 = 0.1404), with no group and site interaction 
observed (F(2,54) = 1.05, p = 0.36, η2 = 0.0066). 
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MRT (mean reaction time to correct hits in milliseconds); RTV (variability of reaction time for correct hits in milliseconds). 
  
Condition Mean (SD) F (1,54) p 
 ADHD BD Control   
      
Omission errors (all) 5.88 (7.36) 8.55 (15.47) 4.47 (5.86) 0.31 0.74 
Commission errors congruent 8.44 (20.1) 6.35 (12.98) 6.37 (10.98) 0.19 0.82 
Commission errors incongruent 37.89 (19.88) 32.4 (22.56) 30.53 (15.36) 0.93 0.40 
MRT hits congruent 374.03 (39.19) 375.52 (47.67) 360.41 (44.88) 0.85 0.43 
MRT hits incongruent 463.73 (57.1) 467.46 (51.31) 451.15 (45.88) 0.46 0.63 
RTV hits congruent 95.43 (31.3) 87.71 (29.08) 82.07 (32.13) 1.285 0.29 
RTV hits incongruent 102.65 (26.61)  99.63 (26.88) 96.89 (31.69) 0.30 0.74 
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Figure 5.1. Grand average event related potentials to correct trials, showing attenuated N2 response (negative-peak within greyed section) in the 
bipolar group compared to ADHD and control groups. Scale shows ms from target, flankers stimuli precede target by 100ms.     


































Topographic maps indicated a clear N2 frontal-central negative component in the ADHD and 
control groups, which was not apparent in the BD group (Figure 5.2, 200 - 250 ms). Instead, the 
BD group showed a persistent fronto-central P2 component (apparent in Figure 5.2 at 150 - 
200ms), followed by centralised positivity during the N2 time window. To examine group 
differences in this preceding P2 component, we undertook an additional analysis to examine 
P2 mean amplitude between 150 - 250 ms after stimulus presentation. A group difference with 
a medium effect size was observed in P2 mean amplitude at FCz (F(2,59) = 3.40, p = 0.04,  η2 =  
0.1120), with the BD group showing a higher amplitude than the ADHD group (p = 0.012) but 
not the control group (p = 0.35).  
 
 
Comparison of amplitude change between P2 and N2 (P2-N2 complex) indicated a trend-level 
group difference with a medium effect size (F(2,54) = 3.05, p = 0.06, η2 =  0.1015). Post-hoc 
comparisons showed the BD group to have reduced amplitude change compared to the ADHD 
group (p = 0.02), with the reduction compared to the control group being at trend-level (p = 
0.08). The ADHD and control groups did not differ in mean amplitude difference between the 
P2 and N2 (p = 0.57) 
 
 
Table 5.2. Group means and standard deviation (in brackets) of N2 and P2 mean amplitude, 
and P2-to-N2 change in mean amplitude, in the incongruent condition. 
 ADHD BD Control 
N2 (μV) Fz -44.64 (171.44) 42.02 (208.49) -47.44 (171.93) 
 FCz -20.29 (178.95) 140.21 (236.87) 19.49 (206.28) 
P2 (μV) FCz -0.48 (1.43) 1.22 (2.19) 0.60 (2.28) 
P2-N2 (μV) FCz 19.81 (177.96) -139.00 (235.10) -18.89 (204.43) 
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A proportion of both clinical groups were taking anti-depressant medication (ADHD: 17%; BD: 
40%). Some participants in the BD group were also taking other treatments (mood stabiliser: 
70%; anti-psychotic: 40%). Of the ADHD participants, 72% were being treated with stimulant 
medication, but ceased treatment 48-hours prior to testing. Within-group samples were too 
small for statistical comparisons; however, effect size calculations indicated that in the BD 
group mood stabilisers may have had a medium effect increasing positivity for N2 and P2 
mean amplitude (i.e. reducing N2 negativity), anti-depressants may have had a small effect 
increasing the negativity of N2 mean amplitude, while anti-psychotics showed limited effect on 
either N2 or P3. In the ADHD group, comparison groups were very small and must be 
cautiously interpreted; however, anti-depressants may have had a large effect increasing 
negativity of N2 and P2 components, while previous treatment with stimulant medications 
may have had a medium effect in attenuating the N2 and small effect in attenuating the P2 





We report suggestive evidence for an attenuation of the N2 in women with BD during the 
Flanker task, which was not observed in women with ADHD or control women. Although the 
group main effect was at a trend level, the effect size for N2 differences was medium and the 
post-hoc comparison between BD and ADHD groups emerged as significant. Additional 
analyses further suggested that the attenuated N2 may be linked to the preceding positive P2 
component, which was elevated in the BD group, compared to the ADHD group. Together, 
these findings indicate potential neurophysiological impairments in women with BD that 





In relation to potential N2 differences between ADHD and BD groups, computational modelling 
by other groups suggests that the N2 represents dominant correct response programming 
before response, which is then reinforced by continued stimulus processing (Yeung and Cohen, 
2006). In this computational model, N2 amplitude is dependent on levels of conflicting 
incorrect response processing (i.e. attending to the flanker stimuli) and thus the level of 
correct response processing needed to overcome this. In our study, if interpreted using this 
cognitive model, it would suggest that the BD group was experiencing reduced levels of 
conflict processing compared to ADHD and potentially the control group. Yet, our finding of an 
enhanced preceding P2 component in the BD group suggests that N2 attenuation in this group 
may not due to differences in conflict monitoring, but rather potentially differences in initial 
conscious perception of the stimuli, compared to the ADHD group. As ERP components are 
additive, the preceding positive P2 component in the BD group would reduce the negativity of 
the N2 component at the scalp, which may otherwise be typical without the presence of this 
enhanced positivity.  
 
 
Our grand averages suggest that the P2 had similar amplitude in both BD and control groups, 
while the topographic maps show that in the BD group there is an additional persistence to 
this component not seen in ADHD and control groups. Although we were unable to directly 
examine component latency in this study (due to adopting a mean amplitude measure which 
can be more robust than peak amplitude to the intra-individual variability across trials 
common in ADHD, which may reduce the amplitude of ERP components (McLoughlin et al., 
2014a)), the grand averages were suggestive of latency differences in the P2 component in the 
BD group. One possibility is that this might be related to desynchronised frontal midline theta 
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oscillations (McLoughlin et al., 2014b) or early pre-attention and sensory gating deficits 
frequently reported in BD (Cabranes et al., 2013, Swann et al., 2013, Lijffijt et al., 2009). 
 
 
As amplitude change between P2 and N2 appeared greatest in the control group, we carried 
out comparison of a combined P2-N2 statistic, which showed the ADHD group to differ from 
the BD group, with an additional trend level difference between BD to control groups. This P2-
N2 component therefore seemed to have some validity in distinguishing BD from the other 
groups, and may be a useful measure of the range of amplitude change between P2 and N2 
components in this paradigm. 
 
 
We did not identify N2 differences between ADHD and control groups that had been reported 
in previous studies (Albrecht et al., 2008, Johnstone et al., 2009, McLoughlin et al., 2009, 
McLoughlin et al., 2014b, Wild-Wall et al., 2009). This could relate to sample differences, as 
the current study is the first one, to the best of our knowledge, with adult female participants. 
The only other previous study on adults with ADHD consisted of male participants (McLoughlin 
et al., 2009). The ERN, the equivalent component to the N2 elicited by errors, shows 
developmental changes in amplitude, increasing from childhood to adolescence and then 
decreasing in older adults (Falkenstein et al., 2001, Herrmann et al., 2010, Segalowitz and 
Dywan, 2009). It is therefore possible that the N2 shows similar developmental differences 
across lifespan which may reduce differences between ADHD and controls in older samples, 
perhaps contributing to that absence of differences in this sample which had a higher mean 
age than the other adult sample of Mcloughlin et al. (2009). Future studies should therefore 
attempt to explore potential gender and age differences in N2 amplitude across lifespan in a 
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larger mixed sample, in order to understand if potential developmental effects on the N2 
follow similar patterns of the ERN.  
 
 
We cannot rule out the possibility that our results would have been influenced by the systemic 
medication differences between groups. Addressing treatment effects on ERP power is 
challenging in cross-disorder investigations, where ethical restrictions limit experimental 
manipulation of prescribed medication. Specifically, in our study, as in similar previous studies, 
it would have been unethical to request participants with BD to stop mood-stabilising or anti-
psychotic medication prior to the assessments. Our BD group showed reduced N2 and 
enhanced P2 amplitude, using a novel paradigm for this sample, of whom 70% were taking 
mood-stabilising and 40% anti-psychotic medication, which could potentially have contributed 
to these ERP differences. The full effects of medications on ERPs are still poorly understood, 
with most studies in both clinical and control populations focusing on the effect of medications 
on the P3 component, suggesting anti-depressant, clozapine antipsychotic medication, and 
mood-stabilisers may normalise the P3 component in psychiatric disorders (Anderer et al., 
2002b, Anderer et al., 2002a, Karaaslan et al., 2003, Barratt et al., 2003, Galletly et al., 2005, 
Umbricht et al., 1998, Urasaki et al., 1994, Tumay et al., 2013, Smith et al., 2006). For the P2, 
there is some evidence that both mood stabilisers and anti-depressants may normalise the P2 
in BD compared to controls (Ethridge et al., 2014, Swann et al., 2013). In this study, although 
we were not able to perform tests of statistical significance due to small numbers in the sub-
groups (supplementary material table S11), effect sizes were suggestive of the influence of 
mood-stabilisers being one of increasing ERP positivity (i.e. attenuation the N2 and enhancing 
the P2), while the influence of anti-depressant medication to be one of increasing negativity of 
the N2 component (i.e. enhancement). This suggests that the effect of medication use on N2 
and P2 components in these disorders is likely to be complex, and we acknowledge this factor 
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as a potential confound of our study. Subsequent studies will require samples which are 
medication naive or non-adherent to their treatment, in order to fully determine if our findings 
represent a potential objective marker for BD, a medication effect, or a contribution of both. 
 
 
Our sample, being a pilot investigation, consisted of relatively small samples, with modest 
differences being identified. Replication using a sample with additional power, or methods 
which provide an improved signal-to-noise ratio, such as single-trial source-based measures 
(McLoughlin et al., 2014a), are now necessary to confirm results. We were also unable to 
examine the ERN/Pe components due to insufficient number of clean error trials post-
processing. Higher numbers of errors could be obtained by increasing the difficulty or duration 
of the task to allow analysis of these components. Further group comparisons using the 
novelty oddball task, which is known to elicit the P3 component and has been previously used 
in the study of BD (Fridberg et al., 2009), would be useful to provide a broader context to 
ADHD-BD ERP comparisons. 
 
 
In conclusion, we show that in this adult female population there is suggestive evidence of N2 
attenuation in the BD group, which may be linked to significantly elevated P2 amplitude in the 
BD group, compared to the ADHD group. Future studies can investigate whether this could 
reflect early sensory processing deficits previously observed in BD, or alternatively potential 
slow-wave synchronicity differences, warranting further investigation of these ERP markers for 





Chapter 6 - The Allocation of Attentional Resources 
and Theta Activity as Candidate Discriminators of 





This study aimed to investigate if attentional resource allocation processes in Attention Deficit 
Hyperactivity Disorder (ADHD) and Bipolar Disorder (BD) differ, despite symptomatic 
similarities in attentional deficits. Over-allocation of attention resources to task-irrelevant 
stimuli, such as novel distractors or non-target stimuli, may interfere with task-relevant 
processing in these disorders, underpinning common behavioural performance and cognitive 
electrophysiological deficits; yet direct comparisons between these disorders remain limited.  
Fronto-central theta power, an index of cortical activation, may also be associated with the 
efficiency of attentional resource allocation in psychiatric and control populations. This study 
compared P3a and P3b event related potential components, which are indices of attentional 
resource allocation, and fronto-central theta power in adults with ADHD and BD. Participants 
were tested on an auditory novelty oddball task, consisting of frequent non-target tones, 
infrequent target tones and novel distractor sounds. P3b at Pz was measured in the target 
condition, and the P3a at FCz was measured in the novel condition. Estimates of theta power 
(3.5 - 7.5 Hz) at FCz were calculated in both conditions. The sample consisted of 59 adult 
women, 19 of whom had ADHD, 20 had BD and 20 were control participants. Group 
differences in P3a or P3b amplitude were not significant, and small effect sizes were present 
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between the psychiatric groups and controls for the P3b, and between the BD group and other 
groups for the P3a. Theta activity showed a main effect of condition, being greater in the novel 
compared to targets condition, but no significant effect of group status was detected. Theta 
power correlated significantly with P3b amplitude in the ADHD group but not in the other 
groups. At the performance level, the BD group also had elevated mean reaction times to 
target stimuli (MRT) compared to the ADHD and controls groups, but groups did not differ on 
variability of reaction times. Overall, we were unable to identify statistically discernable group 
differences in ERP amplitude or theta power between ADHD, BD and control groups in this 
sample of adult women using the oddball task, although we identify candidates for further 
study, particularly P3a amplitude in the novel condition, which was correlated with theta 
power in the ADHD group, but not in the BD or control groups. Both theta power and the P3a 
component have been linked independently to attentional processes in ADHD, and the 
relationship between them may be an important avenue for future investigation. The older age 
of this sample, compared to many other studies of ADHD, or potentially gender effects, might 
account of the null findings in this study. We also report that MRT to targets was able to 





Attention-Deficit Hyperactivity Disorder (ADHD) is characterised by lapses in attention, poor 
focus, and hyperactivity. These characteristics overlap with some symptoms of Bipolar 
Disorder (BD), such as heightened distractibility and restlessness, which can appear as 
behaviourally similar to the symptoms of ADHD, even during euthymic periods (Henry et al., 
2013, Kent and Craddock, 2003, Kitsune et al., submitted, chapter 4, Skirrow et al., 2012). The 
underlying neurophysiological patterns, which give rise to these symptoms, are yet to be 
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elucidated but may relate to attentional resource allocation deficits or inefficiencies (Kok, 
2001, Kramer et al., 1985, Sawaki and Katayama, 2006). No direct comparison of attentional 
resource allocation between ADHD and BD has been carried out to our knowledge but is 
needed to clarify the functional processes in either disorder, and to address questions as to 
whether abnormalities are related to deficits in a common attentional neurocognitive system 
or whether common behavioural deficits arise from divergent neurocognitive processes, 
representing markers useful in the delineation of ADHD and BD.  
 
 
The study of event-related components (ERP) and electroencephalography (EEG) power is 
ideally suited to indexing sub-second cognitive processes such as attentional orientation. The 
P3 (P3b) is a commonly studied ERP component thought to represent conscious stimulus 
evaluation and memory updating (Polich, 2007). As an attention-driven comparison process, 
the P3b indexes the allocation of attentional resources, as P3b amplitude decreases inversely 
with secondary task difficulty (Kok, 2001, Kramer et al., 1985). Most consistently studied in the 
oddball paradigm, the P3b shows higher amplitude following an uncommon target stimulus 
than task-irrelevant non-target stimuli, and manifests as a large positive deflection in summed 
potential between roughly 200-800ms, peaking at around 300ms, at the central parietal 
electrode (Pz) (Polich, 2007).  
 
 
A second P3 component, the P3a, is thought to represent unconscious attentional orientation 
to unpredictable changes and is elicited by infrequent novel stimuli (Snyder and Hillyard, 1976, 
Squires et al., 1975). This component habituates rapidly, has a shorter peak latency around 
250-400 ms, and is maximal at fronto-central electrodes (Courchesne et al., 1975, Polich, 
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2007). As with the P3b, P3a amplitude has been shown to vary with experimental conditions 
such as task difficultly (Katayama and Polich, 1998), and is larger following non-familiar 
distractors than familiar ones (Polich, 2007).  
 
 
Abnormalities in the P3 components have been argued to be markers of psychiatric 
psychopathology (Carlson et al., 1999, Ford, 1999, Jahshan et al., 2012, Jeon and Polich, 2003, 
Porjesz et al., 2005). Widely studied in schizophrenia research, indications are that P3a and 
P3b amplitude attenuation relates to reduced processing resources or deficits in attentional 
resource allocation (Grillon et al., 1990). In BD, attenuated P3b amplitude has been observed 
in the auditory oddball paradigm for participants with Bipolar I Disorder (BD-I), the more 
severe form of the disorder (Bestelmeyer et al., 2009, Bestelmeyer, 2012), and their relatives 
(Pierson et al., 2000) but not in those with Bipolar II Disorder (BD-II), a less severe form of the 
disorder (Andersson et al., 2008). Comparisons between participants with BD and 
schizophrenia suggest that P3b deficits are unable to distinguish the two disorders, leading to 
suggestions that P3b attenuation may be a marker for psychosis-associated neurophysiology in 
both BD and schizophrenia (Bestelmeyer et al., 2009, Ethridge et al., 2012). This is compatible 
with cognitive models of the P3b as an index for attentional resource allocation, as psychosis 
would interfere with the normal attentional response, and therefore alter P3b amplitude. 
Fewer studies have examined the P3a in BD, but those that have indicate attenuation in both 
participants with BD-I and BD-II using the three-stimulus auditory oddball paradigm 
(Andersson et al., 2008, Jahshan et al., 2012), although no P3a amplitude differences are 





P3 components have been more widely studied in ADHD owing to their relevance to 
attentional processing deficits. However, few studies have examined P3 amplitude in adults, 
with the available data being limited to Go/NoGo and Continuous Performance Tasks (CPT) 
which show evidence for P3b attenuation in ADHD (Szuromi et al., 2011); yet data from adult 
females with ADHD is particularly sparse. Attenuated P3b amplitude, compared to controls, 
has been reported in children and adolescents with ADHD in the auditory oddball task in some 
studies (Barry et al., 2003, Holcomb et al., 1986, Johnstone and Barry, 1996, Jonkman et al., 
1997, Ozdag et al., 2004), but not others (Hermens et al., 2005c, Groom et al., 2008, Lazzaro et 
al., 1997, Lazzaro et al., 2001). Studies of the P3a are much more limited but there are reports 
of amplitude attenuation in children and adolescents with ADHD compared to controls on the 
oddball paradigm, and other tasks using novel auditory distractors (Gumenyuk et al., 2004, 
Gumenyuk et al., 2005, Kemner et al., 1996). Some evidence also exists for an elevated P3a 
response to novelty in adults with ADHD (Marzinzik et al., 2012). Age has been cited as the 
possible factor in the heterogeneity of results to date (Barry et al., 2003), although this has not 
been examined directly in developmental studies. 
 
 
Potential P3 abnormalities in ADHD, BD and other disorders could be the result of an 
inefficient allocation of the limited attentional resources available (Sawaki and Katayama, 
2006). For example, allocation of attentional resources to task-irrelevant stimuli such as novel 
distractors or non-target stimuli may interfere with task-relevant processing, particularly when 
target and non-target stimulus are similar, manifesting as a reduced P3b amplitude on target 
trials. Behavioural performance in ADHD supports this model, with ADHD participants often 
showing lower target hit rate, longer mean reaction times to targets, and increased 
commission errors to non-targets and novel stimuli, suggesting interference with task-relevant 
processing (Holcomb et al., 1986, Nigg, 2005, Sergeant et al., 2002). This model assumes that 
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efficient allocation of attentional resources is represented by a large P3b response to targets. 
It is currently unclear if this model extends to the P3a response to novel stimuli, as although 
this component is thought to be engaged in an independent orienting response from the 
memory updating response to repeated target and non-target stimuli (Polich, 2007), this 
process may be influenced by attentional resource allocation deficits if these behaviours 
involve multiple related processes. However, support for a distinction in these processes 
comes from a study which showed that the P3a was elicited even when novel stimuli are task-




Elevated frontal-central theta activity (3.5 - 7 Hz) has also been reported in ADHD during 
attentional tasks (Hermens et al., 2005b). Specifically, fronto-central theta has been implicated 
in response to novelty during trials eliciting the P3a (Demiralp et al., 1999, Fallahpour et al., 
2010). In ADHD, fronto-central elevated theta power compared to controls is reported in 
response to target stimuli in the oddball paradigm (Fallahpour et al., 2010), while in contrast, 
attenuated theta in relation to targets has been reported in oddball paradigm in BD (Atagun et 
al., 2013). Elevated frontal-central theta may be associated with deficits in the orientation to 
task-relevant information (Basareroglu et al., 1992, Yordanova and Kolev, 1998), and has also 
been implicated in arousal regulation in resting state conditions (Lazzaro et al., 1999). Recent 
work is supportive of a relationship between fronto-central theta activity, attention and 
behavioural performance, showing that increased variability of reaction times in ADHD, 
thought to be caused by lapses in attention, and theta activity are phenotypically and 
genetically linked (McLoughlin et al., 2014b). Further examination of fronto-central theta 
activity in relation to P3 indexes of attention, may therefore clarify if theta power is associated 




This study aimed to investigate if attentional resource allocation processes in ADHD and BD 
were similar in light of symptomatic similarities in attentional deficits. We compare P3a 
amplitude to novel stimuli and P3b amplitude to target stimuli between groups. In addition, 
we also examine stimulus-linked fronto-central theta activity in novel and target conditions, to 
investigate the relationship between theta and attentional resource allocation in these 
disorders. We predict that greater theta activity will be observed in the novel condition 
compared to targets in ADHD, BD and control groups. Based on previous literature, in both 
novel and target conditions, we expected the ADHD group to show elevated theta power 
compared to controls, while we predicted the BD group to have reduced theta power, 
compared the control group.  
 
 




One participant with ADHD was excluded from the analysis due to poor data quality. The final 
sample consisted of 19 with ADHD, 20 with BD and 20 control participants (n=59). Participants 
were aged between 20 and 52; mean age or IQ did not differ by group (age: mean (SD): ADHD 
= 38.1 (7.68), BD = 40.3 (7.68), Control = 36.8 (4.38), F = 1.35, p = 0.27; IQ: mean (SD): ADHD = 





Participants with ADHD were recruited from the National Adult ADHD Clinic at the Maudsley 
Hospital. Participants with BD were recruited from the Maudsley Psychosis Clinic and from a 
previous research study (Hosang et al., 2012). Control participants were recruited using the 
Mindsearch volunteer database maintained by the Institute of Psychiatry, and were randomly 
selected from all those meeting recruitment criteria. This study was approved by the 
Camberwell St Giles Research Ethics Committee (approval number 11/LO/0438). All 
participants provided informed consent. Further details of the recruitment process are 





Participants attended a 4.5 hour research session (including breaks) for cognitive-EEG 
assessments, IQ assessment and clinical interviews. Prior to completing the oddball task, 
participants completed 2 x 3-minute resting state recordings, a Continuous Performance Task 
(CPT)(Doehnert et al., 2008), and a variant of the Erikson Flanker task (Albrecht et al., 2009) in 





Participants completed an auditory novelty oddball task, adapted from Laurens et al. (2005), 
consisting of 300 frequent non-target stimuli (1000 Hz tone), 50 infrequent target stimuli (1500 
Hz tones) and 50 infrequent, unique non-repeating novel stimuli, consisting of digital noises 
such as whistles, buzzes and trills. The non-target, target and novel stimuli were presented 
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with a probability level of 0.75, 0.125, and 0.125, respectively. All stimuli had a duration of 200 
ms, with 5 ms rise / 10 ms fall, and were separated with a random inter-trial interval of 
between 1000-1500 ms (average 1250 ms). The order of presentation was pseudorandom, 
while ensuring that no two low probability stimuli (target or novel) occurred consecutively. 
Stimuli were presented in eight blocks of 50 stimuli, with a short rest period between each 
block. Total task duration was approximately 12 minutes. Presentation of stimuli was via 
headphones at 90 dB sound pressure level. During recording participants were asked to still sit 
with their eyes-open and focused on a static fixation mark on a screen directly in front of 
them. Participants responded to targets by pressing a button with the thumb of their 
dominant hand. They were instructed to respond as quickly as possible to target stimuli, and 
not to respond to the infrequent novel and frequent non-target stimuli. Prior to recording, 




Responses to target stimuli within 100-1000ms from onset were counted as correct response; 
failure to respond within this time window was registered as an omission error. Errors of 
commission were responses which occurred within 1000ms of the onset of a novel or non-
target stimuli.  
 
 
The Wechsler Abbreviated Scale of Intelligence Fourth Edition (WASI-IV)(Wechsler, 1999) was 







6.3.4 EEG recording and analysis 
 
The EEG was recorded from a 62 channels DC-coupled recording system (extended 10–20 
montage), using a 500Hz sampling-rate, impedances under 10kΩ, and FCz as the reference 
electrode. The electro-oculograms (EOGs) were recorded from electrodes above and below 
the left eye and at the outer canthi.  
 
 
The EEG data were analysed using Brain Vision Analyzer (2.0) (Brain Products, Germany). Raw 
EEG recordings were down-sampled to 256 Hz, re-referenced to the average of all electrodes, 
and digitally filtered using Butterworth band-pass filters (0.1 to 30 Hz, 24 dB/oct). Ocular 
artifacts were identified using an Infomax Independent Component Analysis algorithm (ICA, 
(Jung et al., 2000)). All trials were also visually inspected for other subtle artefacts, caused by 
muscle movements or jaw clenching etc., and sections containing these manually removed. 
Data with other artifacts exceeding ± 100 μV in any channel or with a voltage step greater than 
50 μV were rejected. Any peripheral channels removed due to technical problems or electrical 
noise were replaced using topographic interpolation following the ICA step.  
 
 
Raw EEG files were segmented based on: 1) target stimuli followed by a correct response and 
2) novel stimuli without commission errors. Segments were stimulus-locked, of -200 ms to 
1000 ms duration, and baseline corrected using the -200 to 0 ms pre-stimulus interval. 
Individual participant averages were created for each condition, but required at least 20 clean 
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trials for inclusion in the analysis. After averaging, mean amplitude was calculated within a 
designated window defined by reference to the grand average. Mean amplitude (μV) was 
calculated between 200 - 500 ms in novel condition at FCz in order to capture the P3a 
component and between 200 - 800 ms at Pz for the P3b component in target condition. 
Selection of electrodes were based on location of the maximal power on the scalp 
topographies within these time windows for the component of interest (Figure 6.1). Frontal 
mean theta power (μV * ms) between 3.5-7 Hz was calculated at FCz using Fast Fourier 
Transform (FFT), and then analysed in novel and target conditions separately. 
 
 
The number of clean segments available did not differ significantly by group in the novel 
condition (mean (SD): ADHD = 46.8 (3.35), BD = 46 (3.53), control = 46.9 (2.29); F(2,56) = 0.58, 
p = 0.56). However, a group difference emerged for the number of clean segments available in 
the target condition (mean (SD): ADHD = 43.6 (4.97), BD = 40.4 (7.62), control = 45.1 (3.78); 
F(2,56) = 3.63, p = 0.03). There were no differences in number of segments between ADHD and 
BD groups (p = 0.22) or ADHD and control groups (p = 0.81), though the BD group had fewer 
clean segments available for analysis compared to controls (p = 0.03). However, all groups had 
sufficient number of segments for analysis. 
 
 
6.3.5 Statistical analyses 
 
ERP data were normally distributed. FFT data were non-normal and transformed using log 
which was the most effective transformation in this data, as determined by the ‘ladder’ 
command in STATA which compares the results of several different transformations on data 
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distribution. Group differences in P3a and P3b mean activity, in novel and target conditions 
respectively, were tested using univariate ANOVAs. Mean theta power was compared using 
repeated measures ANOVA (factors: group (ADHD, BD, control), condition (novel, target)). We 
report p-values (trends are reported at p < 0.7) and effect sizes for all analysis, using Cohen’s d 
where 0.2 is considered a small effect size, 0.5 medium and 0.8 large (Cohen, 1988). Further 
correlations between FFT power and ERP amplitude were conducted to examine the 
relationship between these two measures. 
 
 
Behavioural performance measures were the number of omission errors (non-responses) to 
target trials, mean reaction time (MRT) and reaction time variability (RTV) to targets, the 
number of incorrect responses to novel stimulus, and to non-targets stimulus (commission 
errors). MRT and RTV were normally distributed, and tested using univariate ANOVA. Number 
of target omission errors and novel comission errors were successfully transformed using 
square root, and tested with univariate ANOVAs. Number of non-target commission errors was 
not successfully transformed using any available transformation (cubic, square, square root, 
log, 1/square root, inverse, 1/square, 1/cubic), and was therefore tested using the non-





6.4.1 Behavioural indices  
 
Group differences were observed in target MRT and the number of novel commission errors 
(Table 6.1). The BD group had significantly elevated MRT to targets compared to both ADHD 
 160 
 
and control groups, with these two groups not differing. Commission errors to novel stimuli 
were elevated in the ADHD group compared to controls. The number of omission errors to 
target stimuli showed a trend level difference, with post-hoc comparisons suggesting that the 
BD may have recorded an elevated number of target omission errors compared to controls. 
There were no differences in target RTV or the number of non-target commission errors 





Grand averages and topographies (Figure 6.1) were suggestive of group differences in both 
novel and target conditions; showing reduced peak amplitude in the clinical groups, 
particularly the BD group, however neither of these comparisons reached statistical 
significance (Table 6.1). Effect sizes support the suggestion of potential modest group 
differences in the grand averages with a small effect size between the clinical groups and 
controls in the P3b in target condition and small effect sizes between the ADHD and BD, and 
control and BD groups in the novel condition (Table 6.1). 
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Table 6.1. Means (standard deviation), significance testing and effect sizes for performance indices, P3a and P3b ERP components, and FFT voltage in ADHD, 
bipolar disorder and control participants. 
  ADHD BD Control F† P Post-hoc pairwise (p)  Pairwise effect size (d) 












 Performance Variables           
              
Target hit MRT  450.88 (57.96) 508.97 (79.12) 451.75 (59.66) 4.98 0.01 0.03 1 0.03  0.84 0.01 0.82 
Target hit RTV  107.19 (30.75) 115.88 (21.29) 101.14 (19.60) 1.87 0.16 - - -  0.32 0.23 0.72 
Omission error  2.79 (2.9) 5.2 (5.52) 2 (2.58) 2.86 0.07 0.37 0.78 0.06  0.55 0.29 0.74 
Novel c. error  1.21 (1.36) 0.6 (0.75) 0.45 (0.6) 3.55 0.04 0.13 0.04 0.95  0.56 0.72 0.22 
Non-target c. error   0.79 (1.27) 1.15 (1.23) 0.65 (1.18) 2.8 0.25 - - -  0.29 0.11 0.41 
              
 ERP Mean Activity (µV*ms)           
              
Novel p3a  FCz 1.67 (1.58) 1.28 (2.07) 1.95 (1.47) 0.753 0.48 - - -  0.21 0.18 0.37 
Target p3b Pz 2.45 (1.22) 2.68 (1.73) 3.11 (1.88) 0.817 0.45 - - -  0.16 0.42 0.24 
              
 FFT Theta voltage (µV)           
              
Novel theta FCz 0.86 (0.63) 0.67 (0.52) 0.82 (0.58)       0.32 0.06 0.27 
Target theta FCz 0.68 (0.59) 0.58 (0.5) 0.73 (0.68)       0.18 0.08 0.25 
Condition     7.092 0.01     0.29 0.18 0.15 
Group     0.641 0.53        
Group * condition     0.011 0.99        
See over for legend 
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†H for non-target commission errors 
Target Hit MRT = reaction time of correct response to targets, Target Hit RTV = reaction time variability to targets (i.e SD of reaction time), Omission error =  non-
response to target stimuli, Novel c. error = number of commission errors to novel stimuli, Non-target c. error = number of commission errors to non-target stimuli. 
Target hit RT, Omission error and Novel c. error compared with univariate ANOVA (F), Non-target c. error compared with non-parametric Kruskal-Wallis test (H). 
Novel P3a is the mean event related potential (ERP) activity between 200-500 ms in response to novel stimuli on trials where participants did not make a 
commission error. Target P3b is the mean ERP activity between 200-800 ms where participants correctly responded to the target stimuli with a reaction time of 
between 100 – 1000 ms. FFT theta voltage is the mean theta (3.5 – 7 Hz) activity across 1000 ms stimulus locked epochs in novel or target conditions. Post-hoc and 










6.4.3 Theta Activity 
 
Fronto-central theta activity was compared in both conditions at FCz. In order to be able to 
address the research question of whether there are group differences in the change in power 
between target and novel condition, we tested all factors within a single repeated measures 
ANOVA. This indicated a significant main effect of condition, showing that theta power 
increased in the novel condition compared to the target condition (Figure 6.2). However, no 
main effect of group or a group by condition interaction was detected (Table 6.1). Effect sizes 
for ADHD and BD and BD and control comparisons in theta power in the novel condition were 
small, along with a further small effect size between BD and control groups for theta power in 
the target condition. 
 
 
Correlations between ERP amplitude and FFT power in the ADHD group were significant in the 
target condition and were at trend level in the novel condition. P3 amplitude and FFT power 





Table 6.2. Correlations between ERPs power and theta power in novel and target conditions. 
 
  ADHD BD Control 












        
Target P3b r 0.50  0.08  0.14  
P 0.03*  0.75  0.55  
        
Novel P3a r  0.44  0.11  0.20 
p  0.06†  0.64  0.39 
 
Novel P3a is the mean event related potential (ERP) activity between 200-500 ms in response 
to novel stimuli on trials where participants did not make a commission error. Target P3b is the 
mean ERP activity between 200-800 ms where participants correctly responded to the target 
stimuli with a reaction time of between 100 – 1000 ms. FFT theta voltage is the mean theta 
(3.5 – 7 Hz) activity across 1000 ms stimulus locked epochs in novel or target conditions. † = 











Using a novelty oddball task, which measures attentional resource allocation, we identified 
increased target MRT in the BD group, which differentiated them from ADHD and control 
groups. We also found a significant increase for novel commission errors in the ADHD group 
compared to controls, replicating other findings suggestive of interference with task level 
processing (Holcomb et al., 1986, Nigg, 2005, Sergeant et al., 2002) and a trend level increase 
in target commission errors in the BD group compared to controls, suggesting further possible 
performance level-candidates for ADHD-BD differentiation, as effect sizes for ADHD-BD 
comparisons in both cases were medium. However, we did not observe differences in RTV to 
targets in this study, despite elevated RTV being frequently associated with ADHD (Kuntsi et 
al., 2014), which could be due to particular task demands in this paradigm (Kuntsi et al., 2013). 
 
 
Comparisons of P3a, P3b and theta power did not show significant differences between ADHD, 
BD and control groups in this sample of adult women, which may argue against attentional 
resource allocation deficits underlying common symptoms in both disorders such as lapses in 
attention, poor focus and distractibility. Attenuation of the P3b component in BD has 
previously been reported in adults (Bestelmeyer et al., 2009, Bestelmeyer, 2012, Ethridge et 
al., 2012), and to a wider degree in children and adolescents with ADHD,  although the area 
remains understudied in adults (Barry et al., 2003, Holcomb et al., 1986, Johnstone and Barry, 
1996, Jonkman et al., 1997, Ozdag et al., 2004), However, in both disorders there are several 
example of studies which have failed to detect group differences (Andersson et al., 2008, 
Hermens et al., 2005c, Groom et al., 2008, Lazzaro et al., 1997, Lazzaro et al., 2001). This 
indicates that sample differences are likely to be responsible for the variability in reported 
findings, as both ADHD and BD are known to be heterogeneous diagnostic classifications 
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encompassing wide-ranging symptom profiles. In our study, the absence of group differences 
and the failure to replicate the P3b attenuation observed in some other studies is likely to be 
partly due to heterogeneity within the clinical samples. However, on some measures modest 
effect sizes were present for group comparisons, suggesting that with a larger sample group 
differences might emerge and factors of heterogeneity, which moderate group differences, 
might be identified by examining subgroups within the psychiatric samples. In particular the 
P3a in the novel condition might have future utility in differentiating ADHD from BD, as both 
ADHD-BD and BD-control comparisons showed small effect sizes supported by discernable 
peak differences on grand average graphs.  We would therefore support the use of paradigms 
which explicitly evoke P3a response such as the novelty variant of the oddball paradigm, as 
this may warrant another investigation for the purpose of examine within-group heterogeneity 
in P3a response in larger samples. In contrast, P3b power to targets, the marker assessed in 
the much more commonly studied two-stimulus (target and non-target) version of the oddball, 
showed more limited potential for discriminating between the two psychiatric disorders in this 
sample of adult women, and may be a less preferred candidate for future study.  
 
 
In comparisons of fronto-central theta power, a main effect emerged for condition, with the 
novel condition having higher power than the target condition, indicating that this measure 
was sensitive to experimental effects. However, no effect of group status was observed. As we 
were also unable to identify P3 attenuation in the clinical groups in this study, we were unable 
to confirm if fronto-central theta activity was linked to processes of attentional orientation. As 
with the ERP measures, some small effect sizes were present, showing that any potential 
differences in theta power between the groups is likely to be small and would require large 
samples, more sensitive theta recording or reduced sample heterogeneity in order to 
determine if this is a valuable avenue for further research. Estimates of effect size for ADHD-
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control differences were minimal, suggesting that theta power was largely equivalent in these 
groups using the parameters adopted in this study. This is in contrast with the few studies 
which have examined fronto-central theta during the oddball paradigm in predominantly male 
children and adolescents with ADHD, which reported elevated frontal theta compared to 
controls in both target and novel conditions (Hermens et al., 2005b, Fallahpour et al., 2010). 
The absence of ADHD-control differences in theta power in our study may be due to the older 
age of our sample (mean = 38, SD = 6.78) compared to these studies. Theta power is known to 
decrease strongly with age in resting state investigations of healthy controls (Vlahou et al., 
2014), which is replicated in ADHD samples (Kitsune et al., 2014, chapter 2, supplementary 
material, Liechti et al., 2013). However, we also cannot rule out the possibility that the 
differences between our findings and those of Harmen et al (2005b) and Fallahpour et al 
(2010) are due to gender differences, as this is the first study to examine this marker in a 
female sample, and no published studies to date have directly examined male-female theta 
power differences in ADHD.  
 
 
All groups showed an increase in theta power between target and novel conditions, with a 
significant main effect present. However, the effect size of the theta increase between target 
and novel conditions in the ADHD group was nearly twice the size of those in the other groups. 
Although a condition x group difference was not observed in this study, the effect size 
between conditions in the ADHD group highlights a further potential avenue for future 
investigation. Related to this, in the ADHD group, correlations between theta power and P3b 
amplitude were significant, with a further trend (p = 0.06) observed in the novel condition. No 
significant associations between theta power and P3 ERP amplitude were observed in the 
other groups, supporting arguments that theta power may be specifically linked with deficits in 
attentional processes in ADHD (McLoughlin et al., 2014b). This therefore warrants additional 
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study in adult populations, as group differences in theta power may emerge with a larger 
sample. 
One limitation of our study and a possible alternative explanation for our null findings is the 
effects of medication use in our data. Although the ADHD group abstained from stimulant 
medication use 48 hours prior to testing, participants BD group, and some in the ADHD group, 
continued to take other prescribed medications as it would not be ethical to ask these 
participants to cease taking these types of medications for testing. The full effects of 
medication usage on ERP amplitude are still poorly understood and evidence is inconsistent. 
While studies indicate that anti-depressant and clozapine antipsychotic medication may 
normalise P3 amplitude in psychiatric populations relative to controls (Anderer et al., 2002b, 
Anderer et al., 2002a, Barratt et al., 2003, Galletly et al., 2005, Karaaslan et al., 2003, Umbricht 
et al., 1998), many other studies report no medication effects on the P3 amplitude in a range 
of clinical disorders and ERP paradigms (Isintas et al., 2012, Korostenskaja et al., 2006, 
Semlitsch et al., 1993, Swann et al., 2013, van Laar et al., 2002, Vandoolaeghe et al., 1998). 
More consistently, mood-stabilisers have also been reported to reduce P3 amplitude (Smith et 
al., 2006, Tumay et al., 2013, Urasaki et al., 1994), although a recent study specifically 
examining the P3a in BD did not find differences related to mood stabiliser or antipsychotic 
medication use (Jahshan et al., 2012). To explore further, we calculated separate P3 mean 
amplitudes for ADHD and BD participants currently taken certain classes of medications (anti-
psychotic, anti-depressant, mood stabiliser and stimulant) and those who were not, but within 
group samples proved too small for robust statistical comparison (Supplementary material 
S12). Furthermore, visual representation of ERP power by medication and group status was 
inconclusive (Supplementary material S13). In the novel condition, where distributions on 
these plots appeared more imbalanced, both ADHD and BD participants typically appeared at 
the lower ends of the distributions in both “yes” and “no” treatment groups for all medication 
classes including stimulants, which ADHD participants refrained from taking 48 hours before 
EEG testing. It was therefore not possible to resolve medication effects from those factors 
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associated with psychiatric group status in this study and we acknowledge the medication 
confound as a limitation, while suggesting that subsequent studies attempt to recruit samples 
which are medication naive or non-adherent to their treatment, in order determine the effects 
of medication on P3 amplitude. 
 
 
In conclusion, at the performance level, we show reduced MRT to targets in the BD group, 
which discriminated them from both ADHD and control groups. We did not observe significant 
group differences in P3a or P3b amplitude or theta power using the novelty oddball task in this 
sample of adult women. However, we identify promising candidates for further study, 
particularly P3a amplitude in the novel condition, which was correlated with theta power in 
the ADHD group, but not in the BD or control groups. Although we find no support for our 
original hypothesis of attentional resource allocation deficits in the oddball task in these 
psychiatric populations, data in this area remain sparse, particularly in ADHD where the 
majority of existing studies have focused on predominantly male child and adolescent 
populations. Given theta power is known to decrease with age, the age of our sample may 
have contributed to this study being underpowered to detect attentional deficits. Potential 
gender differences in ERP or theta response in adult women with ADHD also remains to be 










7.1 Summary of overall aims 
 
The first part of this thesis aimed to examine the stability and validity of potential cognitive- 
electrophysiological biomarkers in Attention-Deficit/Hyperactivity Disorder (ADHD) in a large 
sample of adolescents and young adults. In part two, this thesis proceeded to a cross-disorder 
comparison with Bipolar Disorder (BD) in a novel sample of adult women, beginning by 
investigating symptom overlap between the two disorders and testing the efficacy of standard 
clinical instruments to delineate ADHD from euthymic BD. The next two chapters then went on 
to investigate the ability of cognitive-electrophysiological markers to delineate ADHD from BD 
in this cross-disorder sample, both through re-examining ERP components which were 
investigated in part one, and by exploring additional ERP components not previously studied in 
this body of work.  This final chapter now takes an overview of the key findings in both parts of 
this thesis to draw together common themes and to highlight how these data illuminate the 





7.2 Principal findings  
 
7.2.1 The consistency of EEG differences in ADHD 
 
This thesis commenced with a study seeking to determine the consistency and reliability of 
proposed EEG resting state frequency-band biomarkers through comparing data recorded at 
two separate time points between ADHD participants and controls. In this study, the primary 
finding was of higher frequency power in ADHD at lower EEG frequency bands (delta and 
theta) at the beginning of a 1.5 hour testing session but not at the end, and of elevated power 
in higher frequency ranges (beta) at the end of the testing session but not at the beginning. 
This demonstrates that ADHD-control differences are sensitive to the effects of recording 
duration and under-arousal may vary with experimental context. Comparisons of different 
methodological approaches, such as electrode selection (midline vs grouped regions of 
electrodes) and controlling for IQ differences also altered some of the results, suggesting that 
reported findings are, to some extent, dependent on methods employed and that these 
factors require fuller consideration in future studies. 
 
 
7.2.2 Indicators of performance monitoring deficits in ADHD 
 
The second study, using a response-choice arrow flanker ERP paradigm, reported impaired 
conflict monitoring as indexed by attenuated N2 amplitude, and conscious error processing as 
indexed by attenuated Pe amplitude in adolescents and young adults with ADHD. We did not 
find evidence of impaired unconscious error processing as indexed by the ERN component, 
contrary to some other studies which have identified the ERN component as being impaired in 
ADHD. Comparisons between ADHD participants, unaffected siblings of those with ADHD, and 
controls did not show evidence that performance monitoring correlates had the characteristics 
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of an endophenotype for ADHD, as no familial effects were observed. For conflict monitoring, 
topographic maps indicated that the ADHD group did not have an overall reduced maximal N2 
amplitude compared to controls, but did suggest a more frontal topographic distribution of the 
component. Combined with a comparison showing that older and young subgroups displayed 
different case-control conflict monitoring abnormalities, these data suggest atypical fronto-
cortical maturation in ADHD participants, which may explain some inconsistences across 
different samples to date. 
 
 
7.2.3. Symptoms overlap between ADHD and BD 
 
In the second part of this thesis the focus of investigation moved onto a cross-disorder 
comparison of BD and ADHD using clinical and ERP measures. This first study compared the 
two disorders across symptoms of inattention, hyperactivity, mania, depression and emotional 
lability (EL) as assessed using typical diagnostic measures commonly employed in clinical 
settings. This investigation showed that ADHD participants had a high degree of EL and 
hyperactivity symptoms which could be confused with the symptoms of manic episodes in BD, 
and which were not well delineated by standard mania and EL measures. However, this study 
also showed that ADHD interview measures had good discrimination potential, showing both 
sensitivity and specificity to ADHD on account of the inherent temporal component in 
assessment items, and therefore were recommended as the primary diagnostic tool for the 






7.2.4 The specificity of conflict monitoring deficits in ADHD and BD 
 
This investigation compared conflict monitoring processing in adult women with ADHD or BD 
in a flanker task, which were previously reported as potentially attenuated in children and 
adolescents with ADHD in chapter three. In this cross-disorder investigation, a suggestive 
reduction in N2 amplitude (trend-level p = 0.07) was observed in the BD group compared to 
the ADHD group. ADHD-control differences were not detected in this older adult sample, most 
likely due to age-related changes in N2 amplitude across lifespan. Differences in an early 
sensory processing component, specifically the P2 amplitude, were also observed in the BD 
group compared to the ADHD group, and with a trend-level difference being observed 
compared to the control group. This suggested that P2 amplitude enhancement could be a 
specific marker for BD in adult samples. 
 
 
7.2.5 Attentional resource allocation in ADHD and BD 
 
The fifth experiment presented in this thesis investigated indices of attentional resource 
allocation in ADHD and BD in a novelty oddball task, but found no evidence for differences in 
ERP components associated with attentional orientation to novelty or attentional resource 
allocation to targets. However, greater fronto-central theta power, which has been linked to 
deficits in attentional resource allocation, was correlated with the P3b component in the 
ADHD group but not in BD or control groups, suggesting this relationship may index an as yet 
unknown impairment related to attention in ADHD and would make a good candidate for 
further study. Increased reaction time to targets was also able to distinguish the BD group 
from ADHD group in this task. 
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7.3 Diagnostic complications in ADHD and BD 
 
The symptom comparison study (chapter four) highlighted the complexities of symptom 
overlap between ADHD and BD, such as depression, hyperactivity and emotional lability, and 
showed how some standard clinical measures may not be well suited to delineating ADHD 
from euthymic BD.  In order to reduce heterogeneity within the samples, this study focused on 
the relatively severe forms of each disorder (those with persistent ADHD with combined-type 
symptoms in childhood, and current euthymic Bipolar Disorder I), and excluded those who 
were likely to have a comorbidity of ADHD and BD. In a general psychiatric population, such as 
those likely to be encountered in clinical settings, a broader spectrum of both disorders will be 
present along with the presence of other comorbidities, meaning phenotypes will be less well 
defined and harder to identify. Moreover, although chapter four demonstrated that ADHD 
measures which capture episodicity were sensitive to diagnostic differences, many healthcare 
professionals may be unfamiliar with current best practice in relation to the key identifiers in 
each disorder. This suggests that although ADHD clinical measures were effective at 
delineating ADHD from BD, the high level of symptoms and impairment observed in ADHD, 
particularly those of depression and emotional lability, could still be confused with that of BD, 
and objective biological measures of either disorder would be diagnostically valuable. More 
generally, as discussed in chapter one, the shared or specific neurobiological aetiology of these 
disorders is still poorly understood, and studies such as those conducted for chapters two, 
three, five and six represent additional contributions to the growing body of work which 







7.4 Contributions to a neurobiological understanding of ADHD and BD 
 
The neurobiological understanding of ADHD and BD is currently quite limited, with literature 
being fairly sparse and studies often presenting a mixed pattern of results.  Both parts one and 
two of this thesis sought to advance the understanding of cognitive and neurophysiological 
deficits in these disorders by using either 1) a large sample of ADHD adolescents and young 
adults or 2) a novel cross-disorder investigation of ADHD and BD in adult women. In 
combination, these approaches sought to examine the stability or specificity of potential 
biomarkers, in order to highlight shared and/or specific ERP impairments which may underlie 
behavioural, cognitive and symptomatic differences and similarities in these two disorders. 
 
 
7.4.1 Biological markers 
 
In the two cross-disorder electrophysiological studies undertaken there were two cognitive-
electrophysiological markers which emerged as potentially being able to distinguish ADHD 
from BD. Firstly, in the study using an arrow flanker paradigm (chapter five), significant P2 
enhancement was detected in the BD group compared to the ADHD group, with a further 
trend-level difference reported compared to controls. P2 enhancement in the BD group may 
have been responsible for the trend-level reduced negativity of the later N2 component in this 
group. There were further indications that a measure of amplitude change between P2 and N2 
components (P2-N2 complex) may be useful in distinguishing ADHD from BD and could be a 
good candidate for further research, indeed the P2-N2 complex has also been linked to theta 
phase-locking (Freunberger et al., 2007, Kamarajan et al., 2008) which might also play a role in 
attention (McLoughlin et al., 2014b). The P2 component is thought to be associated with initial 
conscious awareness and stimulus classification (Crowley and Colrain, 2004), and so 
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abnormalities in the P2 in BD may be related to similar findings in other studies of early pre-
attention and sensory gating deficits as cognitive impairments in BD. However, previous 
research specifically examining the P2 in BD is underdeveloped, with one other study finding 
the P2 was enhanced in BD participants compared to healthy controls, but which was 
attributed to the presence of psychosis in the clinical group (Ethridge et al., 2014). P2 
abnormalities could represent a useful candidate marker for BD, one which appears to 
distinguish this group from ADHD participants in this sample. However, it is now important 
that further work is conducted to 1) determine if this measure is able to consistently 
distinguish BD from other groups,  2) assess other factors which might influence P2 amplitude 
(such as the presence of psychosis), and 3) to determine the general functional significance of 
the P2 components across modalities and different age groups. It would also be valuable to 
examine the functional relationship between P2 and N2 components in these disorders, to 
confirm if deficits represent a related series of cognitive processes or whether the interaction 
of their amplitudes is merely circumstantial (i.e two independent processes where activity is 
summed at a scalp level). 
 
 
The second potential specific biomarker, this time for ADHD, was detected during an oddball 
paradigm (chapter six). This study examined P3a amplitude to novel stimuli (at Cz), P3b 
amplitude to target stimuli (at Pz) and fronto-central theta power (at FCz) in relation to both 
types of stimuli. Separately the ERP and EEG measures did not show group differences in ERP 
amplitude or EEG power but the correlation of theta power with P3b amplitude to targets was 
significant in the ADHD group but not BD or control groups. Furthermore, a similar pattern was 
observed in the novel condition, with the P3a component being correlated at trend-level in the 
ADHD group but not in the other groups. This suggests a particular functional relationship 
between the ERP measures of attention (P3a, P3b) and theta power in the ADHD group. This 
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idea is supported by research showing that theta has a role in arousal regulation, and so may 
therefore influence the efficiency of attentional processes in ADHD (Lazzaro et al., 1999). 
Other studies have also previously suggested a link between attentional processes and fronto-
central theta activity in cognitive-electrophysiological studies (Demiralp et al., 1999, Fallahpour 
et al., 2010, Hermens et al., 2005b), including genetically-sensitive designs (McLoughlin et al., 
2014b). Cognitive-energetic theories of ADHD suggest that due to persistent under-arousal, 
ADHD participants may require a higher level of overall arousal during tasks in order to 
maintain an equivalent performance level as controls (Sergeant, 2000, Sergeant, 2005). 
Theoretically then, it may be that in this study where attentional ERP components showed no 
group differences, the ADHD adults were adopting compensatory strategies to increase 
arousal and engagement with the tasks, which was apparent as a significant correlation 
between ERP and theta measures. Although this hypothesis remains to be tested directly, the 
fact that this correlation between ERP and theta activity was observed only in the ADHD group, 
and in both conditions, does recommend a further examination of this index as a potential 
marker for ADHD. 
 
 
Enhanced P2 and correlated fronto-central theta-P3a/P3b activity represent the two strongest 
potential disorder-specific biomarkers to emerge from this body of work; one for BD and one 
for ADHD. Both have been identified in a small sample of adult women, and therefore require 
replication, as well as requiring further examination in other experimental contexts. This is 
needed to determine if these significant results are linked to particular characteristics of this 
sample, for instance the age or gender of these participants, and whether these results are 
mediated by other factors such as the presence of particular symptom expression, such as 
psychosis in BD. These results do, however, amount to two novel potential biomarkers, in a 
relatively understudied area of research, where this thesis has uniquely been able to show that 
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these indicators show potential to discriminate between ADHD and euthymic BD in an adult 
female sample. 
7.4.2 Performance indices 
 
Chapters three and five, using the Flanker Task, and chapter six using the Novelty Oddball Task 
reported results for several performance indices. In chapter six, mean reaction time (MRT) to 
targets distinguished the BD group from both ADHD and controls, and could be theoretically 
linked to evidence of early sensory processing deficits if the BD group required additional time 
in order to distinguish targets for non-target stimuli. Greater omission errors (missed targets) 
showed a trend-level difference in the BD group compared to controls and greater commission 
errors (erroneous responses to novel distractors) were present in the ADHD group compared 
to controls, replicating similar findings in other studies which are suggestive of interference 
with task-level processing in ADHD (Holcomb et al., 1986, Nigg, 2005, Sergeant et al., 2002). In 
the flanker task, the investigation presented in chapter three, using the large sample of 
adolescent and young adults with ADHD, reported that all performance indicators (commission 
errors (incorrect response to stimulus), omission errors (non-responses), mean reaction time 
(MRT) and reaction time variability (RTV)), showed significant ADHD-control differences. 
However, in chapter five using the same task to evaluate the cross-disorder sample of adult 
women, significant differences were not observed on any of these performance indices. 
However, between the two studies, mean scores on these indexes were similar. The exception 
to this observation was commission errors in the incongruent condition of the Flanker Task, 
where error rates appeared lower across all groups in the older adult sample than the 
adolescent and young adult sample, perhaps implying that ceiling effects could have 






In summary, performance measures appear variable and are task dependent; although showed 
strong differences in some cases and therefore have value as indicators of cognitive deficits 
and can also support theoretical interpretations of cognitive-electrophysiological data. The 
observation of potentially specific deficits in each disorder might also be used to develop novel 
experimental designs to more easily explore the precise characteristics of neurobiological 
deficits in each condition using large samples; such as for instance how deficits in these 
conditions change over lifespan and whether energetic factors influence performance across 
the different types of measures and paradigms. In future, specifically examining correlations 
between cognitive-electrophysiological data and performance indices may help to illustrate, 
with greater clarity, the relationships between case-control differences in ERP or EEG 
measures and behavioural impairments. Examining such correlations will be increasingly 
important as research moves towards assessing the utility of alternative classification 
frameworks such as RDoC, which hinge upon identifying underlying impairments in 
neurocognitive systems across diagnostic boundaries through the use of converging evidence 
from multiple behavioural and neurophysiological indices. 
 
 
7.4.3 Maturational factors 
 
Chapter two provided evidence for variable cortical arousal in adolescents and young adults 
with ADHD, by demonstrating that resting-state EEG band power differences between ADHD 
and controls varied across time, between two recordings separated by a 1.5 hour testing 
session. Some previous literature had argued that EEG band power differences, such as the 
ratio of theta to beta activity (T:B), might represent a stable biomarker for ADHD, although 
more recent studies had contested these views (Arns et al., 2013, Liechti et al., 2013). The 
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resting-state investigation conducted here supported arguments that these EEG markers of 
ADHD are unstable, and are not reliable enough for diagnostic application when processed 
using standard analysis techniques. Furthermore, comparisons between older and younger 
subgroups within this sample indicated age-related changes in ADHD and control participants 
for EEG power, with reduced power in all bands being observed in the older groups. This was 
replicated in Global Field Synchronisation (GFS) scores, which were positivity correlated with 
age, suggesting lower phase synchronization in younger participants at earlier stages of 
cortical maturation, compared to adult samples (Koenig and Pascual-Marqui, 2009). In chapter 
three, where evidence of deficits and altered topography of conflict monitoring processes in 
ADHD was presented, the exact nature of ADHD-control differences differed between older or 
younger subgroups of the full sample. The data from the first part of this thesis focused on 
adolescents and young adults with ADHD therefore suggests that ERP indicators for ADHD are 
somewhat fluid with age, supporting theories of delayed cortical maturation in ADHD (Rubia et 
al., 2000, Shaw et al., 2007). If correct, this would also explain why the pattern of results 
reported in EEG and ERP studies of ADHD have been inconsistent overall, as the ranges of age 
within a sample could alter results. Such finding may also suggest that differences could be 
easier to detect in adult samples, given a similar sample size, as there may be less 
neurophysiological heterogeneity caused by the extensive changes in neural connections 
which takes place as part of cortical maturation in adolescent samples.  
 
 
7.4.4 Conflict monitoring 
 
Chapters three and five both examined the N2 component, which is associated with conflict 
monitoring in the Flanker Task. Chapter three used an endophenotype approach in a large 
sample of adolescences and young adults, comparing N2 amplitude for participants with 
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ADHD, their unaffected siblings and unaffected controls, showing that there were suggestive 
(trend-level) differences in the ADHD group compared to controls. The unaffected ADHD 
siblings and control groups did not differ in this analysis. In contrast, chapter five compared N2 
amplitude in adult women with ADHD, BD or controls. This analysis provided different results, 
showing suggestive (trend-level) N2 attenuation in the BD group, which was likely linked a 
significantly enhanced preceding P2 component, while the ADHD and control groups did not 
differ. The differences in results between chapters three and five show that the N2 does not 
represent a stable shared or specific biomarker for either of these disorders, without the 
consideration of other factors which may be influencing results, such as other preceding 
atypical components or sample age. These factors need to be carefully accounted for in future 
studies. The inconsistency of results between these two studies mimics that of the literature 
on N2 deficits in children with ADHD, where both positive and null findings are reported in the 
few published studies to date (Albrecht et al., 2008, Johnstone et al., 2009, Johnstone and 
Galletta, 2013, Jonkman et al., 1999, Jonkman et al., 2007, Wild-Wall et al., 2009), with a very 
limited number of adolescents or adults studies available for comparison (McLoughlin et al., 
2009, McLoughlin et al., 2014b). The most likely factor to account for these mixed results in 
the two studies presented in this thesis, which had identical data collection and analysis 
procedures, is the age differences between the samples. As previously discussed, age is likely 
to play a significant role in the size of potential case-control differences and therefore in the 
power to detect them. There is evidence showing that the detection of performance 
monitoring deficit in ADHD may be increasingly difficult with advancing age, owing in a large 
part to the cognitive decline of control samples in older adults (Falkenstein et al., 2001, 
Herrmann et al., 2010). This may explain why ADHD-control differences were apparent in the 
adolescent and young adult ADHD sample, but were not observed in the sample of older adults 
tested in chapter five. Gender differences between the samples also remains a possible 
explanation, as the adolescent and young adult sample consisted of a mixed sample, which 
included a high number of male participants, while the older adult sample consisted 
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exclusively of women. As there is currently very little data available for women with ADHD, 
particularly amongst older adults, questions remain as to whether possible neurophysiological 
gender differences exist, which will only be conclusively determined once direct gender 
comparisons have been carried out in these paradigms.  
 
 
7.4.5 Attentional resource allocation 
 
In chapter six, this thesis investigated the specificity of P3a and P3b components and their 
relationship to theta power as markers of attentional resource allocation processes in ADHD 
and BD using a novelty oddball task. Overall, this study was not able to identify statistically 
discernible group differences in ERP amplitude or theta power between ADHD, BD and control 
groups in this sample of adult women. However, grand averages showed ERP amplitude which 
was indicative of potential differences in P3a and P3b components, suggesting that group 
delineation may have been possible with increased power. The P3b component has been 
argued to be a marker of psychiatric psychopathology (Carlson et al., 1999, Ford, 1999, 
Jahshan et al., 2012, Jeon and Polich, 2003, Polich, 2007, Porjesz et al., 2005). However, there 
are several examples of P3 deficits not being replicated in studies of ADHD and BD (Andersson 
et al., 2008, Groom et al., 2008, Hermens et al., 2005c, Lazzaro et al., 1997, Lazzaro et al., 
2001). One view is that sample differences and ERP heterogeneity within these clinical samples 
could be masking potential effects and may pose challenges in searching for reliable 
biomarkers in ADHD and BD, which can both have a diverse manifestation of symptoms, even 
within the relatively well-defined more severe forms of each disorder. The pattern of null 
results for ERP amplitude measures reported in chapter six is not dissimilar to other studies 
which have been unable to detect previously reported differences in equivalent samples. This 
therefore highlights the need for research to move beyond current categorical models of 
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diagnostic classification for research samples, as this approach may be introducing 
heterogeneity via the inclusion of participants with different neurophysiological aetiology, 
which may be masking otherwise detectable neurophysiological differences (Insel et al., 2010, 
Morris and Cuthbert, 2012).  
 
 
Furthermore, the absence of differences in attentional (P3a & P3b) components in chapter six 
in comparison with the suggestive differences in conflict monitoring (N2) components in 
chapter five in the same sample may indicate that unconscious cognitive processes could be 
more consistent and/or be less heterogeneous and offer better candidates for further study as 
biomarkers than attentionally dependent components. If lapses in attention were present this 
could affect indices of conscious cognitive processing, such as the P3 (Kam et al., 2012, 
O'Connell et al., 2009b), further increasing variability in trial-by-trial ERP response and 
reducing power to detect group differences in smaller samples. Although this variability itself, 
may be key to understanding the underlying cognitive impairments in BD and ADHD, the use of 
specific methods developed to investigate within-participant variability may more easily 
elucidate differences between clinical groups and controls than standard processing 
techniques, which rely on averaging of all trials during a recording session, including those 
trials where a reduced awareness may have been present. 
 
 
7.5 Methodological factors 
 
This thesis commenced with two studies seeking to examine the reliability of cognitive- 
electrophysiological markers for ADHD (chapters two and three): the first examining the 
consistency of EEG resting state band power differences at two separate time points, and the 
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other examining performance monitoring deficits in an ERP paradigm. In the resting state 
study, the primary findings indicated that case-control differences changed with recording 
context (i.e. whether a resting state recording was conducted at the beginning or end of an 
EEG recording session). This study also questioned the previous broad support for theta/beta 
ratio (T:B) as a potential EEG biomarker for ADHD, along with other recent studies (Arns et al., 
2013, Liechti et al., 2013). This investigation went on to compare several different 
methodological approaches to determine if the adoption of alternative analysis approaches, 
such as the uses of midline electrodes vs regions consisting of grouped electrodes, could 
account for discrepancies between studies prior to 1998 and more recent investigations. 
Comparisons of analyses using data from electrode regions vs singular midline electrodes 
showed that the use of electrode regions was apparently more sensitive to beta activity while 
being less sensitive to theta and alpha band power, while the opposite was true for 
approaches using midline electrodes only. Although this study was unable to replicate T:B 
differences for ADHD using either method, similar to Liechti et al. (2013), this demonstrated 
that methodological differences could contribute to the variability of reported findings within 
the literature. In addition, as ADHD is commonly associated with lower IQ (Kuntsi et al., 2004), 
but is inconsistently controlled for in EEG analyses, this study went onto compare results with 
and without statically controlling for differences in IQ. The conclusions of this investigation 
were that IQ differences did have a small, but significant, effect on reported results, and may 
also contribute to some variability of published studies to date. However, the issue of co-
varying IQ has also been regarded as problematic in psychiatric research where non-random 
group allocation is the norm, as in removing the covariate one also removes the proportion of 
the independent variable related to the covariate in question (Miller and Chapman, 2001). If 
the covariate and the independent variable are related, as may be the case with ADHD 
symptoms and IQ, subsequent statistical analysis only captures the aspect of ADHD symptoms 
score unrelated to IQ, and therefore may not fully capture the relationship between the 
independent and dependent variable fully (Dennis et al., 2009). In the study presented in 
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chapter two, this statistical effect may account for the reduction in significance of delta and 
theta group comparisons in secondary analysis which controlled for IQ. Ideally then, if 
controlling for IQ due to group differences, studies should also ensure that results are 
presented without such correction, so that the potential effect of removing the proportion of 
the independent variable which covaries with the covariate can be quantified. 
The second study (chapter three), which reported impaired conflict monitoring and conscious 
error processing in ADHD, showed that although the ADHD group did not have reduced 
maximal N2 amplitude overall, a different topographic distribution of amplitude was present. 
Had this study elected to adopt an approach only comparing the groups at the electrode 
where N2 amplitude was greatest (Fz), it would not have reported significant site*group 
differences, providing another example to illustrate that methodological considerations can be 
critical in the accurate representation of neurophysiological differences between clinical 
groups and controls. Furthermore, despite this being the largest study of this kind to date, it 
did not find evidence of impaired unconscious error processing in ADHD. This was contrary to a 
number of other studies included in a meta-analysis which had identified this component 
(ERN) as being impaired in ADHD (Geburek et al., 2013). However, generally studies 
investigating performance monitoring using flanker tasks have been methodologically 
heterogeneous, which may partially explain inconsistencies in the literature thus far (Shiels 
and Hawk, 2010). Chapter three in particular adopted an area amplitude measure as this 
method is more robust to the variability in peak amplitude, suggesting that the results 
presented in this thesis may represent a more accurate reflection of unconscious error 
processing in ADHD. However, the inconsistency of approaches, and subsequently differences 
in results, illustrates how variability in methodological considerations may be contributing to 
difficulties in replicating potential finding and adding to the challenges in our understanding of 





Research into neurophysiological deficits in psychiatric disorders is a small but emerging field, 
with consensus around the best methodological approach to adopt in the collection and 
analysis of EEG and ERP data taking time to develop. However, it is clear that methodological 
factors can have a significant influence on results and many of the effects themselves remain 
poorly understood and require further study. It is therefore important that such variables are 
given fuller consideration in future studies, and multiple approaches tested, if this field is to 
produce evidence of robust, reliable biomarkers which have clinical utility.  
 
 
7.6 Clinical implications 
 
This thesis presents evidence for some potential markers of ADHD and BD; however, the 
overall picture is of potentially variable biomarkers, sensitive to sample characteristics and 
methodological factors. For example, the two studies focusing just on ADHD showed potential 
EEG biomarkers for ADHD which vary by methodology and context (Kitsune et al., 2014, 
chapter two), and age-dependent differences observed in ERP correlates of conflict monitoring 
in the Flanker task (chapter three). Both of these research areas can offer further contributions 
to the understanding of neurophysiological deficits in ADHD, although methodological and 
contextual variability will firstly need to be better understood. Given the currently poor 
conceptualisation of moderating factors and the potential for inconsistencies of findings, such 
indices would not currently seem suited to clinical use for diagnostic differentiation with other 
disorders without further study. 
It may also be that EEG resting state paradigms inherently may not provide appropriately 
controlled conditions with which to reliably measure levels of cognitive activation, as there is 
little means of controlling or identify the cognitive processes occurring during resting state 
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conditions. If participants are engaged in a variety of uncontrolled mental activities, then there 
is likely to be a greater range of spectral power fluctuations and therefore reduced power for 
case-control differentiations. ERP measures or EEG collected under controlled conditions may 
therefore then be the preferred candidates for providing more consistent outcomes which 
would be essential in clinical environments, as task-based paradigms offer a higher degree of 
control over cognitive processes than resting state conditions. However, the ERP studies 
presented in this work show that there are many factors still to be understood, in particular 
developmental changes in ERP amplitude across lifespan, and how heterogeneity within the 
clinical samples studied contributes to the variability in reported findings to date. This suggests 
that the next steps in identifying ADHD and BD biomarkers will need to adopt consistent 
methodologies, more homogenous sample demographics and more subtle experimental 
manipulations in an attempt to control for the many factors which may be influencing findings 
and to confirm if there are particular biomarkers which can be consistently elicited under 
certain conditions. Indeed, on the basis of chapters two, three, five and six, it might be 
concluded that ERP measures currently appeared better suited to this, showing clearer case-
control differences, presumably as task paradigms offer a higher degree of control over 
cognitive processes than resting state conditions.  
 
 
Methodological factors such as electrode selection, and whether or not to account for other 
variables such as IQ, can also influence findings, but there is variability in the methodologies 
adopted in ERP analyses. It is therefore necessary to agree standard methodological 
approaches, such as how to deal with covariates, before these methods are recognised to have 
a viable clinical utility. Furthermore, currently analysis techniques require the use of averaging 
data from several participants in order to extract meaningful data from the background noise 
of EEG/ERP recording, which means that many research approaches are unsuited to providing 
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the individual-level data which would be required at a clinical level for diagnostic use. It will 
also be important to build up adequate data on the consistency and profile of ERP components 
in large control populations across lifespan to act as age-specific norms in order to provide 
reliable comparison samples for clinical research and assessments. Such clinical use may 
therefore not be possible until the use of more advanced methodological approaches, such as 
Independent Component Analysis (ICA) decomposition becomes widespread. This approach 
can in some cases provide improved signal-to-noise ratio to examine data from single 
participants compared to simple averaging approaches. Once data becomes available from 
several large-scale studies using these methods, it may be possible to demonstrate the 




In chapter three, this thesis examined the ability of some standard clinical measures to 
delineate ADHD from euthymic BD. Although only an initial comparison in a small sample of 
adult women, it demonstrated that ADHD measures, which combine both a detailed disorder-
specific description of ADHD symptoms with a temporal component, was able to discriminate 
between participants with ADHD or BD, unlike BD or emotional lability measures. Although 
these results require replication in larger, more representative clinical samples, they indicate 
that while a neurophysiological understanding of these disorders is still immature, ruling out 
ADHD with well-administered ADHD-specific clinical measures combined with good knowledge 
of the distinctions and commonalities between the disorders may currently be the best 
available method of delineating ADHD from BD in clinical contexts. 
 




7.7.1 Clinically relevant samples 
 
From a clinical perspective chapter four evaluated symptom overlap between ADHD and 
euthymic BD. This study had defined inclusion criteria for the more severe forms of ADHD and 
BD, in an attempt to recruit a more homogeneous sample. However, comparisons which 
include additional samples closer to clinical realities would further enhance the usefulness of 
this research, as determining the potential for misdiagnosis between ADHD and BD under a 
broader range of conditions could be informative from a clinical perspective. For instance, it 
might be expected that delineation may be easier during manic episodes where BD symptoms 
are greatly pronounced, while in contrast differentiation may be more challenging in 
comparisons with Bipolar Disorder II and cyclothymia where reduced symptom severity is likely 
to make clinical identification more difficult; yet this remains to be confirmed empirically. In 
addition, due to ethical constraints, some of the BD group assessed in this body of work, as 
with most previous similar studies, were being treated with mood stabilisers and/or 
antipsychotic medications during testing. As the effects of medications on the outcome indices 
used here is poorly understood, particularly in relation to cognitive-electrophysiological 
measures, research on medication naive or non-adherent groups of BD participants would be 
valuable to qualifying possible effects on reported findings.  
 
 
7.7.2 Understanding variability in results 
 
The thesis put forward some cognitive-electrophysiological candidate biomarkers for ADHD 
and BD for future study, where replications should now be sought in additional independent 
samples. Evidence indicated that conflict monitoring correlates showed age-specific 
differences, which could relate to atypical cortical development in ADHD, and that EEG indices 
were susceptible to contextual differences, which may be due to short term fluctuations in 
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arousal or motivation during long experimental sessions. In light of this evidence of factors 
which can contribute to short and long-term variability in case-control differences, it is 
important to try to understand if these factors are contributing to inconsistencies in reported 
results within the literature. Firstly, studies should attempt to account for the effect of 
contextual factors on results, such as the influence of proceeding paradigms or experimental 
procedures, which may alter arousal over time. This could be tested in greater detail by 
conducting studies where EEG resting state recordings are carried out at several points 
throughout a recording session, to explore how cortical activation, and potentially case-control 
differences, change throughout experimental durations. Rest-to-task or task-to-task transition 
experiments may also prove informative. Secondly, data on the change of cognitive deficits 
and electrophysiological response across lifespan is needed particularly for developmental 
disorders such as ADHD, to support interpretations of cortical maturational abnormalities and 
age-related decline in these samples, which may be contributing to variability in reported case-
control differences. Two different approaches would be required for this. Firstly, existing 
studies, which have conducted age comparisons, have typically adopted the use of broad age 
groups (e.g. 7-18, 18+), which may not fully capture the rapidly changing processes of cortical 
maturation during adolescence. With larger samples there is the possibility of dividing groups 
into several smaller age bands or using continuum approaches, which may be better placed to 
investigate altered cortical maturation in ADHD samples and map out temporal changes with 
finer resolution. Alternatively, a superior but more challenging approach would involve 
longitudinal studies which repeatedly test the same participants throughout childhood and 
adolescence to examine changes within individuals. Secondly, there is also limited data 
available in cognitive-electrophysiological changes with age in older populations, particularly 
among those with ADHD or BD diagnoses. There is evidence showing that cognitive-
electrophysiological response to stimuli may decrease with age in controls (Falkenstein et al., 
2001, Herrmann et al., 2010), but it is not known if those with psychiatric disorders show 
similar patterns of decline throughout lifespan, and whether these factors alter observable 
 195 
 
case-control differences, which may make the identification of deficits related to psychiatric 
disorders harder to distinguish in older age groups. Such studies would also require broad 
cross-sectional samples of different ages, or preferably take the form of longitudinal 
investigations, which may more conclusively quantify changes in cognitive-electrophysiological 
response across lifespan. 
 
 
7.7.3 Advanced analysis approaches 
 
Previous research, including studies presented here, contribute to suggestions that ADHD may 
be a disorder characterised by high variability in performance measures and cognitive-
electrophysiological responses (Castellanos et al., 2005, Castellanos and Tannock, 2002, 
Lazzaro et al., 1997, Sonuga-Barke and Castellanos, 2007, Vaurio et al., 2009). The majority of 
common analysis approaches adopted in EEG and ERP studies, including those in this thesis, 
rely on several stages of averaging to remove noise and to extract meaningful waveforms from 
the data. However, these techniques also sacrifice trial-by-trial variations within each 
individual’s data, meaning that the underlying variability in cognitive-electrophysiological 
response in ADHD may not be fully represented. In the absence of highly reliable biomarkers 
for ADHD, new standardised approaches are now required which have the power to directly 
examine the degree of variability in EEG or ERP response on a trial-by-trial basis in individual 
participants, while retaining the power to overcome the low signal to noise ratio in cognitive-
electrophysiological data. Approaches such as time-frequency analysis or individual-level 
Independent Component Analysis (ICA) have potential in this regard as they can avoid group-
level averaging, but are yet to reach the wide-spread usage required to produce the quantity 
of data necessary to conclude whether these methods produce a greater consistency of results 
than traditional approaches. However, the use of these newer techniques may be particularly 
important in order to study temporary lapses in attention thought to underlie the increased 
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RTV generally observed in ADHD, and theta power fluctuations which may also be linked to 
attentional deficits, as these indicators are difficult to examine in detail using conventional 
averaging approaches (McLoughlin et al., 2014a, McLoughlin et al., 2014b). 
 
 
7.7.4 Reducing heterogeneity 
 
In all studies reported in this thesis, including those with large samples (chapters two and 
three), the effect sizes for cognitive-electrophysiological group comparisons were generally 
small, suggesting that overall there was much within-group heterogeneity which could be 
limiting the studies’ power to detect differences. Conceptually, the adoption of stringent 
inclusion criteria is undertaken to reduce sample heterogeneity by including only those 
participants meeting certain diagnostic criteria. However, even within these diagnoses, 
substantial heterogeneity may still be present due to different expressions of symptoms within 
the disorder between individuals, different aetiologies or other factors such as undiagnosed 
comorbidities, or the subclinical expressions of population traits which interact with the 
symptoms of the primary diagnosis. This issue is not limited to the investigations of this thesis, 
but is demonstrated by the lack of consistency in ADHD and BD neurophysiological research 
generally, and more broadly that of neurobiological research into psychiatric disorders as a 
whole, as evidenced the difficulties encountered in identifying generic variants associated with 
psychiatric illness in large scale Genome-Wide Association studies (GWAs). Such matters have 
led to proposals by NIHR of the Research Domain Criteria (RDoC) (National Institute of Mental 
Health, 2014), which advance that researchers now need to move beyond categorical 
definitions of psychiatric disorders in order to directly study common underlying impairments 
in neurocognitive systems across diagnostic boundaries. This approach aims to find new ways 
of grouping or separating clusters of symptoms based on dimensional deviations from typical 
functioning, and conceptualises existing diagnostic categories as the combined profile of 
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several specific cognitive or emotional impairments. It has been suggested that this data-
driven neurobiological framework is necessary to tackle the heterogeneity and comorbidity 
observed in current clinical diagnostic categories, which are thought to be limiting the ability of 
neurophysiological and genetic studies to identify robust biomarkers associated with current 
disorder concepts (Insel et al., 2010). As the studies conducted as parts of this thesis show, 
larger samples which are restricted to only severe forms of these disorders, do not reduced 
heterogeneity enough to move our neurobiological understand of these disorders to the next 
level. This highlights the challenges associated with identifying disorder-specific markers on 
account of variability in case-control differences. Future research may be able to expedite 
progress by adopting a flexible dimensional model, which is likely to better represent the 
complex interplay of cognitive and neurological systems which underlie symptom patterns in 
psychiatric illness. The design of such studies might include samples of individuals with 
common symptoms such as attentional deficits, without having stringently defined diagnostic 
inclusion categories, and in doing so may then clarify the aetiologies of specific deficits at a 
level below that of clinical diagnosis. This approach may also better conceptualise 
comorbidities and co-occurring symptoms from the perspective of a collection of related 
deficits which may or may not have common shared aetiologies. Such approaches would also 
include a greater range of participants, such as those with less severe forms of disorders such 
as BD-II, and those with comorbidities which are often excluded from current research despite 
evidence that these are extremely common in psychiatric populations. Such samples would 
also be more representative of populations likely to present to mental health services, and 
therefore findings could offer further advantages of being more generalizable to typical clinical 
populations. Yet, it is also likely that these samples will need to be larger than those currently 
employed in neurophysiological studies, in order to have the power to identify subgroups 
within samples, and to make use of genetically sensitive designs. However, the low per-
participant data collection costs and increasing sophisticated automatic analysis techniques 
mean that cognitive-electrophysiological approaches are well suited to this role, and hence the 
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next stage of research into biological markers for mental illness may take the form of very 
large-scale neurophysiological investigations able to resolve the aetiologies of symptoms in 






7.8.1 Multiple testing corrections 
 
The exploratory nature of the cognitive-electrophysiological investigations in this study meant 
that standard multiple testing corrections were not applied to avoid an increased type-II error 
rate, which may have prevented studies from identifying candidate biomarkers for future 
investigation. In light of the limited current knowledge of ADHD and BD neurocognitive 
processes, this was an undesirable outcome, so emphasis was placed on instead interpreting 
both effect sizes as well as significance levels. However, in light of the exploratory nature of 
this research, it is imperative that future replications are conducted before firm conclusions 
are to be drawn. In the investigation of symptom overlap (chapter four), the outcome 
measures were well tested clinical scales with norming data available. In this case, given the 
reliability of the clinical measures and the high number of individual tests employed, a more 
conservative approach was favourable and appropriate multiple testing corrections were 





7.8.2 Medication effects 
 
A common challenge associated with psychiatric research and particularly cross-disorder 
investigations is accounting for potential medication effects within research data. In the 
samples employed here the ADHD group abstained from taking stimulant medication 48 hours 
prior to testing. However, it was not possible to control for the effects of previous long-term 
medication use in these studies. In the adult FEBA sample both the BD group and a few of the 
ADHD participants were taking non-stimulant medications, continued to take their prescribed 
treatments during testing, as the potential risk of adverse effects from stopping treatment 
would have been unethical. The effect of non-stimulant medications on EEG and ERP measures 
is these disorders is still poorly understood, with an inconsistent literature with positive and 
negative findings, suggesting paradigm specific and disorder-specific effects (Anderer et al., 
2002a, Galletly et al., 2005, Jahshan et al., 2012, Karaaslan et al., 2003, Smith et al., 2006, 
Swann et al., 2013, Tumay et al., 2013, Umbricht et al., 1998). This means it is unclear to what 
degree medications may have affected results in the investigations using the adult sample in 
this thesis. Both chapters five and six undertook additional within-group comparisons of those 
taking medications against those who were not, in an attempt to quantify these differences; 
however, due to the small sample size in these pilot investigations, it was not possible to 
accurately resolve the effects on the data. Further work is therefore needed to directly 
examine the effect of medications in the ERP measures adopted here. 
 
 
7.8.3 Sample size, age and gender effects 
 
For the adult studies (chapters four, five and six) this sample represented a novel pilot sample, 
and was therefore of limited size, which may have reduced the samples ability to resolve those 
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Chapters three and five both investigated N2 case-control differences in ADHD in two separate 
samples. Potential differences emerged in the large sample of adolescents which were 
predominantly male, but not in the smaller, older-adult female sample. It is likely that changes 
in N2 amplitude with age underlie these differences between studies, as chapter three also 
demonstrated different patterns of atypical N2 amplitude between older and younger 
subgroups within the larger adolescent sample. However, these studies did not directly test 
age-related differences between these two experimental samples, so this factor remains to be 
tested directly. In addition, possible gender differences were not tested directly and remain to 




7.8.4 Comorbidities and subclinical symptoms 
 
In this thesis experimental samples were selected based on existing ADHD or BD diagnosis, 
with any with a diagnosed comorbidity between ADHD and BD being excluded during 
recruitment. However, given the shared symptoms between ADHD and BD, and the 
demonstrated complexities in diagnostic differentiation, it is possible that the adult FEBA 
sample may have contained some participants with undiagnosed ADHD in the BD sample and 
vice versa. Moreover, as both disorders are considered the extreme end of normally 
distributed behavioural traits in the general population, both groups would be expected to 
show some subclinical expressions of the other disorder. What remains unclear is whether 
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associated symptoms of these disorders, such as mood instability and depression in ADHD or 
hyperactivity in BD relate to the primary diagnosis or can be accounted for by co-occurring 
symptoms which do not have a shared aetiology. This research adopted the use of current 
diagnostic frameworks in sample selection to ensure research was relevant to current clinical 
conceptualisations; however, this meant that it was not able to generalise to broader clinical 
or non-clinical samples or fully explore the relationship between these disorders and their 
various comorbidities. Such work will be required to understand the nature of the relationship 
between the overlapping continuums of ADHD and BD symptoms fully. 
 
 
7.9 Overall conclusions 
 
In summary, this thesis aimed to understand and compare ADHD and BD based on cognitive-
neurophysiological abnormalities and clinical symptoms. Presented herein was a comparison 
of the symptoms of inattention, hyperactivity, mania, depression and emotional lability (EL) in 
ADHD and BD using typical clinical diagnostic measures. Symptoms of depression, mania and 
EL were not found to reliability distinguish ADHD from euthymic BD, although conversely 
ADHD measures had good discrimination potential, on account of the inherent temporal 
component in assessment items, and may currently be the best available method of 
delineating ADHD from BD in clinical contexts. Cognitive-electrophysiological data also 
identified some possible candidate biomarkers for both ADHD and BD disorders, including two 
disorder-specific cognitive-electrophysiological markers which dissociated ADHD from BD. 
These studies also demonstrate that ADHD-control differences are sensitive to changes in 
activation over longer recording durations and also vary by age. However, the relatively small 
effect sizes observed in many cognitive-electrophysiological comparisons suggests that the 
broad disorder classifications and heterogeneity within these classifications will make resolving 
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the fine details of shared or specific cognitive impairments in ADHD and BD challenging. 
Moreover, these data also show that methodological and sample differences may be 
contributing to variability within the literature to date, and need to be further understood. 
Further comparison studies are needed, including ones which are able to explore differences 
within groups as much as between groups to understand shared vs characteristic deficits in 
different expressions of each disorder, and untangle confusion arising from symptom overlap 
and comorbidities. It is in this way that we will gradually move towards understanding the 
potentially varied neurobiological underpinnings of ADHD and BD, and perhaps in future, 
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S4.  Comparison of adolescents aged 12-18 and adults 18+ within ADHD and control samples. 
 
   ADHD  test statistic 
age-comparison 
Control test statistic 
age-comparison 
 Age  12-18 18+   12-18 18+   
 n  38 38   53 32   
  Region µV (SD) µV (SD) F p µV (SD) µV (SD) F p 
Delta Time 1 Frontal 4.5 (2.6) 2.15 (0.92) 7.939 0.006* 2.8 (1.41) 1.91 (1.06) 10.129 0.002* 
  Central 4.12 (2.69) 1.87 (1.02) 
  
2.57 (1.42) 1.62 (0.75) 
  
  Parietal 5.96 (4.06) 2.79 (1.55) 
  
3.52 (1.93) 2.24 (1.26) 
  
 Time 2 Frontal 4.44 (2.55) 3.04 (1.46) 
  
3.69 (1.78) 2.79 (1.23) 
  
  Central 3.67 (2.76) 2.06 (1.05) 
  
3.05 (1.81) 1.88 (0.88) 
  
  Parietal 5.46 (4.38) 3.03 (1.27) 
  
4.34 (2.6) 2.64 (1.06) 
  
Theta Time 1 Frontal 0.91 (0.56) 0.53 (0.3) 8.715 0.004* 0.65 (0.3) 0.41 (0.2) 17.515 0.001* 
  Central 0.96 (0.71) 0.52 (0.35) 
  
0.67 (0.34) 0.4 (0.18) 
  
  Parietal 1.25 (1.02) 0.7 (0.45) 
  
0.81 (0.42) 0.53 (0.33) 
  
 Time 2 Frontal 0.87 (0.55) 0.64 (0.38) 
  
0.74 (0.29) 0.54 (0.26) 
  
  Central 0.88 (0.75) 0.54 (0.37) 
  
0.72 (0.39) 0.46 (0.24) 
  
  Parietal 1.1 (0.97) 0.75 (0.49) 
  




   
        
Alpha Time 1 Frontal 0.81 (0.57) 0.57 (0.5) 3.738 0.057† 0.63 (0.4) 0.5 (0.62) 4.589 0.035* 
  Central 1.07 (0.9) 0.73 (0.8) 
  
0.82 (0.61) 0.54 (0.42) 
  
  Parietal 1.59 (1.24) 1.25 (1.49) 
  
1.36 (1.34) 1 (1.39) 
  
 Time 2 Frontal 0.8 (0.45) 0.73 (0.67) 
  
0.72 (0.46) 0.58 (0.42) 
  
  Central 0.99 (0.83) 0.86 (0.96) 
  
0.97 (0.87) 0.64 (0.59) 
  
  Parietal 1.41 (1.15) 1.48 (1.65) 
  
1.64 (1.56) 1.22 (1.48) 
  
Beta Time 1 Frontal 0.2 (0.13) 0.14 (0.06) 6.514 0.012* 0.16 (0.11) 0.13 (0.06) 6.389 0.013* 
  Central 0.21 (0.13) 0.13 (0.06) 
  
0.17 (0.11) 0.12 (0.06) 
  
  Parietal 0.25 (0.14) 0.17 (0.07) 
  
0.21 (0.12) 0.15 (0.09) 
  
 Time 2 Frontal 0.23 (0.15) 0.17 (0.07) 
  
0.18 (0.1) 0.13 (0.05) 
  
  Central 0.22 (0.15) 0.17 (0.11) 
  
0.18 (0.12) 0.13 (0.06) 
  
  Parietal 0.26 (0.15) 0.21 (0.14) 
  
0.22 (0.13) 0.17 (0.08) 
  
T:B Time 1 Frontal 5.64 (2.83) 4.43 (1.99) 2.456 0.121 5.34 (2.69) 4.2 (2.07) 4.770 0.032* 
  Central 5.75 (2.88) 4.45 (1.95) 
  
5.26 (2.65) 4.24 (1.86) 
  
  Parietal 5.7 (3.03) 4.36 (1.98) 
  
4.95 (2.38) 4.02 (1.88) 
  
 Time 2 Frontal 4.97 (2.62) 4.42 (1.57) 
  
5.37 (2.51) 4.66 (1.69) 
  
  Central 5.54 (3.39) 4.37 (1.76) 
  
5.48 (2.53) 4.59 (1.76) 
  
  Parietal 5.23 (3.23) 4.26 (1.68) 
  
5.34 (2.64) 4.2 (1.82) 
  




S5. Mean amplitude in µV and standard deviation (SD), prior to transformations, and with age and gender controlled for, in ADHD and control groups across 
frequency bands and theta/beta ratio at Fz, Cz and Pz 
   Delta Theta Alpha Beta T:B 
 Electrode     µV (SD) µV (SD) µV (SD) µV (SD) µV (SD) 
        
Fz T1 Control 3.23 (2.22) 0.64 (0.36) 0.64 (0.53) 0.18 (0.17) 0.18 (0.17) 
 
T1 ADHD 4.29 (3.38) 0.85 (0.62) 0.8 (0.66) 0.22 (0.18) 0.22 (0.18) 
 
T2 Control 4.11 (3.28) 0.74 (0.4) 0.71 (0.51) 0.16 (0.12) 0.16 (0.12) 
 
T2 ADHD 4.52 (3.62) 0.85 (0.61) 0.85 (0.72) 0.21 (0.18) 0.21 (0.18) 
                
        
Cz T1 Control 2.07 (1.41) 0.56 (0.38) 0.62 (0.47) 0.19 (0.13) 0.19 (0.13) 
 
T1 ADHD 3 (3.59) 0.74 (0.64) 0.77 (0.75) 0.19 (0.17) 0.19 (0.17) 
 
T2 Control 2.59 (1.44) 0.66 (0.37) 0.71 (0.68) 0.19 (0.17) 0.19 (0.17) 
 
T2 ADHD 2.72 (1.92) 0.7 (0.55) 0.78 (0.87) 0.23 (0.21) 0.23 (0.21) 
                
  
       
Pz T1 Control 2.84 (1.85) 0.7 (0.5) 1.26 (1.49) 0.18 (0.13) 0.18 (0.13) 
 
T1 ADHD 4.3 (3.72) 0.96 (0.91) 1.43 (1.49) 0.2 (0.14) 0.2 (0.14) 
 
T2 Control 3.58 (3.42) 0.81 (0.76) 1.7 (2.39) 0.18 (0.14) 0.18 (0.14) 
 
T2 ADHD 4.03 (3.37) 0.87 (0.85) 1.38 (1.47) 0.21 (0.17) 0.21 (0.17) 
 
              
 




S6. Significance values and effect sizes for ANCOVA factors and interactions, controlling for age, gender, using data from mid-line electrode (Fz, Cz, Pz).  
 Delta Theta Alpha Beta  T:B 
Time 
F 0.00 1.60 0.90 0.01 0.14 
p 0.984 0.207 0.345 0.905 0.905 
η2 0.0001 0.0094 0.0054 0.0001 0.0001 
Region  
F 2.08 4.16 4.46 0.15 0.15 
p 0.127 0.016* 0.012* 0.860 0.860 
η2 0.0009 0.0248 0.0271 0.0009 0.0009 
Group 
F 6.92 2.97 1.14 4.19 2.62 
p 0.009* 0.870 0.288 0.107 0.107 
η2 0.0341 0.0150 0.0066 0.0141 0.0141 
Group*Region 
F 1.63 0.82 0.97 2.14 2.14 
p 0.198 0.440 0.380 0.120 0.120 
η2 0.0133 0.0049 0.0059 0.0133 0.0133 
Group*Time 
F 3.37 4.70 1.54 0.32 0.32 
p 0.068† 0.032* 0.217 0.570 0.570 
η2 0.0020 0.0274 0.0092 0.0020 0.0021 
Activity bands defined as: delta 0.5-3.4Hz, theta 3.5-7.5Hz, alpha 7.5-12Hz, beta 12-30Hz. * denotes significant at p<0.05.  † denotes trend level effect at p<0.08. 




S7. Significance values and effect sizes for ANCOVA factors and interactions, controlling for age, gender, and IQ, using data from mid-line electrode (Fz, Cz, Pz).  
 Delta Theta Alpha Beta  T:B 
Time 
F 0.64 0.26 0.48 0.06 0.63 
p 0.425 0.610 0.827 0.802 0.802 
η2 0.0039 0.0015 0.0003 0.0004 0.0004 
Region  
F 3.52 2.09 2.53 0.68 0.68 
p 0.031* 0.125 0.091 0.505 0.508 
η2 0.0215 0.0126 0.0156 0.0043 0.0043 
Group 
F 3.74 1.57 0.98 0.70 0.70 
p 0.055† 0.212 0.324 0.403 0.403 
η2 0.0191 0.0081 0.0057 0.0039 0.0039 
Group*Region 
F 0.37 0.10 0.55 0.53 0.53 
p 0.658 0.893 0.577 0.591 0.591 
η2 0.0023 0.0006 0.0034 0.0033 0.0033 
Group*Time 
F 5.03 5.09 2.21 0.05 0.05 
p 0.026* 0.025* 0.014* 0.824 0.824 
η2 0.0305 0.0299 0.0132 0.0003 0.0003 
Activity bands defined as: delta 0.5-3.4Hz, theta 3.5-7.5Hz, alpha 7.5-12Hz, beta 12-30Hz. * denotes significant at p<0.05.  † denotes trend level effect at p<0.08. 





S8. Significance values for ANCOVA factors and interactions, controlling for age and gender, using global field synchronisation scores and showing covariate 
interaction with the dependent variable. 
  Delta Theta Alpha Beta 
Group 
F 1.26 0.43 0.32 0.11 
p 0.263 0.512 0.575 0.738 
Age 
F 7.93 13.80 6.83 4.63 
p 0.005* 0.000* 0.010* 0.033* 
Gender 
F 6.63 6.28 0.01 0.37 
p 0.110 0.013* 0.936 0.543 
Condition 
F 0.01 3.21 0.27 0.04 
p 0.929 0.075† 0.607 0.849 
Condition*Age 
F 0.00 3.44 0.41 0.27 
p 0.964 0.066† 0.523 0.870 
Condition*Gender 
F 0.20 2.37 1.05 0.27 
p 0.653 0.126 0.308 0.606 
Condition*Group 
F 1.90 2.21 1.11 1.11 
p 0.170 0.139 0.295 0.294 
 





S9. Correlations of age with global field synchronisation. 
 
Delta T1 Theta T1 Alpha T1 Beta T1 Delta T2 Theta T2 Alpha T2 Beta T2 
Pearson r 0.21 0.34 0.2 0.14 0.17 0.15 0.15 0.12 
p 0.006* <0.0001* 0.009* 0.068† 0.029* 0.062† 0.052* 0.132 
 













S11. Mean N2 and P2 mean amplitude at FCz compared across those undergoing treatment with different classes of medications 
 
ADHD BD 






Mood stabiliser Yes 0 0 - - 14 70% 172.46 (259.23) 1.44 (2.19) 
 




 - -   0.49 0.33 
          
Anti-depressant Yes  3 17% -139.95 (119.71) -2.19 (2.05) 8 40% 91.79 (194.12) 1.05 (2.14) 
 




 0.93 1.42   0.34 0.12 
          
Anti-psychotic Yes  0 0 - - 8 40% 148.44 (271.03) 1.2 (2.73) 
 




 - -   0.06 0.01 
          
Stimulant Yes  13 72% 5.62 (190.92) -0.28 (1.18) 0 0% - - 
 




 0.56 0.43   - - 
 




Appendix 4. Supplementary materials for chapter 6 
S12. Mean (standard deviation) P3a and P3b amplitude and mean (standard deviation) fronto-central theta power (µV) in novel and target conditions for those 
currently taking different classes of medications 
  ADHD BD 
  n Target P3b Novel P3a Target theta Novel theta n Target P3b Novel P3a Target theta Novel theta 
            
Mood stab YES 19 - - - - 14 2.84 (1.98) 1.19 (2.16) 0.66 (0.46) 0.63 (0.29) 
 NO 0 - - - - 6 2.31 (0.98) 1.48 (2.04) 0.39 (0.57) 0.78 (0.9) 
            
Antidep YES  3 2.25 (2.44) 2.39 (3.3) 0.66 (0.56) 1.26 (1.08) 8 2.81 (1.92) 0.52 (2.15) 0.63 (0.59) 0.74 (0.3) 
 NO  16 2.48 (0.99) 1.53 (1.19) 0.68 (0.62) 0.78 (0.53) 12 2.59 (1.68) 1.79 (1.95) 0.55 (0.45) 0.63 (0.64) 
            
Antipsy YES  0 - - - - 8 2.38 (1.93) 0.91 (1.07) 0.52 (0.3) 0.56 (0.31) 
 NO 18 - - - - 12 2.88 (1.64) 1.52 (2.56) 0.62 (0.6) 0.75 (0.63) 
            
Stim YES  14 2.36 (1.16) 1.23 (1.29) 0.71 (0.64) 0.82 (0.54) 0 - - - - 
 NO 5 2.68 (1.5) 2.87 (1.84) 0.59 (0.49) 0.97 (0.9) 20 - - - - 
Abbreviations: Mood Stab: Mood stabiliser; Antidep: Anti-depressant medication; Antipsy: Anti-psychotic medication; Stim: Stimulant medication. ADHD 
participants were not taking stimulant medications at the time of testing. Novel P3a is the mean event related potential (ERP) activity between 200-500 ms at FCz 
in response to novel stimuli on trials where participants did not make a commission error. Target P3b is the mean ERP activity between 200-800 ms at Pz where 
participants correctly responded to the target stimuli with a reaction time of between 100 – 1000 ms. Target Theta and Novel Theta is the mean theta band power 






S13. ERP power in target (P3b) or novel (P3a) conditions by medication status and group for mood stabiliser, antidepressant, antipsychotic and stimulant 
medication classes.  
 

















Participants currently being treated with stimulants refrained from taking their medications 48 hours before testing, all other participants continued their normal 
treatment routine during testing. P3b as recorded at Pz, P3a as recorded at FCz. Theta activity in both target and novel conditions recorded at FCz. Theta power 
used in analysis: 3.5-7.5 Hz. Target condition includes only trials where participants correctly responded to the target stimuli with a reaction time of between 100 – 
1000 ms. The novel condition only includes trials where participants did not make commission errors.    
